
<html lang="en"     class="pb-page"  data-request-id="cbaddee1-0737-4e75-8f0b-87e9e7162343"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-16;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b00807;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK)" /></meta><meta name="dc.Creator" content="Tim F.  Ryder" /></meta><meta name="dc.Creator" content="Matthew F.  Calabrese" /></meta><meta name="dc.Creator" content="Gregory S.  Walker" /></meta><meta name="dc.Creator" content="Kimberly O.  Cameron" /></meta><meta name="dc.Creator" content="Allan R.  Reyes" /></meta><meta name="dc.Creator" content="Kris A.  Borzilleri" /></meta><meta name="dc.Creator" content="Jake  Delmore" /></meta><meta name="dc.Creator" content="Russell  Miller" /></meta><meta name="dc.Creator" content="Ravi G.  Kurumbail" /></meta><meta name="dc.Creator" content="Jessica  Ward" /></meta><meta name="dc.Creator" content="Daniel W.  Kung" /></meta><meta name="dc.Creator" content="Janice A.  Brown" /></meta><meta name="dc.Creator" content="David J.  Edmonds" /></meta><meta name="dc.Creator" content="Heather  Eng" /></meta><meta name="dc.Creator" content="Angela C.  Wolford" /></meta><meta name="dc.Creator" content="Amit S.  Kalgutkar" /></meta><meta name="dc.Description" content="Studies on indole-3-carboxylic acid derivatives as direct activators of human adenosine monophosphate-activated protein kinase (AMPK) α1β1γ1 isoform have culminated in the identification of PF-0640..." /></meta><meta name="Description" content="Studies on indole-3-carboxylic acid derivatives as direct activators of human adenosine monophosphate-activated protein kinase (AMPK) α1β1γ1 isoform have culminated in the identification of PF-0640..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 23, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00807" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00807" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00807" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00807" /></link>
        
    
    

<title>Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00807" /></meta><meta property="og:title" content="Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0013.jpeg" /></meta><meta property="og:description" content="Studies on indole-3-carboxylic acid derivatives as direct activators of human adenosine monophosphate-activated protein kinase (AMPK) α1β1γ1 isoform have culminated in the identification of PF-06409577 (1), PF-06885249 (2), and PF-06679142 (3) as potential clinical candidates. Compounds 1–3 are primarily cleared in animals and humans via glucuronidation. Herein, we describe the biosynthetic preparation, purification, and structural characterization of the glucuronide conjugates of 1–3. Spectral characterization of the purified glucuronides M1, M2, and M3 indicated that they were acyl glucuronide derivatives. In vitro pharmacological evaluation revealed that all three acyl glucuronides retained selective activation of β1-containing AMPK isoforms. Inhibition of de novo lipogenesis with representative parent carboxylic acids and their respective acyl glucuronide conjugates in human hepatocytes demonstrated their propensity to activate cellular AMPK. Cocrystallization of the AMPK α1β1γ1 isoform with 1–3 and M1–M3 provided molecular insights into the structural basis for AMPK activation by the glucuronide conjugates." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00807"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00807">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00807&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00807&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00807&amp;href=/doi/10.1021/acs.jmedchem.8b00807" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7273-7288</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00782" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00854" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1<i>H</i>-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Tim F. Ryder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tim F. Ryder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tim+F.++Ryder">Tim F. Ryder</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew F. Calabrese</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew F. Calabrese</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+F.++Calabrese">Matthew F. Calabrese</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory S. Walker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory S. Walker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+S.++Walker">Gregory S. Walker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kimberly O. Cameron</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kimberly O. Cameron</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly+O.++Cameron">Kimberly O. Cameron</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Allan R. Reyes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Allan R. Reyes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine Research Unit, Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Allan+R.++Reyes">Allan R. Reyes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kris A. Borzilleri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kris A. Borzilleri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kris+A.++Borzilleri">Kris A. Borzilleri</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jake Delmore</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jake Delmore</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine Research Unit, Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jake++Delmore">Jake Delmore</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Russell Miller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Russell Miller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine Research Unit, Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Russell++Miller">Russell Miller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ravi G. Kurumbail</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ravi G. Kurumbail</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ravi+G.++Kurumbail">Ravi G. Kurumbail</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jessica Ward</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessica Ward</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine Research Unit, Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Ward">Jessica Ward</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel W. Kung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel W. Kung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+W.++Kung">Daniel W. Kung</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5019-1939" title="Orcid link">http://orcid.org/0000-0002-5019-1939</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Janice A. Brown</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Janice A. Brown</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Janice+A.++Brown">Janice A. Brown</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David J. Edmonds</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Edmonds</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Edmonds">David J. Edmonds</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9234-8618" title="Orcid link">http://orcid.org/0000-0001-9234-8618</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heather Eng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heather Eng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Eng">Heather Eng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angela C. Wolford</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angela C. Wolford</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angela+C.++Wolford">Angela C. Wolford</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Amit S. Kalgutkar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amit S. Kalgutkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (617)551-3336. E-mail: <a href="/cdn-cgi/l/email-protection#88c9e5e1fca6e3e9e4effdfce3e9fac8f8eee1f2edfaa6ebe7e5"><span class="__cf_email__" data-cfemail="df9eb2b6abf1b4beb3b8aaabb4bead9fafb9b6a5baadf1bcb0b2">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amit+S.++Kalgutkar">Amit S. Kalgutkar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9701-756X" title="Orcid link">http://orcid.org/0000-0001-9701-756X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00807&amp;href=/doi/10.1021%2Facs.jmedchem.8b00807" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7273–7288</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 23, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 May 2018</li><li><span class="item_label"><b>Published</b> online</span>23 July 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 August 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00807</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7273%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTim%2BF.%2BRyder%252C%2BMatthew%2BF.%2BCalabrese%252C%2BGregory%2BS.%2BWalker%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D16%26contentID%3Dacs.jmedchem.8b00807%26title%3DAcyl%2BGlucuronide%2BMetabolites%2Bof%2B6-Chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2BAcid%2B%2528PF-06409577%2529%2Band%2BRelated%2BIndole-3-carboxylic%2BAcid%2BDerivatives%2Bare%2BDirect%2BActivators%2Bof%2BAdenosine%2BMonophosphate-Activated%2BProtein%2BKinase%2B%2528AMPK%2529%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7288%26publicationDate%3DAugust%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00807"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1699</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00807" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;F. Ryder&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;F. Calabrese&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;S. Walker&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;O. Cameron&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;R. Reyes&quot;},{&quot;first_name&quot;:&quot;Kris&quot;,&quot;last_name&quot;:&quot;A. Borzilleri&quot;},{&quot;first_name&quot;:&quot;Jake&quot;,&quot;last_name&quot;:&quot;Delmore&quot;},{&quot;first_name&quot;:&quot;Russell&quot;,&quot;last_name&quot;:&quot;Miller&quot;},{&quot;first_name&quot;:&quot;Ravi&quot;,&quot;last_name&quot;:&quot;G. Kurumbail&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Ward&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;W. Kung&quot;},{&quot;first_name&quot;:&quot;Janice&quot;,&quot;last_name&quot;:&quot;A. Brown&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Edmonds&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Eng&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;C. Wolford&quot;},{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;S. Kalgutkar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;7273-7288&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00807&quot;},&quot;abstract&quot;:&quot;Studies on indole-3-carboxylic acid derivatives as direct activators of human adenosine monophosphate-activated protein kinase (AMPK) α1β1γ1 isoform have culminated in the identification of PF-06409577 (1), PF-06885249 (2), and PF-06679142 (3) as potential clinical candidates. Compounds 1–3 are primarily cleared in animals and humans via glucuronidation. Herein, we describe the biosynthetic preparation, purification, and structural characterization of the glucuronide conjugates of 1–3. Spectral characterization of the purified glucuronides M1, M2, and M3 indicated that they were acyl glucuronide derivatives. In vitro pharmacological evaluation revealed that all three acyl glucuronides retained selective activation of β1-containing AMPK isoforms. Inhibition of de novo lipogenesis with representative parent carboxylic acids and their respective acyl glucuronide conjugates in human hepatocytes demonstrated their propensity to activate cellular AMPK. Cocrystallization of the AMPK α1β1γ1 isoform with 1–3 and M1–M3&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00807&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00807" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00807&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00807" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00807&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00807" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00807&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00807&amp;href=/doi/10.1021/acs.jmedchem.8b00807" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00807" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00807" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00807%26sid%3Dliteratum%253Aachs%26pmid%3D30036059%26genre%3Darticle%26aulast%3DRyder%26date%3D2018%26atitle%3DAcyl%2BGlucuronide%2BMetabolites%2Bof%2B6-Chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2BAcid%2B%2528PF-06409577%2529%2Band%2BRelated%2BIndole-3-carboxylic%2BAcid%2BDerivatives%2Bare%2BDirect%2BActivators%2Bof%2BAdenosine%2BMonophosphate-Activated%2BProtein%2BKinase%2B%2528AMPK%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D16%26spage%3D7273%26epage%3D7288%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291645" title="Acyls">Acyls</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/jmcmar.2018.61.issue-16/20180823/jmcmar.2018.61.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Studies on indole-3-carboxylic acid derivatives as direct activators of human adenosine monophosphate-activated protein kinase (AMPK) α1β1γ1 isoform have culminated in the identification of PF-06409577 (<b>1</b>), PF-06885249 (<b>2</b>), and PF-06679142 (<b>3</b>) as potential clinical candidates. Compounds <b>1</b>–<b>3</b> are primarily cleared in animals and humans via glucuronidation. Herein, we describe the biosynthetic preparation, purification, and structural characterization of the glucuronide conjugates of <b>1</b>–<b>3</b>. Spectral characterization of the purified glucuronides M1, M2, and M3 indicated that they were acyl glucuronide derivatives. In vitro pharmacological evaluation revealed that all three acyl glucuronides retained selective activation of β1-containing AMPK isoforms. Inhibition of de novo lipogenesis with representative parent carboxylic acids and their respective acyl glucuronide conjugates in human hepatocytes demonstrated their propensity to activate cellular AMPK. Cocrystallization of the AMPK α1β1γ1 isoform with <b>1</b>–<b>3</b> and M1–M3 provided molecular insights into the structural basis for AMPK activation by the glucuronide conjugates.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Acyl glucuronidation represents a key component in the metabolic clearance of numerous carboxylic acid-containing drugs.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> The conjugation reaction is catalyzed by a family of microsomal uridine 5′-diphospho-glucuronosyltransferase (UGT) enzymes in the presence of a cofactor uridine 5′-diphosphoglucuronic acid (UDPGA), which also serves as the donor of the β-<span class="smallcaps smallerCapital">d</span>-glucuronic acid residue.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> Acyl glucuronides are considerably polar (relative to the parent carboxylic acid precursors) due to the hydrophilic nature of the glucuronic acid moiety and are entirely ionized at physiological pH (7.4), possessing p<i>K</i><sub>a</sub> values between 3 and 4.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Consequently, acyl glucuronide transport between the site of formation (e.g., small intestine and liver) and blood, bile, or other tissues is generally restricted due to their inability to passively diffuse across membrane barriers.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Hepatobiliary and renal transport proteins, therefore, play a crucial role in the elimination of acyl glucuronides via biliary or urinary excretion routes.<a onclick="showRef(event, 'ref1 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref9 ref10 ref11 ref12 ref13">(1,9−13)</a></div><div class="NLM_p">Because of these aforementioned physicochemical attributes, the process of acyl glucuronidation is generally considered to render the parent carboxylic acid into a pharmacologically inactive compound. Consistent with this notion, scenarios where glucuronide conjugates (including acyl glucuronides) retain primary pharmacology associated with their parent precursors are extremely rare, which is in contrast to the identification of active metabolites generated in the course of oxidative metabolism by cytochrome P450 (CYP) enzymes.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Frequently discussed cases of pharmacologically active glucuronides include morphine-6-<i>O</i>-glucuronide and the phenolic glucuronide conjugate of ezetimibe, which retain μ-opioid receptor agonism and inhibition of intestinal cholesterol absorption noted with the parent compounds morphine and ezetimibe, respectively.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14−17)</a> Likewise, the acyl glucuronide metabolites of the anticoagulant dabigatran,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> the immunosuppresant mycophenolic acid,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and the adenosine A1 receptor antagonist tonapofylline<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> appear to be the only known examples where acyl glucuronide conjugates have demonstrated primary pharmacology associated with the parent predecessor drugs.</div><div class="NLM_p">Recently, we disclosed structure–activity relationship studies on a series of indazole- and indole-3-carboxylic acid derivatives as direct activators of human adenosine monophosphate-activated protein kinase (AMPK), which culminated in the identification of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1<i>H</i>-indole-3-carboxylic acid (PF-06409577, <b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) as a single-digit nanomolar activator of the human α1β1γ1 AMPK isoform.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> AMPK is a heterotrimeric serine/threonine kinase that is made of a catalytic α subunit in complex with two regulatory subunits, β and γ. Seven subunits (α1, α2, β1, β2, γ1, γ2, and γ3) can theoretically assemble to generate as many as 12 possible AMPK complexes, which have differential tissue distribution and function.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Binding of AMP to the γ subunit of AMPK promotes phosphorylation of a key threonine (Thr172) on its activation loop by upstream kinases. This activating phosphorylation of Thr172 has been shown to increase the kinase activity of AMPK by 500–1000-fold.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Significant reduction in AMPK activity has been reported in the glomeruli of diabetic subjects as compared to healthy individuals,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and chronic treatment with AMPK activators such as metformin and 5-aminoimidazole-4-carboxamide ribonucleotide has been shown to restore AMPK activity and improve kidney function in rodent models of diabetic nephropathy.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Among the two known β subunits, β1 appears to be the predominant subunit in kidney as suggested by mRNA levels.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of indole-3-carboxylic acid-based α1β1γ1 AMPK activators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> has been advanced into first-in-human clinical trials as a clinical candidate for the treatment of diabetic nephropathy on the basis of its selectivity toward activation of the β1 AMPK isoform, favorable preclinical pharmacokinetics, pharmacodynamics, and safety. As outlined in our previous publication,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><b>1</b> is resistant to CYP-catalyzed oxidation(s) in NADPH-supplemented liver microsomes from preclinical species (e.g., rat, dog, and monkey) and human. Subsequent studies in UDPGA-supplemented liver microsomes and cryopreserved hepatocytes from preclinical species and human, however, revealed that <b>1</b> was metabolized to a single monoglucuronide metabolite by an UGT isoform(s). The present article describes our efforts in the biochemical synthesis, purification, and structural characterization of the glucuronide conjugate of <b>1</b> and related analogues PF-06885249 (<b>2</b>) and PF-06679142 (<b>3</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) from the indole-3-carboxylic acid series of AMPK activators, which have been recently described as potential back-up agents with extended half-lives arising from a net reduction in glucuronidation rates and renal excretion, relative to <b>1</b>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The biotransformation profile of <b>2</b> and <b>3</b> in human hepatocytes demonstrated that the predominant route of metabolism also involved glucuronidation (similar to the metabolic fate of <b>1</b> in human hepatocytes). Considering the similarities in log <i>D</i> values for <b>1</b>, <b>2</b>, and <b>3</b>, we reasoned that the increased resistance of <b>2</b> and <b>3</b> toward glucuronidation occurred from a reduction in metabolic rate caused by a diminished affinity for the UGT binding site due to unfavorable active site interactions of the 5-aryl (compound <b>2</b>) or 4-fluoro (compound <b>3</b>) substituents rather than a straightforward decrease in lipophilicity.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p last">During the course of this investigation, available analytical (mass and NMR spectra) data and chemical derivatization studies suggested that the glucuronide conjugates obtained upon incubation of the parent compounds <b>1</b>–<b>3</b> in UDPGA-supplemented human liver microsomes were acyl glucuronides. In vitro pharmacological evaluation revealed that the acyl glucuronide metabolites were selective activators of the human β1-containing AMPK isoforms, which was consistent with their ability to inhibit de novo lipogenesis in primary human hepatocytes. Solution of the cocrystal structures of the human α1β1γ1 AMPK isoform with the parent carboxylic acids and their corresponding acyl glucuronide metabolites provided insights into the structural basis for AMPK activation by these phase II conjugation products.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Metabolites of Indole-3-carboxylic Acid-Based AMPK Activators in Human Hepatocytes</h3><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> depicts a full-scan HPLC-UV chromatogram of reaction mixtures of compounds <b>1</b>, <b>2</b>, and <b>3</b> (10 μM each) in cryopreserved human hepatocytes incubated for 4 h at 37 °C. <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> indicates the retention time (<i>t</i><sub>R</sub>), exact mass (MH<sup>+</sup>), and key diagnostic fragment ions for compounds <b>1</b>–<b>3</b> and their metabolites. A single metabolite M1, M2, and M3 was observed when compounds <b>1</b>, <b>2</b>, or <b>3</b> were incubated in human hepatocytes, respectively. The exact protonated mass (MH<sup>+</sup>) of M1, M2, and M3 was 176 Da higher than the exact masses of the corresponding carboxylic acid precursors, implying that these metabolites were generated via monoglucuronidation of the parent compounds by a human UGT enzyme(s). No oxidative metabolites derived from CYP-mediated catalysis were observed in the human hepatocyte incubations with compounds <b>1</b>–<b>3</b>. Structural assignments for relevant fragment ions in the collision-induced dissociation spectra of compounds <b>1</b>–<b>3</b> and their corresponding metabolites M1–M3 are presented in the Supporting Information (SI) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figures S1–S3</a>). Theoretical exact masses of the proposed fragment ion structures in the mass spectra of <b>1</b>–<b>3</b>, and their metabolites were consistent with the observed accurate masses (<2 ppm difference) (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HPLC-UV chromatograms of reaction mixtures of <b>1</b> (A), <b>2</b> (B), and <b>3</b> (C) in cryopreserved human hepatocytes incubated at 37 °C for 4 h. The final concentration of <b>1</b>–<b>3</b> in the hepatocyte incubations was 10 μM. Earlier eluting peaks (<i>t</i><sub>R</sub> ∼ 3.0–4.0 min) were also observed in hepatocyte incubations at <i>t</i> = 0 h and are background noise.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Observed Mass Spectral Characteristics of Compounds <b>1</b>, <b>2</b>, and <b>3</b> and Their Corresponding Glucuronide Conjugates in Cyropreserved Human Hepatocytes</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0012.gif" alt="" id="gr12" /></img><div></div></div><div class="NLM_p">Indole-3-carboxylic acid <b>1</b> possesses two functional groups (tertiary alcohol and carboxylic acid) capable of undergoing glucuronidation. Hydroxylamine, which selectively transamidates acyl glucuronide metabolites and is inert toward reaction with glucuronide conjugates of alcohols,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> was used as a chemical derivatization reagent to establish the site of glucuronidation in <b>1</b>. Overnight treatment of the human hepatocyte extract of <b>1</b> with hydroxylamine at ambient temperature led to a near quantitative conversion of M1 (<i>t</i><sub>R</sub> = 7.10 min, MH<sup>+</sup> = 518.1212) to the corresponding hydroxamic acid derivative (<b>4</b>, <i>t</i><sub>R</sub> = 7.25 min, MH<sup>+</sup> = 357.1000) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), suggesting that M1 was an acyl glucuronide metabolite. The mass spectrum of <b>4</b> is provided in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S4</a> in the SI.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. HPLC-UV chromatograms (<i>t</i> = 0 h, A, and <i>t</i> = 24 h, B) of human hepatocytes extract of <b>1</b> treated with hydroxylamine at room temperature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of the available mass spectral and chemical derivatization studies, M1, M2, and M3 were assigned as the corresponding acyl glucuronide conjugates of compounds <b>1</b>, <b>2</b>, and <b>3</b>, respectively.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Biosynthesis of the Glucuronide Metabolites</h3><div class="NLM_p">Glucuronide conjugates M1, M2, and M3 were isolated and purified by semipreparative HPLC fraction collection of UDPGA-supplemented human liver microsomal incubations of <b>1</b>, <b>2</b>, and <b>3</b>, respectively, as outlined in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The <sup>1</sup>H NMR spectrum of purified M1 in DMSO-<i>d</i><sub>6</sub> showed all of the expected 1-phenylcyclobutanol and chloroindole resonances (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In addition, proton resonances (δ 5.61, 3.60, 3.37, 3.31, and 3.24 ppm), which are consistent with the addition of a β-<span class="smallcaps smallerCapital">d</span>-glucuronic acid residue to the carboxylic acid group in <b>1</b>, were also present in the <sup>1</sup>H NMR spectrum of M1. The position of attachment of the glucuronide residue was further established with heteronuclear multiple-bond correlation spectroscopy (HMBC) data, which provided a correlation from the anomeric <sup>1</sup>H resonance at δ 5.61 to a carbon with a chemical shift of δ 163.1 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Such a correlation is only possible if the M1 isolate is an acyl glucuronide. Correlation spectroscopy (COSY) and heteronuclear single-quantum correlation spectroscopy (HSQC) data also indicated these <sup>1</sup>H resonances are consistent with the addition of a glucuronic acid moiety to <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figures S5 and S6</a> in the SI).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <sup>1</sup>H NMR spectra of <b>1</b> and biochemically synthesized glucuronide M1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <sup>1</sup>H–<sup>13</sup>C HMBC spectra of biosynthesized M1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The <sup>1</sup>H NMR spectra of the M2 isolate depicted the anticipated aromatic and aliphatic resonances of <b>2</b> and also contained proton resonances consistent with the addition of a β-<span class="smallcaps smallerCapital">d</span>-glucuronic acid moiety to <b>2</b> (δ 5.59, 3.79 and 3.43–3.26 ppm) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). COSY and HSQC NMR spectroscopy data also revealed that the <sup>1</sup>H resonances are consistent with the addition of a glucuronide residue to <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figures S7 and S8</a> in the SI).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <sup>1</sup>H NMR spectra of <b>2</b> (A) and biochemically synthesized M2 (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The <sup>1</sup>H NMR spectra of the M3 isolate depicted all of the aromatic and aliphatic resonances of <b>3</b> in addition to resonances (δ 5.62, 3.69, 3.42–3.14 ppm) consistent with the addition of a β-<span class="smallcaps smallerCapital">d</span>-glucuronic acid residue to <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The <sup>1</sup>H spectra of the isolated material also depicted resonances that were attributed to rotameric forms of M3. The position of attachment of the glucuronide motif was established on the basis of the HMBC data, which indicated a correlation from the anomeric <sup>1</sup>H resonance at δ 5.62 ppm to a carbon with a unique chemical shift of δ 161.8 ppm (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Furthermore, COSY and HSQC <sup>1</sup>H NMR data are also consistent with the addition of a glucuronide motif to parent carboxylic acid <b>3</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figures S9 and S10</a> in the SI).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <sup>1</sup>H NMR spectra of <b>3</b> (A) and biosynthesized M3 (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <sup>1</sup>H–<sup>13</sup>C HMBC spectra of biosynthesized M3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Determination of the Concentrations of M1, M2, and M3 in DMSO-<i>d</i><sub>6</sub></h3><div class="NLM_p">Because of the universal response of hydrogens in an NMR experiment, <sup>1</sup>H NMR is an excellent quantitative tool for assessing the concentrations of isolates of small molecules for which there is no synthetic standard available.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> The response of an NMR system to a nanomole of a specific hydrogen in a given molecule will be the same as the response to a nanomole of a specific hydrogen in a calibrating compound such as maleic acid when the experimental parameters are identical.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> As a consequence, isolated metabolites can be quantitated using calibrating solutions of organic chemicals that are unrelated to the isolated material. In the present situation, quantitation of the purified isolates in DMSO-<i>d</i><sub>6</sub> (used for NMR characterization) was performed by external calibration against the <sup>1</sup>H NMR spectrum of 10 mM maleic acid standard using the electronic reference to access in vivo concentrations 2 function within Topspin as outlined in previous publications from our laboratory.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> The final concentrations of the biosynthesized isolates of M1, M2, and M3 in DMSO-<i>d</i><sub>6</sub> were determined to be 2.4, 0.52, and 14.3 mM, respectively, by quantitative NMR spectroscopy.</div><div class="NLM_p last">Chemically synthesized<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> acyl glucuronide derivatives of <b>1</b>, <b>2</b>, and <b>3</b> possessed identical <i>t</i><sub>R</sub> on HPLC-UV (M1, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S11</a>; M2, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S13</a>; M3, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S15</a> ), mass (M1, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S12</a>; M2, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S14</a>; M3, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S16</a>), and <sup>1</sup>H NMR (M1, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S6</a>; M2, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S8</a>; M3, SI <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S10</a>) spectral characteristics as the biosynthesized metabolites M1, M2, and M3, respectively, which confirmed that M1, M2, and M3 were acyl glucuronides. Details on the methodology utilized to synthesize acyl glucuronides M1, M2, and M3 will be the topic of an independent publication.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Stability of M1–M3 in Buffer</h3><div class="NLM_p last">Certain immune-mediated drug toxicities associated with carboxylic acid-based drugs have been linked to the formation of acyl glucuronide metabolites.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Under physiological conditions, acyl glucuronides can covalently modify proteins via a simple transacylation reaction or through an acyl migration within the β-<i>O</i>-glucuronide unit to a reactive α-hydroxy-aldehyde species.<a onclick="showRef(event, 'ref1 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref1 ref40 ref41">(1,40,41)</a> Condensation between the α-hydroxy-aldehyde motif and a lysine residue or an amine group of the N terminus in proteins leads to the formation of a glycated conjugate. A recent Food and Drug Administration guidance on this topic suggests that simple <i>O</i>-glucuronides, <i>O</i>-sulfates, and/or quaternary <i>N</i><sup>+</sup>-glucuronides may be considered benign from a human safety perspective, However, qualification of circulating acyl glucuronide metabolites in animals and humans is needed because of the aforementioned reactivity concerns.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Consequently, we examined the degradation kinetics of the biochemically isolated M1 (the principal metabolite of our clinical candidate PF-06409577 (<b>1</b>) in animals and humans) in deuteriated phosphate buffer (pH ∼ 7.4) at 37 °C using a previously published NMR method based on the disappearance of the anomeric resonance of the β-<i>O</i>-1-acyl glucuronide motif in structurally diverse acyl glucuronide conjugates.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The analysis was also repeated with acyl glucuronides M2 and M3. Repeated <sup>1</sup>H NMR analysis (approximately every 25 min over 21 h) monitoring for the integrated peak area of the anomeric protons (δ ∼ 5.7–5.8 ppm) revealed that M1, M2, and M3 isolated from the biochemical incubations was inert toward hydrolysis or acyl migration (<i>t</i><sub>1/2</sub> > 21 h) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S17</a> in SI). Overall, these observations are consistent with structure–toxicity correlations between covalent binding to liver microsomes and/or serum albumin and acyl glucuronide migration rates. Acyl glucuronides derived from aromatic carboxylic acids (such as <b>1</b>) and carboxylic acids with a higher degree of alkyl substitution at the α-carbon exhibit lower reactivity with protein nucleophiles, suggesting that inherent electronic and steric effects likely modulate the overall rate of acyl glucuronide rearrangement.<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43−45)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro Pharmacology</h3><div class="NLM_p">A previously described<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> time-resolved fluorescence resonance energy transfer (TR-FRET) activation/protection assay was used to assess AMPK activation by <b>1</b>–<b>3</b> and their corresponding acyl glucuronide metabolites M1–M3. Incorporating a protein phosphatase 2a (PP2a) treatment prior to initiation of the kinase reaction allowed the identification of both allosteric activators and protectors from dephosphorylation of Thr172. The output from this analysis was normalized relative to AMP as a 100% control, and an increase in signal in this assay relative to the vehicle control indicated that a compound allosterically activated the enzyme, protected Thr172 from dephosphorylation, or both. Initial pharmacological evaluation was performed with the human α1β1γ1 AMPK isoform that is predominantly expressed in the kidney,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> and the same assay format was also used to assess isoform selectivity (human α1β2γ1, human α2β1γ1, human α2β2γ1, and human α2β2γ3). Consistent with our previous reports,<a onclick="showRef(event, 'ref21 ref29'); return false;" href="javascript:void(0);" class="ref ref21 ref29">(21,29)</a> parent carboxylic acids <b>1</b>–<b>3</b> potently activate human AMPK isoforms that contained the β1 subunit (including α1β1γ1) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Under these experimental conditions, acyl glucuronide standards of M1, M2, and M3 also selectively activated human β1 isoforms, albeit with 9–19-fold loss in potency (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Parent carboxylic acids and the acyl glucuronide conjugates possessed little to no activity against β2-containing isoforms of human AMPK (see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Our previously described in vitro surface plasmon resonance (SPR) binding assay<a onclick="showRef(event, 'ref21 ref46'); return false;" href="javascript:void(0);" class="ref ref21 ref46">(21,46)</a> was also utilized to confirm a direct interaction of the test compounds with the AMPK α1β1γ1 isoform. Biotinylated human recombinant AMPK α1β1γ1 isoform was captured onto a streptavidin sensor chip, and analytes were injected over the surface. Correlation of binding affinities (<i>K</i><sub>d</sub>) and kinetic parameters (<i>k</i><sub>on</sub>, <i>k</i><sub>off</sub>) with the functional response observed in biochemical assays provided additional confidence in the observed structure–activity relationships (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Data for Indole-3-carboxylic Acids <b>1</b>–<b>3</b> and Corresponding Acyl Glucuronide Metabolites M1–M3</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">activation-protection (TR-FRET)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">AMPK isoform</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> nM (CI)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">%AMP (CI)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">permeability (RRCK)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a><i>P</i><sub>app</sub> × 10<sup>–6</sup> cm/s</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">α1β1γ1</td><td class="colsep0 rowsep0" align="center">1.9 (1.1–3.3)</td><td class="colsep0 rowsep0" align="center">208 (196–219)</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β1γ1</td><td class="colsep0 rowsep0" align="center">11.3 (7.6–16.9)</td><td class="colsep0 rowsep0" align="center">153 (145–161)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α1β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ3</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M1</td><td class="colsep0 rowsep0" align="left">α1β1γ1</td><td class="colsep0 rowsep0" align="center">38.1 (28–52)</td><td class="colsep0 rowsep0" align="center">195 (185–204)</td><td class="colsep0 rowsep0" align="char" char=".">–0.14</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β1γ1</td><td class="colsep0 rowsep0" align="center">275 (189–401)</td><td class="colsep0 rowsep0" align="center">140 (129–152)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α1β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ3</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">α1β1γ1</td><td class="colsep0 rowsep0" align="center">7.0 (4.0–12)</td><td class="colsep0 rowsep0" align="center">206 (192–219)</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β1γ1</td><td class="colsep0 rowsep0" align="center">27 (19–38)</td><td class="colsep0 rowsep0" align="center">152 (144–160)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α1β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ3</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M2</td><td class="colsep0 rowsep0" align="left">α1β1γ1</td><td class="colsep0 rowsep0" align="center">76.0 (55.3–104)</td><td class="colsep0 rowsep0" align="center">193 (182–203)</td><td class="colsep0 rowsep0" align="char" char=".">–0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β1γ1</td><td class="colsep0 rowsep0" align="center">353 (255–491)</td><td class="colsep0 rowsep0" align="center">154 (143–165)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α1β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ3</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">α1β1γ1</td><td class="colsep0 rowsep0" align="center">8.0 (5.0–12.2)</td><td class="colsep0 rowsep0" align="center">179 (168–189)</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β1γ1</td><td class="colsep0 rowsep0" align="center">6.0 (4.5–8.1)</td><td class="colsep0 rowsep0" align="center">145 (140–150)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α1β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ3</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M3</td><td class="colsep0 rowsep0" align="left">α1β1γ1</td><td class="colsep0 rowsep0" align="center">59 (41–85)</td><td class="colsep0 rowsep0" align="center">193 (181–204)</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β1γ1</td><td class="colsep0 rowsep0" align="center">332 (239–461)</td><td class="colsep0 rowsep0" align="center">147 (137–157)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α1β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ1</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">α2β2γ3</td><td class="colsep0 rowsep0" align="center">>40000</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Mean EC<sub>50</sub> data reported as the mean of at least 3 replicates and 90% confidence intervals (CI). %AMP is the amount of activation relative to the AMP control at maximum concentration of the test compound.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">log <i>D</i> was measured at pH 7.4 using the previously described shake-flask method.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Passive absorptive permeability (<i>P</i><sub>app</sub>) was measured in Ralph Russ canine kidney (RRCK) cells as previously described.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> ND: not determined.</p></div></div></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. TR-FRET data (90% confidence intervals) for α1β1γ1 AMPK activation by <b>1</b> and M1 (A), <b>2</b> and M2 (B), and <b>3</b> and M3 (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro SPR Data for Direct Binding of Indole-3-carboxylic Acids <b>1</b>–<b>3</b> and Corresponding Acyl Glucuronide Metabolites M1–M3 to Human AMPK α1β1γ1 Isoform</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">dissociation <i>t</i><sub>1/2</sub> (s)</th><th class="colsep0 rowsep0" align="center" char="±"><i>k</i><sub>on</sub> × 10<sup>5</sup> ± SE (M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="±"><i>k</i><sub>off</sub> × 10<sup>–3</sup> ± SE (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="±">binding <i>K</i><sub>D</sub> ± SE (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">82.11 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">9.42 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">8.44 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">8.96 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M1</td><td class="colsep0 rowsep0" align="char" char="±">19.80 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">3.10 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">35.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">112.9 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">103.74 ± 2.10</td><td class="colsep0 rowsep0" align="char" char="±">4.92 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">6.68 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">13.6 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M2</td><td class="colsep0 rowsep0" align="char" char="±">30.13 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">1.10 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">23.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">209.1 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">67.94 ± 0.64</td><td class="colsep0 rowsep0" align="char" char="±">7.08 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">10.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">14.4 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M3</td><td class="colsep0 rowsep0" align="char" char="±">15.30 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">2.29 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">45.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">197.8 ± 3.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Dissociation <i>t</i><sub>1/2</sub> = ln(2)/<i>k</i><sub>off</sub>; kinetic parameters (<i>k</i><sub>on</sub>, <i>k</i><sub>off</sub>) were obtained by a global fit using at least three concentrations and at least three replicates. <i>K</i><sub>d</sub> was determined by the standard equation, <i>K</i><sub>d</sub> = <i>k</i><sub>off</sub>/<i>k</i><sub>on</sub>; SE = standard error.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> AMPK Cocrystal Structures with Activators</h3><div class="NLM_p">We had previously described the crystal structure of <b>1</b> and <b>2</b> bound to the α1β1γ1 isoform of AMPK at ∼3.4 and 3.5 Å, respectively.<a onclick="showRef(event, 'ref21 ref29 ref49'); return false;" href="javascript:void(0);" class="ref ref21 ref29 ref49">(21,29,49)</a> AMPK adopts an elongated conformation in which the regulatory carbohydrate-binding module motif of the β-subunit sits atop the catalytic kinase domain of the α-subunit.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> The interface between these two domains generates a novel site termed the “Allosteric Drug and Metabolite (ADaM)” site, and it is within this binding pocket that indole-3-acid activator <b>1</b> binds (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A). The carboxylate moiety in <b>1</b> forms an ion-pair with Lys29, while the indole NH donates a hydrogen bond to Asp88 of the kinase module. The chlorine and the phenyl substituents form lipophilic interactions with both nonpolar amino acids from both the α and β subunits. In addition, the indole core forms a π–cation interaction with the side chain guanidinium group of Arg83.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Crystal structures of AMPK α1β1γ1 with acyl glucuronide conjugates M1–M3. (A) Overall topology of AMPK α1β1γ1 illustrating compound <b>1</b> bound to the ADaM site. Structure derived from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5">5KQ5</a>.pdb.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (B) Overlay of bound pose of compounds <b>1</b> and M1 (top) together with a surface representation of the ADaM site from the M1 structure (gray surface). (C) Overlay of bound poses of M1, M2, and M3 along with electron density over ligand from each crystal structure (2<i>f</i><sub>o</sub> – <i>f</i><sub>c</sub> map contoured at 1σ).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To better understand the binding of the acyl glucuronide metabolites, we determined the crystal structure of the α1β1γ1 isoform with the biochemical isolate of M1 in DMSO-<i>d</i><sub>6</sub> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). Despite glucuronidation of the C-3 carboxyl acid moiety, M1 retains binding at the ADaM site with a binding pose that is remarkably similar to the parent indole acid. The glucuronic acid moiety projects toward solvent and is easily accommodated within the exit tunnel of the α/β interface. The acidic moiety in the acyl glucuronide metabolite can potentially adopt multiple poses, a suggestion that we cannot rule out with certainty based on electron density, however, a pose with the acid directed “up” toward the β-subunit gave the best fit to electron density and was chosen as the modeled conformation (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S18</a> in SI). Regardless of binding pose, the ion-pair interaction with Lys29 of the α-subunit is lost with M1, which may be the potential cause for the loss in potency of the aglycone derivative. However, the glucuronide does remain in the vicinity of polar residues contributed by both α and β subunits, including Arg83 of β, which could partially compensate for this loss. In addition, we also solved the crystals structures of AMPK with the acyl glucuronide metabolites M2 and M3 (isolated and purified from human liver microsomes) and observed similar results (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C). Several key interactions between the indole NH and protein, including a hydrogen bond to α-Asp88, are preserved while the glucuronide motif in all three compounds occupies a similar space at the border of the binding site.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Activation of AMPK Activity in Human Hepatocytes</h3><div class="NLM_p">AMPK activation in primary hepatocytes leads to an acute increase in phosphorylation of Ser79 in acetyl-CoA carboxylase (ACC) and a concomitant decrease in de novo production of fatty acids.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> We elected to examine activation of cellular AMPK by representative parent carboxylic acid derivatives <b>1</b> and <b>2</b> and their respective acyl glucuronide metabolites M1 and M2 by treating primary human hepatocytes with the test compounds for 1 h and measuring the phosphorylation of the AMPK substrate ACC and the rate of [<sup>14</sup>C]-acetate incorporation into lipid species. Parent carboxylic acids <b>1</b> and <b>2</b> and their corresponding acyl glucuronide derivatives M1 and M2 caused a dose dependent increase in the phosphorylation status of ACC at Ser79, with an EC<sub>50</sub> of 0.11 μM (compound <b>1</b>) and 0.28 μM (compound <b>2</b>), 3.27 μM (M1), and 2.11 μM (M2), respectively (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Additionally, Parent carboxylic acids <b>1</b> and <b>2</b> as well as the corresponding acyl glucuronide derivatives M1 and M2 demonstrated a marked reduction in [<sup>14</sup>C]-acetate incorporation (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Figure S19</a> in SI), with apparent IC<sub>50</sub> values of 0.40 μM (compound <b>1</b>) 0.42 μM (compound <b>2</b>), 11 μM (M1), and 25 μM (M2), respectively. The estimated IC<sub>50</sub> for inhibition of de novo lipogenesis and ACC phosphorylation with <b>1</b> is consistent with the value obtained in our recent study examining ACC phosphorylation and suppression of lipid synthesis in primary hepatocytes from animals and human.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The apparent right-shift in cellular IC<sub>50</sub> values (relative to the values measured with the recombinant human β1 kinase) for AMPK activation by the parent carboxylic acids and their respective acyl glucuronide conjugates possibly reflects their nonspecific binding to hepatocytes/media. Furthermore, in the case of the acyl glucuronide derivatives M1 and M2, it is likely that their impaired passive permeability (<i>P</i><sub>app</sub>) relative to the parent carboxylic acid derivatives as measured in Ralph Russ canine kidney (RRCK) cells<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) further impedes access to AMPK expressed intracellularly in the hepatocyte. Determination of intracellular unbound concentrations of the test compounds in this assay could potentially shed additional light on this discrepancy. As such, it is noteworthy to point out that incubation of the individual acyl glucuronide metabolites M1 and M2 (at a concentration of 10 μM each) with primary human hepatocytes revealed complete resistance (<i>t</i><sub>1/2</sub> > 400 min, intrinsic clearance (CL<sub>int</sub>) < 3.0 μL/min/10<sup>6</sup> cells) toward metabolism (including potential hydrolytic cleavage to the parent compounds <b>1</b> and <b>2</b>, respectively).</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Increase in Ser79 phosphorylation of the specific AMPK substrate ACC in primary human hepatocytes following treatment with compounds <b>1</b>, <b>2</b>, M1, and M2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Intravenous Pharmacokinetics of M1 in Animals</h3><div class="NLM_p">The preclinical disposition of the acyl glucuronide metabolite M1 was further investigated as part of the regulatory package supporting human safety and pharmacokinetics studies with <b>1</b>. Like the parent compound <b>1</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> M1 exhibited high plasma protein binding in rat (plasma unbound fraction, <i>f</i><sub>u,p</sub> = 0.0044 (<b>1</b>), 0.0018 (M1)), monkey (<i>f</i><sub>u,p</sub> = 0.032 (<b>1</b>), 0.028 (M1)), and human (<i>f</i><sub>u,p</sub> = 0.017 (<b>1</b>), 0.019 (M1)). The intravenous pharmacokinetics of M1 (and the previously reported values for the parent compound <b>1</b>) in rats and monkeys are shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Following intravenous administration, M1 demonstrated low plasma clearance (CL<sub>p</sub>) in rats (0.99 mL/min/kg) and monkeys (9.85 mL/min/kg) and was well distributed with steady state distribution volumes (<i>V</i><sub>dss</sub>) ranging from 0.84–4.05 L/kg. Relative to <b>1</b>, the CL<sub>p</sub> values of M1 were considerably lower in rats and similar in monkeys. The percentage of dose recovered in urine over 24 h as unchanged M1 was ∼1.0% (rat) and 9.8% (monkey), which is considerably lower than the values noted with <b>1</b> (rats, 15.9%,and monkeys, 20.6%). The in vivo conversion of M1 to <b>1</b> was also studied by monitoring the plasma samples for the formation of <b>1</b>. Comparison of the unbound area under the plasma–time concentration (AUC) curve for M1 and <b>1</b> revealed M1/<b>1</b> ratios of 0.035 and 0.22, in rats and monkeys, respectively, suggestive of low potential for the enterohepatic recirculation<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> of <b>1</b> potentially via β-glucuronidase mediated hydrolysis of M1 in the small intestine of preclinical species. In rat, monkey, and human hepatocytes, M1 was resistant toward metabolic turnover (<i>t</i><sub>1/2</sub> > 240 min, CL<sub>int</sub> < 6 μL/min/10<sup>6</sup> cells). Finally, qualitative HPLC-UV examination of pooled (0–7 h) rat bile revealed substantial quantities of M1 following iv administration of <b>1</b> to bile-duct cannulated rats (data not shown), implying that the acyl glucuronide derivative generated through the glucuronidation of <b>1</b> is predominantly eliminated via biliary excretion possibly mediated by the efflux transport proteins (e.g., multidrug resistance-associated protein 2 and breast cancer resistant protein<a onclick="showRef(event, 'ref1 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref1 ref56 ref57">(1,56,57)</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Intravenous Pharmacokinetics<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> of <b>1</b> and M1 in Rats and Monkeys</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">analyte</th><th class="colsep0 rowsep0" align="center">CL<sub>p</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>(0–24)</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">unbound metabolite/parent AUC ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">1.0 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="center">rat</td><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center">22.6 ± 3.05</td><td class="colsep0 rowsep0" align="center">744 ± 103</td><td class="colsep0 rowsep0" align="center">0.85 ± 0.54</td><td class="colsep0 rowsep0" align="center">1.06 ± 1.06</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M1</td><td class="colsep0 rowsep0" align="center">0.5 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">rat</td><td class="colsep0 rowsep0" align="center">M1</td><td class="colsep0 rowsep0" align="center">0.99 (0.75,1.24)</td><td class="colsep0 rowsep0" align="center">8850 (11000,6700)</td><td class="colsep0 rowsep0" align="center">0.4 (0.27,0.52)</td><td class="colsep0 rowsep0" align="center">6.96 (7.11,6.81)</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">101</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">1.0 (<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="center">monkey</td><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center">8.57 ± 2.33</td><td class="colsep0 rowsep0" align="center">1970 ± 577</td><td class="colsep0 rowsep0" align="center">2.33 ± 0.99</td><td class="colsep0 rowsep0" align="center">8.54 ± 2.98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M1</td><td class="colsep0 rowsep0" align="center">1.0 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">monkey</td><td class="colsep0 rowsep0" align="center">M1</td><td class="colsep0 rowsep0" align="center">9.85 (7.09,12.6)</td><td class="colsep0 rowsep0" align="center">1750 (2240,1260)</td><td class="colsep0 rowsep0" align="center">4.52 (3.13,5.91)</td><td class="colsep0 rowsep0" align="center">18 (17.3,18.7)</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">303 (257,349)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">All experiments involving animals were conducted in our AAALAC-accredited facilities and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Pharmacokinetic parameters were calculated from plasma concentration–time data and are reported as mean (±SD for <i>n</i> = 3 or greater and average values for <i>n</i> = 2 with individual values provided). Intravenous pharmacokinetics were conducted in male gender of each species (Wistar Han rats and cynomolgus monkeys). Solution formulation for the intravenous dose included 10% DMSO/30% PEG400/60% water.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Taking into account the hurdles associated with the synthesis of acyl glucuronide metabolites,<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> we initially utilized UDPGA-supplemented human liver microsomes to rapidly biosynthesize acyl glucuronide conjugates (M1–M3) of AMPK activators <b>1</b>–<b>3</b>. Determination of the concentrations of the purified acyl glucuronide conjugate stock solutions in DMSO-<i>d</i><sub>6</sub> by quantitative NMR spectroscopy allowed preliminary evaluation of their potential to activate human AMPK α1β1γ1 in recombinant kinase assays and human hepatocytes. The acyl glucuronide stock solutions were also utilized in the solution of the corresponding AMPK:acyl glucuronide cocrystal structures, which provided insights into the structural basis for AMPK activation by the polar aglycones relative to their parent carboxylic acid precursors.</div><div class="NLM_p">The potential for synergistic contribution of the acyl glucuronides toward activation of kidney AMPK in rodents (and potentially humans) administered with the parent carboxylic acid precursors<a onclick="showRef(event, 'ref21 ref29'); return false;" href="javascript:void(0);" class="ref ref21 ref29">(21,29)</a> remains unclear at the present time. The lower passive permeability of the acyl glucuronides (relative to the parent precursors) in the RRCK assay would suggest that the conjugates (relative to the parent carboxylic acid precursors) will demonstrate minimal activation of AMPK in rodent models of diabetic nephropathy. However, as noted in the literature,<a onclick="showRef(event, 'ref1 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref9 ref10 ref11 ref12 ref13">(1,9−13)</a> active transport of the acyl glucuronide conjugates generated in the small intestine and/or liver by intestinal, hepatic (e.g., organic anion transporting polypeptides 1A2, 1B1, and 1B3, multidrug resistant protein 3 and 4) and renal (e.g., organic anion transporters 1 and 3) transporters across cell membranes will ultimately govern their disposition and their potential to activate of AMPK in the site of action. As demonstrated in our pharmacokinetic studies on M1 in rats and monkeys, pharmacological evaluation of the acyl glucuronide conjugates M1–M3 in rodent models of diabetic nephropathy is likely to be compromised to some degree given their propensity to undergo β-glucuronidase-mediated hydrolysis to the parent carboxylic acid precursors. In addition, the potential for translatability of animal pharmacology data to humans will be confounded due to the marked species differences in the expression of β-glucuronidases (e.g., rat ≫ human).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Finally, considering the physicochemical properties of acyl glucuronide conjugates, it is noteworthy to point out that assessment of in vivo animal pharmacology would only be possible via intravenous administration of the preformed acyl glucuronide standard, which presents the risk of producing misleading data compared to the “real world” situation where conjugation of the parent carboxylic acid occurs in the gut wall and/or liver and the glucuronide conjugate relies upon active transport proteins for passage across tissues.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61,62)</a> As such, the complexities surrounding in vivo pharmacological assessments with glucuronide conjugates is further exemplified by the fact that it has taken over three decades to provide concrete evidence that the analgesic action of morphine in humans is mediated by the morphine-6-glucuronide conjugate, formed in vivo.<a onclick="showRef(event, 'ref63 ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65 ref66">(63−66)</a></div><div class="NLM_p">Apart from the prerequisite regulatory Metabolites in Safety Testing (MIST) guidance on safety assessment (reactivity) of acyl glucuronide metabolites,<a onclick="showRef(event, 'ref61 ref67'); return false;" href="javascript:void(0);" class="ref ref61 ref67">(61,67)</a> our present case study with the indole-3-carboxylic acid-based AMPK activators suggests that additional diligence may be warranted toward studying on-target pharmacology of acyl glucuronide metabolites that are derived from carboxylic acid-based drug candidates. This is of particular importance when acyl glucuronidation constitutes the primary clearance mechanism and/or in cases (e.g., dabigatran) where the pharmacological target resides in the extracellular matrix and does not require cell penetration by an acyl glucuronide conjugate.</div><div class="NLM_p last">Finally, detailed characterization of the human UGT enzyme(s) responsible for the glucuronidation of <b>1</b> to M1 is currently in progress as part of studies to support the clinical development program of <b>1</b>. These results will be reported in due course alongside the first-in-human oral single ascending dose pharmacokinetics for the clinical candidate <b>1</b>, wherein circulating concentrations of its glucuronide conjugate M1 were also measured and found to be comparable to that of the parent compound.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Experimental Methods</h3><div class="NLM_p last">All experiments involving animals were conducted in our AAALAC-accredited facilities and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Indole-3-carboxylic acid derivatives <b>1</b>–<b>3</b> (chemical and isomeric purity >99% by HPLC and NMR) were synthesized at Pfizer Worldwide Research and Development (Groton, CT) by using previously published protocols.<a onclick="showRef(event, 'ref21 ref29'); return false;" href="javascript:void(0);" class="ref ref21 ref29">(21,29)</a> Cryopreserved human hepatocytes (lot RHT; pooled, <i>n</i> = 5 male livers and <i>n</i> = 5 female livers) were obtained from BioreclamationIVT (Baltimore, MD), and pooled (pool of 50 livers from male/female) human liver microsomes were purchased from BD Gentest (Woburn, MA). Alamethicin, UDPGA, MgCl<sub>2</sub>, and DMSO were purchased from Sigma-Aldrich (St. Louis, MO). Solvents used for bioanalysis were of analytical or HPLC grade (Thermo Fisher Scientific, Waltham, MA). Purity of biosynthesized acyl glucuronide metabolites was assessed by reversed-phase HPLC with UV detection at λ 290 nm (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Supporting Information</a>); all tested compounds demonstrated >95% purity.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Metabolite Identification Studies in Human Hepatocytes</h3><div class="NLM_p last">Cryopreserved human hepatocytes were thawed and suspended in Williams’ E medium (ThermoFisher Scientific, Waltham, MA) supplemented with 24 mM NaHCO<sub>3</sub> and 10% fetal bovine serum at 2 × 10<sup>6</sup> viable cells/mL. Compounds <b>1</b>–<b>3</b> were individually incubated (10 μM final concentration) with hepatocytes at 37 °C for 4 h with gentle agitation. A gas mixture of O<sub>2</sub>:CO<sub>2</sub> (95:5) maintained at ∼2.5 kPa for ∼5 s was passed through this mixture at every hour of incubation. Flasks were corked immediately after gassing. Reactions were stopped by addition of ice-cold acetonitrile (10 mL) and centrifuged (3000<i>g</i>, 15 min). The supernatants were dried under a steady stream of nitrogen, reconstituted with 25% aqueous acetonitrile (250 μL), and analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) for metabolite formation. Qualitative assessment of metabolites was conducted using a Thermo Orbitrap Elite mass spectrometer (ThermoFisher Scientific, Waltham, MA) operating in positive ion electrospray mode. The HPLC system consisted of an Accela quaternary solvent delivery pump, an Accela autoinjector, and a Surveyor PDA Plus photodiode array detector. The autoinjector was programmed to inject 50 μL of reconstituted sample onto a Phenomenex Kinetex column (2.1 mm × 100 mm, 2.6 μm) using a gradient consisting of a mixture of 0.1% formic acid in water (solvent A) and acetonitrile (solvent B) at a flow rate of 400 μL/min. The binary gradient was as follows: solvent A to solvent B ratio was held at 95:5 (v/v) for 0.5 min and then adjusted to 35:65 (v/v) from 0.0 to 11 min and 5:95 (v/v) from 11 to 13 min, where it was held for 1.0 min and then returned to 95:5 (v/v) for 1.0 min before the next analytical run. Postcolumn flow was split such that the mobile phase was introduced into the mass spectrometer via an ion spray interface at a rate of 50 μL/min. The remaining flow was diverted to the photodiode array detector positioned in line to provide simultaneous UV detection and a total ion chromatogram. Xcalibur software version 2.2 SP1.48 was used to control the HPLC/MS system. Full scan data were collected at 15000 resolution. Data dependent product ion scans of the two most intense ions found in the full scan were obtained at 15000 resolution. The dynamic exclusion function was used with a 10 s exclusion duration after three successive product ion scans with an early exclusion if the precursor ion felt below a signal-to-noise ratio of 20. Initial full scans were performed between <i>m</i>/<i>z</i> 50 and 1000. Parent carboxylic acid derivatives and identifiable metabolites eluted in the first 30 min. Metabolites were identified in the full-scan mode (from <i>m</i>/<i>z</i> 100 to 850) by comparing <i>t</i> = 0 h samples with <i>t</i> = 4 h human hepatocytes samples, and structural information was generated from the mass spectra of the molecular ions (MH<sup>+</sup>).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Biosynthesis of Glucuronide Analogues</h3><div class="NLM_p last">Acyl glucuronides M1, M2, and M3 were biosynthesized as follows. Individual parent carboxylic acid derivatives <b>1</b>–<b>3</b> (500 μM) were incubated in UDPGA-supplemented human liver microsomes (four separate 10 mL incubations). Phosphate buffer (0.1 M pH 7.4) was aliquoted into a 50 mL centrifuge tube followed by the addition of MgCl<sub>2</sub> (3.3 mM), human liver microsomes (1 mg/mL), alamethicin (10 μg/mL), and UDPGA (2 mM). The reactions were initiated with the addition of the parent carboxylic acid derivatives and allowed to incubate in a shaking water bath for 2 h at 37 °C. Reactions were quenched by the addition of 30 mL of ice-cold acetonitrile per incubation. Samples were concentrated using an evaporative centrifuge at 37 °C then reconstituted with 2 mL of 5% acetonitrile in water (total volume for all incubation) combining incubates. The four reconstituted samples were combined and injected onto a semiprep HPLC system in six separate injections (300 μL). The semiprep HPLC consisted of a Shimadzu SiL-HTC autosampler, two LC-20AD solvent pumps, an SPD-M20A diode array detector, and a FRC-10 A fraction collector. Separation was performed on a Zorbax RX C8, 9.4 mm × 250 mm, 5 μM semipreparative HPLC column. For M1 and M3, the mobile phase consisted of 0.1% formic acid (mobile phase A) and acetonitrile (mobile phase B) at a flow rate of 4 mL/min. The mobile phase composition commenced at 95% A/5% B was held at that composition for 5 min, followed by a linear gradient to 35% A/65% B at 35 min. A second gradient was then executed to 5% A/95% B at 45 min, these conditions were held at this composition for 5 min, and the system was re-equilibrated at initial conditions for 5 min prior to the next injection. For M2, the mobile phase composition commenced at 95% A/5% B was held at that composition for 5 min, followed by a linear gradient to 30% A/70% B at 35 min. A second gradient was then executed to 5% A/95% B at 45 min, these conditions were held at this composition for 5 min, and the system was re-equilibrated at initial conditions for 5 min prior to the next injection. From all chromatographic separations, fractions were collected at 0.5 min intervals. Aliquots (25 μL) of fractions at <i>t</i><sub>R</sub> of UV peaks believed to be the acyl glucuronide metabolite and the parent carboxylic acid were verified by LC-MS/MS analysis. Fractions containing the isolated acyl glucuronides were combined and concentrated to dryness using evaporative centrifugation under nitrogen gas.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Derivatization of Acyl Glucuronide Metabolite M1 with Hydroxylamine</h3><div class="NLM_p last">Aliquots of collected fractions containing M1 were treated with hydroxylamine as previously described<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> to examine the potential for in situ aminolysis of the acyl glucuronide moiety to the corresponding hydroxamic acid derivatives in the presence of hydroxylamine. The aliquots were split into two equal fractions using one as a control. A 5 μL aliquot of hydroxylamine was added to the test sample, and a 5 μL aliquot of water was added to the control sample. Both samples were allowed to remain at room temperature for 1 h before reanalysis by LC-MS/MS.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> NMR Sample Analysis</h3><div class="NLM_p">Isolated samples were reconstituted in 0.1 mL of DMSO-<i>d</i><sub>6</sub> “100%” (Cambridge Isotope Laboratories, Andover, MA) and placed in a 1.7 mm NMR tube which had been stored in a dry argon atmosphere. The <sup>1</sup>H and <sup>13</sup>C spectra were referenced using residual DMSO-<i>d</i><sub>6</sub> (1H δ = 2.50 ppm relative to tetramethylsilane, δ = 0.00, <sup>13</sup>C δ = 39.50 ppm relative to tetramethylsilane, δ = 0.00). NMR spectra were recorded on a Bruker Avance 600 MHz (Bruker BioSpin Corporation, Billerica, MA) controlled by Topspin V3.2 and equipped with a 1.7 mm TCI Cryo probe. 1D spectra were recorded using an approximate sweep width of 8400 Hz and a total recycle time of approximately 7 s. The resulting time-averaged free induction decays were transformed using an exponential line broadening of 1.0 Hz to enhance signal-to-noise. The 2D data were recorded using the standard pulse sequences provided by Bruker. At minimum, a 1K × 128K data matrix was acquired using a minimum of two scans and 16 dummy scans with a spectral width of 10000 Hz in the f2 dimension. The 2D data sets were zero-filled to at least 1k data points. Postacquisition data processing were performed with either Topspin V3.2 MestReNova Mnova 9.1. Quantitation of NMR isolates was performed by external calibration against the <sup>1</sup>H NMR spectrum of an authentic 10 mM maleic acid standard compared to that of the isolated glucuronides using the electronic reference to access in vivo concentrations 2 function within Topspin V3.2 as outlined in our previous publications.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a></div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (2<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>,6<i>S</i>)-6-((6-Chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1<i>H</i>-indole-3-carbonyl)oxy)-3,4,5-trihydroxytetrahydro-2<i>H</i>-pyran-2-carboxylic acid (M1)</h4><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.37 (s, 1H), 8.25 (d, <i>J</i> = 5.0 Hz, 3H), 7.96 (s, 1H), 7.69 (s, 1H), 7.57 (d, <i>J</i> = 7.8 Hz, 2H), 7.43 (d, <i>J</i> = 7.8 Hz, 2H), 5.61 (d, <i>J</i> = 8.0 Hz, 1H), 3.60 (d, <i>J</i> = 10.1 Hz, 1H), 3.37 (t, <i>J</i> = 9.5 Hz, 1H), 3.31 (t, <i>J</i> = 8.8 Hz, 1H), 3.24 (t, <i>J</i> = 8.5 Hz, 1H), 2.46 (t, <i>J</i> = 4.3 Hz, 1H), 2.30 (ddd, <i>J</i> = 6.8, 9.2, 11.9 Hz, 2H), 1.95 (tt, <i>J</i> = 4.8, 9.8 Hz, 1H), 1.70 (dt, <i>J</i> = 8.0, 10.5 Hz, 1H).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (2<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>,6<i>S</i>)-6-((6-Chloro-5-(6-(dimethylamino)-2-methoxypyridin-3-yl)-1<i>H</i>-indole-3-carbonyl)oxy)-3,4,5-trihydroxytetrahydro-2<i>H</i>-pyran-2-carboxylic Acid (M2)</h4><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.13 (d, <i>J</i> = 3.1 Hz, 1H), 8.22 (d, <i>J</i> = 3.0 Hz, 1H), 7.84 (s, 1H), 7.60 (s, 1H), 7.34 (d, <i>J</i> = 8.1 Hz, 1H), 6.22 (d, <i>J</i> = 8.2 Hz, 1H), 5.59 (d, <i>J</i> = 7.7 Hz, 1H), 5.42 (s, 1H), 5.35 (s, 1H), 5.27 (s, 1H), 3.79 (d, <i>J</i> = 9.5 Hz, 1H), 3.77 (s, 3H), 3.43–3.26 (m, 3H), 3.07 (s, 6H).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (2<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>,6<i>S</i>)-6-((4,6-Difluoro-5-(4-((<i>S</i>)-tetrahydro-2<i>H</i>-pyran-2-yl)phenyl-1<i>H</i>-indole-3-carbonyl)oxy)-3,4,5-trihydroxytetrahydro-2<i>H</i>-pyran-2-carboxylic Acid (M3)</h4><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.56 (s, 1H), 8.26 (d, <i>J</i> = 11.5 Hz, 1H), 7.50–7.35 (m, 4H), 7.30 (d, <i>J</i> = 9.4 Hz, 1H), 5.62 (d, <i>J</i> = 8.1, 1H), 4.38 (dd, <i>J</i> = 2.1, 11.1 Hz, 1H), 4.04 (d, <i>J</i> = 11.8 Hz, 1H), 3.70 (d, <i>J</i> = 10.53 Hz, 1H), 3.63–3.50 (m, 2H), 3.42–3.14 (m, 3H), 1.88 (dt, <i>J</i> = 3.1, 4.1, 10.7 Hz, 2H), 1.74–1.44 (m, 4H).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Stability of M1 in Phosphate Buffer</h3><div class="NLM_p last">The stability of M1, M2, and M3 in phosphate buffer (pH = 7.4) was examined by <sup>1</sup>H NMR spectroscopy. A 5 μL aliquot of the pure NMR isolate of M1, M2, or M3 (in DMSO-<i>d</i><sub>6</sub>) was diluted with 45 μL of the 10:90 D<sub>2</sub>O:0.1 mM phosphate buffer (pH = 7.4) mixture. The samples were placed in a 1.7 mM NMR tube and were repeatedly scanned for ∼21 h with a <sup>1</sup>H presaturation NMR experiment designed to suppress the signal due to water with the probe temperature set to 37 °C.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> In Vitro Pharmacology Studies</h3><div class="NLM_p last">Recombinant AMPK complexes and human PP2A alpha1 (Uniprot <a href="https://P677751" class="ext-link">P677751</a>) were expressed and purified as previously described.<a onclick="showRef(event, 'ref21 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref21 ref50 ref51">(21,50,51)</a> The TR-FRET activation assay was performed as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> SPR Studies</h3><div class="NLM_p last">Experiments were performed on a Biacore 3000 instrument (GE Healthcare). Bap-tagged AMPK α1β1γ1 was captured onto a streptavidin sensor chip to levels ranging from 4000 to 6000 RU. Compound binding experiments were performed in 25 mM Tris, pH 7.5, 150 mM NaCl, 250 μM Tris(2-carboxyethyl)phosphine hydrochloride, 0.01% P20, 0.5 mg/mL BSA, 2% DMSO, and 150 μM AMP at 25 °C. Binding responses were processed using Scrubber 2 (BioLogic Software Pty Ltd.) to zero, x-align, double reference, and corrected for excluded volume effects of DMSO in the data. Experiments were carried out with at least <i>n</i> = 3 for three or more compound concentrations with 3-fold dilutions. The compound concentrations were based on the EC<sub>50</sub> with the top concentration chosen to be several fold over the EC<sub>50</sub> to achieve saturation. Compounds were injected at a flow rate of 50 μL/min, total contact time of 120 s, and dissociation time of 600 s. Rate parameters (<i>k</i><sub>on</sub>, <i>k</i><sub>off</sub>,) and corresponding affinity constant (<i>K</i><sub>D</sub> = <i>k</i><sub>off</sub>/<i>k</i><sub>on</sub>) were determined by globally fitting the experimental data to a simple 1:1 interaction model using Biaeval (GE Healthcare).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Cocrystallization of AMPK with Acyl Glucuronide Metabolites</h3><div class="NLM_p last">AMPK was expressed, purified, and crystallized as previously reported,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> with the exception that native Ser108 of the β-subunit was reinstated in place of the phosphomimetic aspartic acid. Ser108 was phosphorylated in vitro upon AMPK activation with Camkkb as confirmed by mass spectrometry. Data were collected at the IMCA-CAT beamlines at the Advanced Photon Source, and each structure was solved from a single data set using our previous α1β1γ1 model for molecular replacement.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Apo crystals were soaked overnight in mother liquor supplemented with 10% glycerol in the presence of 200 μM staurosporine, 400 μM AMP, and 500 μM of individual acyl glucuronide metabolite isolates and frozen in a matched solution containing 25–30% glycerol for cryoprotection. Refinement was carried out principally using autoBUSTER.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a> Nucleotide content was modeled as previously described including the tentative modeling of ADP at site 1, and all caveats and limitations described previously apply here as well.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> X-ray data collection and refinement statistics are provided in SI, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">Table S1</a>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> AMPK Activation and Inhibition of de Novo lipogenesis in Primary Human Hepatocytes</h3><div class="NLM_p last">Cryopreserved human hepatocytes (BD Biosciences, lot no. BD310) were thawed rapidly at 37 °C and poured into 45 mL of prewarmed BD-Biosciences CryoHepatocyte Recovery Media (BD Biosciences no. 454560). Cells were pelleted at 1000<i>g</i> for 10 min at room temperature. Supernatent was aspirated, and cells were resuspended in 5 mL of Plating Media (Celsis InVitro Technologies no. Z99029). Cells were counted using a hemocytometer and trypan blue to determine viable cell concentration. Cells were then plated in a 48-well collagen I coated plates (BD Biocoat no. 356505) at a density of 150000 cells/well and allowed to attach to the plates overnight. After overnight incubation, the media was replaced with Williams E (16.5 mM glucose) for a 1 h serum starvation followed by replacement with Williams E media containing test compounds. Following a 1 h incubation with varying concentrations of the test compounds (<b>1</b>, <b>2</b>, M1, and M2), 10 μL of <sup>14</sup>C-2-acetic acid (0.1 μCi/μL) was added and the mixture was allowed to incubate for an additional hour. Media was then removed and the cells washed once with warm Williams E media and lysed with 0.25 mL of MPER lysis buffer (ThermoScientific no. 78505). Cells lysates were stored at 4 °C overnight, and 0.24 mL of the lysis solution was transferred to a glass scintillation vial containing 2 mL of Microscint E Scintillation fluid (PerkinElmer 6013661), vortexed, and centrifuged at 2000<i>g</i> for 3 min. Radioactivity was counted on a TriCarb counter. For measurement of ACC phosphorylation, cells were treated with test compounds for 1 h and lysed in cell lysis buffer for subsequent MSD ELISA measurements. For ACC MSD assays, MSD streptavidin gold plates (Mesoscale Devices, L15SA-2) were blocked in 1% Blocker A (Mesoscale Diagnostics, R3AA-2), diluted in 1× Tris wash buffer, and incubated at 37 °C for 1 h. Following incubation, wells were washed three times with 200 μL of 1× Tris wash buffer, and 25 μg of the protein samples of interest were added to each well, then incubated at 37 °C for 2 h. Wells were then washed three times with 200 μL of 1× Tris wash buffer, then either phospho-ACC antibody (Millipore, 07-303) at 50 ng/well or total ACC antibody (Cell Signaling, 3676) at 25 ng/well, diluted in 1% blocker A, were added to respective wells and incubated for 1.5h at 37 °C. Wells were then washed with 1× Tris wash buffer once, then 50 ng of MSD Sulfo-Tag antibody (Mesoscale Diagnostics, R32AB-1) was added to each well and incubated at 37 °C for 1 h. Wells were washed three times with 1× Tris Wash Buffer, 150 μL of 1× MSD read buffer (Mesoscale Diagnostics, R92TC-2) was added to each well, and the plate was read on an MSD plate reader (Mesoscale Diagnostics, Sector S600).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Pharmacokinetics Studies in Rats and Monkeys with M1</h3><div class="NLM_p last">All experiments involving animals were conducted in our AAALAC-accredited facilities and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Male jugular vein/carotid artery double cannulated Wistar–Han rats (250 g), obtained from Charles River Laboratories (Wilmington, MA), and male cynomolgus monkeys (7 kg) were used for these studies. Animals were fasted overnight and through the duration of the study (1.0 or 2.0 h), whereas access to water was provided ad libitum. M1 was administered intravenously in 10% DMSO/30% PEG400/60% water via the carotid artery (rats, <i>n</i> = 2) or femoral vein (monkeys, <i>n</i> = 2) at a dose of 0.5 (rats) or 1.0 (monkeys) mg/kg in a dosing volume of 1 mL/kg. Serial blood samples were collected in heparinized tubes before dosing and 0.033, 0.083, 0.25, 0.5, 1, 2, 4, 7, 24, and 48 h after dosing. Blood samples from the various pharmacokinetic studies were centrifuged to generate plasma and treated with 1 M citric acid to prevent any potential ex vivo hydrolysis of M1 to <b>1</b>. All plasma samples were kept frozen until analysis. Urine samples (0–7.0, 7.0–24, and 24–48 h) were also collected after intravenous administration to rats and monkeys. Aliquots of plasma or urine (20–25 μL) were transferred to 96-well blocks, and acetonitrile (150–200 μL) containing internal standard was added to each well. Supernatant was dried under nitrogen and reconstituted with 100 μL of acetonitrile/water and analyzed by liquid chromatography tandem mass spectrometry, and concentrations of M1 and <b>1</b> in plasma and/or urine were determined by interpolation from a standard curve. M1 and <b>1</b> was detected using electrospray ionization in the multiple reaction monitoring mode monitoring for mass-to-charge (<i>m</i>/<i>z</i><sup>+</sup>) transition 518 → 500 and 342 → 324, respectively.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Determination of Pharmacokinetic Parameters of M1 in Rats and Monkeys</h3><div class="NLM_p last">Pharmacokinetic parameters of M1 in rats and monkeys were determined using noncompartmental analysis (Watson v.7.4, Thermo Scientific, Waltham, MA. The area under the plasma concentration–time curve from <i>t</i> = 0 to 24 h (AUC<sub>0–24</sub>) was estimated using the linear trapezoidal rule. Systemic plasma clearance (CL<sub>p</sub>) was calculated as the intravenous dose divided by AUC. The terminal rate constant (<i>k</i><sub>el</sub>) was calculated by a linear regression of the log-linear concentration–time curve, and the terminal elimination <i>t</i><sub>1/2</sub> was calculated as 0.693 divided by <i>k</i><sub>el</sub>. Apparent steady state distribution volume (<i>V</i><sub>dss</sub>) in animals were determined as the intravenous dose divided by the product of AUC and <i>k</i><sub>el</sub>. Percentage of unchanged M1 excreted in urine over 24 h was calculated using the following equation: amount (in mg) of M1 in urine over the 24 h interval post dose/actual amount of M1 dose administered (mg) × 100%.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00807" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00807" class="ext-link">10.1021/acs.jmedchem.8b00807</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional experimental information for: Procedure for plasma protein binding, mass spectra of <b>1</b>–<b>3</b> and M1–M3, comparative HPLC-UV chromatograms and mass spectra for the biochemical and synthetic acyl glucuronides M1–M3, COSY NMR spectra of M1–M3, comparative HSQC NMR spectra of biochemical and synthetic acyl glucuronides M1–M3, degradation kinetics of M1–M3 in deuteriated phosphate buffer (pH 7.4), inhibition of de novo lipogenesis, X-ray data collection and refinement statistics, crystallization and refinement methods (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf">jm8b00807_si_001.pdf (1.44 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_002.csv">jm8b00807_si_002.csv (0.74 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structure coordinates for compounds M1, M2, and M3 will be deposited to the RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00807" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit S. Kalgutkar</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design and , Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9701-756X" title="Orcid link">http://orcid.org/0000-0001-9701-756X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#36775b5f42185d575a5143425d57447646505f4c53441855595b"><span class="__cf_email__" data-cfemail="692804001d470208050e1c1d02081b29190f00130c1b470a0604">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim F. Ryder</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew F. Calabrese</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory S. Walker</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly O. Cameron</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design and , Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan R. Reyes</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine Research Unit and , Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kris A. Borzilleri</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jake Delmore</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine Research Unit and , Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Russell Miller</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine Research Unit and , Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravi G. Kurumbail</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Ward</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine Research Unit and , Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel W. Kung</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5019-1939" title="Orcid link">http://orcid.org/0000-0002-5019-1939</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janice A. Brown</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Edmonds</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design and , Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9234-8618" title="Orcid link">http://orcid.org/0000-0001-9234-8618</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Eng</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela C. Wolford</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pfizer Worldwide Research &
Development, Groton, Connecticut 06340, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through the contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Yuxia Mao for compound formulation support. Crystallographic data were collected at IMCA-CAT (17-ID) at the Advanced Photon Source. IMCA was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman–Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACC</td><td class="NLM_def"><p class="first last">Acetyl-CoA Carboxylase</p></td></tr><tr><td class="NLM_term">ADaM</td><td class="NLM_def"><p class="first last">allosteric drug and metabolite</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">adenosine monophosphate-activated protein kinase</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the plasma concentration–time curve</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance; CL<sub>p</sub>, plasma clearance</p></td></tr><tr><td class="NLM_term">COSY</td><td class="NLM_def"><p class="first last">correlation spectroscopy</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u,p</sub></td><td class="NLM_def"><p class="first last">plasma unbound fraction</p></td></tr><tr><td class="NLM_term">HMBC</td><td class="NLM_def"><p class="first last">heteronuclear multiple bond–bond correlation spectroscopy</p></td></tr><tr><td class="NLM_term">HSQC</td><td class="NLM_def"><p class="first last">heteronuclear single-quantum correlation spectroscopy</p></td></tr><tr><td class="NLM_term">LC-MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography tandem mass spectrometry</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent passive permeability</p></td></tr><tr><td class="NLM_term">PP2a</td><td class="NLM_def"><p class="first last">protein phosphatase 2a</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">RRCK</td><td class="NLM_def"><p class="first last">Ralph Russ canine kidney cells</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>R</sub></td><td class="NLM_def"><p class="first last">retention time</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">UDPGA</td><td class="NLM_def"><p class="first last">uridine 5′-diphosphoglucuronic acid</p></td></tr><tr><td class="NLM_term">UGT</td><td class="NLM_def"><p class="first last">uridine 5′-diphospho-glucuronosyltransferase</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>dss</sub></td><td class="NLM_def"><p class="first last">steady-state distribution volume.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 69 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Acyl glucuronides: the good, the bad and the ugly</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1002/bdd.720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1002%2Fbdd.720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=20830700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=367-395&author=S.+L.+Reganauthor=J.+L.+Maggsauthor=T.+G.+Hammondauthor=T.+G.+Lambertauthor=D.+P.+Williamsauthor=B.+K.+Park&title=Acyl+glucuronides%3A+the+good%2C+the+bad+and+the+ugly&doi=10.1002%2Fbdd.720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Acyl glucuronides: the good, the bad and the ugly</span></div><div class="casAuthors">Regan, Sophie L.; Maggs, James L.; Hammond, Thomas G.; Lambert, Craig; Williams, Dominic P.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">367-395</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Acyl glucuronidation is the major metabolic conjugation reaction of most carboxylic acid drugs in mammals.  The physiol. consequences of this biotransformation have been investigated incompletely but include effects on drug metab., protein binding, distribution and clearance that impact upon pharmacol. and toxicol. outcomes.  In marked contrast, the exceptional but widely disparate chem. reactivity of acyl glucuronides has attracted far greater attention.  Specifically, the complex transacylation and glycation reactions with proteins have provoked much inconclusive debate over the safety of drugs metabolised to acyl glucuronides.  It has been hypothesised that these covalent modifications could initiate idiosyncratic adverse drug reactions.  However, despite a large body of in vitro data on the reactions of acyl glucuronides with protein, evidence for adduct formation from acyl glucuronides in vivo is limited and potentially ambiguous.  The causal connection of protein adduction to adverse drug reactions remains uncertain.  This review has assessed the intrinsic reactivity, metabolic stability and pharmacokinetic properties of acyl glucuronides in the context of physiol., pharmacol. and toxicol. perspectives.  Although numerous expts. have characterised the reactions of acyl glucuronides with proteins, these might be attenuated substantially in vivo by rapid clearance of the conjugates.  Consequently, to delineate a relationship between acyl glucuronide formation and toxicol. phenomena, detailed pharmacokinetic anal. of systemic exposure to the acyl glucuronide should be undertaken adjacent to detg. protein adduct concns. in vivo.  Further investigation is required to ascertain whether acyl glucuronide clearance is sufficient to prevent covalent modification of endogenous proteins and consequentially a potential immunol. response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ1hIcbM_oZ7Vg90H21EOLACvtfcHk0lh33vwlCVSKww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3L&md5=8c45d4dbb68c12bd128af1dba7a08c16</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fbdd.720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.720%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DS.%2BL.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DLambert%26aufirst%3DT.%2BG.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAcyl%2520glucuronides%253A%2520the%2520good%252C%2520the%2520bad%2520and%2520the%2520ugly%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2010%26volume%3D31%26spage%3D367%26epage%3D395%26doi%3D10.1002%2Fbdd.720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reger, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C.</span></span> <span> </span><span class="NLM_article-title">Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2004.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.abb.2004.02.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2004&pages=219-225&author=K.+Sakaguchiauthor=M.+Greenauthor=N.+Stockauthor=T.+S.+Regerauthor=J.+Zunicauthor=C.+King&title=Glucuronidation+of+carboxylic+acid+containing+compounds+by+UDP-glucuronosyltransferase+isoforms&doi=10.1016%2Fj.abb.2004.02.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2004.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2004.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DSakaguchi%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DStock%26aufirst%3DN.%26aulast%3DReger%26aufirst%3DT.%2BS.%26aulast%3DZunic%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26atitle%3DGlucuronidation%2520of%2520carboxylic%2520acid%2520containing%2520compounds%2520by%2520UDP-glucuronosyltransferase%2520isoforms%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D424%26spage%3D219%26epage%3D225%26doi%3D10.1016%2Fj.abb.2004.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miners, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, P. I.</span></span> <span> </span><span class="NLM_article-title">Drug glucuronidation in humans</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(91)90065-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2F0163-7258%2891%2990065-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1792239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK38Xht1ShsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=347-369&author=J.+O.+Minersauthor=P.+I.+Mackenzie&title=Drug+glucuronidation+in+humans&doi=10.1016%2F0163-7258%2891%2990065-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drug glucuronidation in humans</span></div><div class="casAuthors">Miners, John O.; Mackenzie, Peter I.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-69</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ∼270 refs.  Glucuronidation is a major metabolic pathway for a large no. of drugs in humans.  Conjugation of drugs and other chems. with glucuronic acid is catalyzed by the multigene UDP-glucuronosyltransferase family.  It is believed that a no. (unspecified at present) of glucuronosyltransferase isoenzymes, which probably differ in terms of substrate specificity and regulation, contribute to drug glucuronidation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpydPex6hIr_rVg90H21EOLACvtfcHk0ljz3bB-a4p3Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1ShsL8%253D&md5=2a01262fbd35772f7bbcb37e29cc1797</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2891%2990065-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252891%252990065-T%26sid%3Dliteratum%253Aachs%26aulast%3DMiners%26aufirst%3DJ.%2BO.%26aulast%3DMackenzie%26aufirst%3DP.%2BI.%26atitle%3DDrug%2520glucuronidation%2520in%2520humans%26jtitle%3DPharmacol.%2520Ther.%26date%3D1991%26volume%3D51%26spage%3D347%26epage%3D369%26doi%3D10.1016%2F0163-7258%2891%2990065-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faed, E. M.</span></span> <span> </span><span class="NLM_article-title">Properties of acyl glucuronides. Implications for studies of the pharmacokinetics and metabolism of acidic drugs</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.3109/03602538409033562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.3109%2F03602538409033562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=6396057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaL2MXnt1Wktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1984&pages=1213-1249&author=E.+M.+Faed&title=Properties+of+acyl+glucuronides.+Implications+for+studies+of+the+pharmacokinetics+and+metabolism+of+acidic+drugs&doi=10.3109%2F03602538409033562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of acyl glucuronides:  implications for studies of the pharmacokinetics and metabolism of acidic drugs</span></div><div class="casAuthors">Faed, Ellen M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">1213-49</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    </div><div class="casAbstract">A review with 168 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo4GdIX4n_frVg90H21EOLACvtfcHk0ljz3bB-a4p3Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXnt1Wktw%253D%253D&md5=4527f2890ac2410f7fdf7816c69d68b3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3109%2F03602538409033562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602538409033562%26sid%3Dliteratum%253Aachs%26aulast%3DFaed%26aufirst%3DE.%2BM.%26atitle%3DProperties%2520of%2520acyl%2520glucuronides.%2520Implications%2520for%2520studies%2520of%2520the%2520pharmacokinetics%2520and%2520metabolism%2520of%2520acidic%2520drugs%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D1984%26volume%3D15%26spage%3D1213%26epage%3D1249%26doi%3D10.3109%2F03602538409033562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span> <span> </span><span class="NLM_article-title">Unusual glucuronides</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1239</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.045096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.112.045096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1239-1251&author=U.+A.+Argikar&title=Unusual+glucuronides&doi=10.1124%2Fdmd.112.045096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.045096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.045096%26sid%3Dliteratum%253Aachs%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26atitle%3DUnusual%2520glucuronides%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1239%26epage%3D1251%26doi%3D10.1124%2Fdmd.112.045096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paine, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrighton, S. A.</span></span> <span> </span><span class="NLM_article-title">The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1081/DMR-120000653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1081%2FDMR-120000653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11768770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=273-297&author=M.+B.+Fisherauthor=M.+F.+Paineauthor=T.+J.+Strelevitzauthor=S.+A.+Wrighton&title=The+role+of+hepatic+and+extrahepatic+UDP-glucuronosyltransferases+in+human+drug+metabolism&doi=10.1081%2FDMR-120000653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism</span></div><div class="casAuthors">Fisher, Michael B.; Paine, Mary F.; Strelevitz, Timothy J.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">273-297</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  At present, the methods and enzymol. of the UDP-glucuronosyltransferases (UGTs) lag behind that of the cytochromes P 450 (CYPs).  About 15 human UGTs have been identified, and knowledge about their regulation, substrate selectivity, and tissue distribution has progressed recently.  Alamethicin has been characterized as a treatment to remove the latency of microsomal glucuronidations.  Most UGT isoforms appear to have a distinct hepatic and/or extrahepatic expression, resulting in significant expression in kidney, intestine, and steroid target tissues.  The gastrointestinal tract possesses a complex expression pattern largely contg. members of the UGT1A subfamily.  Thus, these forms are poised to participate in the first pass metab. of oral drugs.  The authors and others have identified a significant expression of UGT1A1 in human small intestine, an enzyme possessing considerable allelic variability and a polymorphic expression pattern in intestine.  Intestinal glucuronidation therefore plays a major role not only in first pass metab., but also in the degree of interindividual variation in overall oral bioavailability.  Due to issues such as significant genetic variability and tissue localization in first-pass organs, clearance due to UGT1A1 should be minimized for new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrThMjjbeI-nbVg90H21EOLACvtfcHk0lj2MOXYNS9SLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVGqsg%253D%253D&md5=7a35a3d8dcba636ac4bcac54a13f47b1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1081%2FDMR-120000653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120000653%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DPaine%26aufirst%3DM.%2BF.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520role%2520of%2520hepatic%2520and%2520extrahepatic%2520UDP-glucuronosyltransferases%2520in%2520human%2520drug%2520metabolism%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2001%26volume%3D33%26spage%3D273%26epage%3D297%26doi%3D10.1081%2FDMR-120000653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tukey, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strassburg, C. P.</span></span> <span> </span><span class="NLM_article-title">Human UDP-glucuronosyltransferases: metabolism, expression and disease</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.40.1.581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1146%2Fannurev.pharmtox.40.1.581" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2000&pages=581-616&author=R.+H.+Tukeyauthor=C.+P.+Strassburg&title=Human+UDP-glucuronosyltransferases%3A+metabolism%2C+expression+and+disease&doi=10.1146%2Fannurev.pharmtox.40.1.581"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.40.1.581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.40.1.581%26sid%3Dliteratum%253Aachs%26aulast%3DTukey%26aufirst%3DR.%2BH.%26aulast%3DStrassburg%26aufirst%3DC.%2BP.%26atitle%3DHuman%2520UDP-glucuronosyltransferases%253A%2520metabolism%252C%2520expression%2520and%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2000%26volume%3D40%26spage%3D581%26epage%3D616%26doi%3D10.1146%2Fannurev.pharmtox.40.1.581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, J. K.</span></span> <span> </span><span class="NLM_article-title">Roles of glucuronidation and UDPglucuronosyltransferases in xenobiotic bioactivation reactions</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/S0009-2797(00)00198-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2FS0009-2797%2800%2900198-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11154740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=171-193&author=J.+K.+Ritter&title=Roles+of+glucuronidation+and+UDPglucuronosyltransferases+in+xenobiotic+bioactivation+reactions&doi=10.1016%2FS0009-2797%2800%2900198-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions</span></div><div class="casAuthors">Ritter, J. K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">171-193</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 121 refs.  Glucuronide conjugates represent one of the major types of naturally occurring phase 2 metabolites of xenobiotics and endobiotics.  The process underlying their formation, glucuronidation, is normally considered detoxifying, because glucuronides usually possess less intrinsic biol. or chem. activity than their parent aglycons and they are rapid excreted.  However, a no. of glucuronide conjugates are known that are active and may contribute to pharmacol. activities or toxicities assocd. with their parent compds.  These include two classes of glucuronides with electrophilic chem. reactivity (N-O-glucuronides of hydroxamic acids and acyl glucuronides of carboxylic acids) and several types of glucuronides that impart biol. effects through non-covalent interactions (morphine 6-O-glucuronide, retinoid glucuronides, and D-ring glucuronides of estrogens).  Glucuronides may thus contribute to clin. significant effects, including environmental arylamine-induced carcinogenesis, drug hypersensitivity and other toxicities assocd. with carboxylic acid drugs, morphine analgesia, and cholestasis from estrogens.  This review summarizes the rat and human UDP-glucuronosyltransferases that may be involved in the formation of bioactive glucuronides, including their substrate- and tissue-specificity and genetic and environmental influences on their activity.  This knowledge may be useful for enhancing the therapeutic efficacy and minimizing the risk of adverse effects assocd. with xenobiotics that undergo bioactivating glucuronidation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1oYTW1Dg3VLVg90H21EOLACvtfcHk0lj2MOXYNS9SLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlOmsw%253D%253D&md5=ef694b6d692a426a695de41d37199ec3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900198-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900198-8%26sid%3Dliteratum%253Aachs%26aulast%3DRitter%26aufirst%3DJ.%2BK.%26atitle%3DRoles%2520of%2520glucuronidation%2520and%2520UDPglucuronosyltransferases%2520in%2520xenobiotic%2520bioactivation%2520reactions%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D129%26spage%3D171%26epage%3D193%26doi%3D10.1016%2FS0009-2797%2800%2900198-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sallustio, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabordo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nation, R. L.</span></span> <span> </span><span class="NLM_article-title">Hepatic disposition of electrophilic acyl glucuronide conjugates</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.2174/1389200003339153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.2174%2F1389200003339153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11465081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlOrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=163-180&author=B.+C.+Sallustioauthor=L.+Sabordoauthor=A.+M.+Evansauthor=R.+L.+Nation&title=Hepatic+disposition+of+electrophilic+acyl+glucuronide+conjugates&doi=10.2174%2F1389200003339153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic disposition of electrophilic acyl glucuronide conjugates</span></div><div class="casAuthors">Sallustio, B. C.; Sabordo, L.; Evans, A. M.; Nation, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-180</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 148 refs.  Acyl glucuronides are a unique class of electrophilic metabolites, capable of non-enzymic reactions including acylation and/or glycation of endogenous macromols., hydrolysis to reform the parent aglycon, and intra-mol. rearrangement.  Three human UDP-glucuronosyltransferases (UGTs) catalyzing the hepatic glucuronidation of carboxylic acid drugs have been identified, UGT1A3, UGT1A9 and a UGT2B7 variant.  Within the liver, acyl glucuronides also undergo enzymic hydrolysis by β-glucuronidase and esterases which, like the UGTs, are located in the endoplasmic reticulum.  In addn., the liver also transports acyl glucuronides between the sinusoidal circulation and bile.  Due to their polarity, membrane transport of acyl glucuronides is carrier-mediated, resulting in the establishment of significant concn. gradients between sinusoidal circulation, hepatocyte and bile, in the order of 1:50:5000 in these compartments, resp.  As a result of exposure to high acyl glucuronide concns., the liver is a major target of protein adduct formation.  Dipeptidylpeptidase IV, UGTs and tubulin have been identified as intra-hepatic targets of adduct formation by acyl glucuronides.  Adduct formation results in altered protein activity and potentially contributes to hepatotoxicity.  Hepatic protein adducts are also immunogenic and may cause immune mediated cytotoxicity.  Both intra- and extra-hepatic exposure to acyl glucuronides depends not only on the efficiency of glucuronidation and hydrolysis by the liver, but also on the efficiency of the hepatic membrane transport systems.  Thus, changes in membrane transporter activities, as may occur due to satn. or drug-drug interactions, can significantly affect acyl glucuronide disposition, adduct formation and the disposition of parent aglycon, thereby affecting clin. efficacy and toxicity of acyl glucuronide forming drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-AkLxhuBjD7Vg90H21EOLACvtfcHk0ljMPV4JEHOrJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlOrs7o%253D&md5=dee87ae191547acf3e8b2e87fb87a013</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F1389200003339153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200003339153%26sid%3Dliteratum%253Aachs%26aulast%3DSallustio%26aufirst%3DB.%2BC.%26aulast%3DSabordo%26aufirst%3DL.%26aulast%3DEvans%26aufirst%3DA.%2BM.%26aulast%3DNation%26aufirst%3DR.%2BL.%26atitle%3DHepatic%2520disposition%2520of%2520electrophilic%2520acyl%2520glucuronide%2520conjugates%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2000%26volume%3D1%26spage%3D163%26epage%3D180%26doi%3D10.2174%2F1389200003339153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scialis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span> <span> </span><span class="NLM_article-title">Hepatic disposition of gemfibrozil and its major metabolite gemfibrozil 1-O-β-glucuronide</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3943</span>– <span class="NLM_lpage">3952</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWhs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=3943-3952&author=E.+Kimotoauthor=R.+Liauthor=R.+J.+Scialisauthor=Y.+Laiauthor=M.+V.+Varma&title=Hepatic+disposition+of+gemfibrozil+and+its+major+metabolite+gemfibrozil+1-O-%CE%B2-glucuronide&doi=10.1021%2Facs.molpharmaceut.5b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide</span></div><div class="casAuthors">Kimoto, Emi; Li, Rui; Scialis, Renato J.; Lai, Yurong; Varma, Manthena V. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3943-3952</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gemfibrozil (GEM), which decreases serum triglycerides and low d. lipoprotein, perpetrates drug-drug interactions (DDIs) with several drugs.  These DDIs are primarily attributed to the inhibition of drug transporters and metabolic enzymes, particularly cytochrome P 450 (CYP) 2C8 by the major circulating metabolite gemfibrozil 1-O-β-glucuronide (GG).  Here, we characterized the transporter-mediated hepatic disposition of GEM and GG using sandwich-cultured human hepatocytes (SCHH) and transporter-transfect systems.  Significant active uptake was noted in SCHH for the metabolite.  GG, but not GEM, showed substrate affinity to org. anion transporting polypeptide (OATP) 1B1, 1B3, and 2B1.  In SCHH, glucuronidation was characterized affinity consts. (Km) of 7.9 and 61.4 μM, and biliary excretion of GG was obsd.  Furthermore, GG showed active basolateral efflux from preloaded SCHH and ATP-dependent uptake into membrane vesicles overexpressing multidrug resistance-assocd. protein (MRP) 2, MRP3, and MRP4.  A math. model was developed to est. hepatic uptake and efflux kinetics of GEM and GG based on SCHH studies.  Collectively, the hepatic transporters play a key role in the disposition and thus det. the local concns. of GEM and more so for GG, which is the predominant inhibitory species against CYP2C8 and OATP1B1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooA1I3axUaVLVg90H21EOLACvtfcHk0lhKUNmBI2VtXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWhs7jP&md5=2000815ba3930a0f8f4dbbeb15dd444e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00411%26sid%3Dliteratum%253Aachs%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26atitle%3DHepatic%2520disposition%2520of%2520gemfibrozil%2520and%2520its%2520major%2520metabolite%2520gemfibrozil%25201-O-%25CE%25B2-glucuronide%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D3943%26epage%3D3952%26doi%3D10.1021%2Facs.molpharmaceut.5b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, A. M.</span></span> <span> </span><span class="NLM_article-title">Membrane transport as a determinant of the hepatic elimination of drugs and metabolites</span>. <i>Clin. Exp. Pharmacol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">970</span>– <span class="NLM_lpage">974</span>, <span class="refDoi"> DOI: 10.1111/j.1440-1681.1996.tb01151.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1111%2Fj.1440-1681.1996.tb01151.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=8911743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK28XmsFGntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=970-974&author=A.+M.+Evans&title=Membrane+transport+as+a+determinant+of+the+hepatic+elimination+of+drugs+and+metabolites&doi=10.1111%2Fj.1440-1681.1996.tb01151.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane transport as a determinant of the hepatic elimination of drugs and metabolites</span></div><div class="casAuthors">Evans, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10/11</span>),
    <span class="NLM_cas:pages">970-974</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">A review, with 32 refs.  The liver is ideally suited for the efficient uptake of drugs from sinusoidal blood.  For most drugs, uptake into hepatocytes across the basolateral membrane occurs via passive diffusion, with minimal reliance on carrier-mediated transport systems.  Often, this passive diffusion is so efficient that uptake is rate-limited by the delivery of the drug to the liver (i.e. blood flow) rather than membrane transport per se.  For highly polar mols., passive diffusion no longer represents an efficient mode of hepatocellular uptake and there is an increased reliance on carrier-mediated transport systems.  For these compds., membrane transport may dictate the overall efficiency of hepatic elimination.  Drug metabolites, particularly conjugated metabolites, such as sulfates and glucuronides, are invariably more polar than their precursors and are more likely to experience hepatocyte membranes as diffusional barriers.  In the presence of such a barrier, the hepatocellular disposal of a locally formed metabolite will depend critically on the presence and activity of carrier-mediated transport systems for sinusoidal efflux and biliary excretion.  Transporters of current interest include P-glycoproteins, which are responsible for the biliary excretion of a range of org. cations, and the canalicular multispecific org. anion transporter.  Intracellular trapping of hepatically formed metabolites, secondary to low membrane permeability, is clin. important as many metabolites are potentially hepatotoxic and/or capable of interfering with the hepatic transport of endogenous compds. or other drugs and metabolites.  In addn., if the metabolite is unstable, intracellular accumulation can lead to the regeneration of the precursor and 'futile cycling' within hepatocytes.  An increased understanding of the factors influencing the intracellular concns. of drugs and hepatically formed metabolites in the liver will improve our ability to specifically treat liver disorders, such as hepatocellular carcinoma and malaria, and minimize the risk of hepatotoxicity from drugs and other xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGdJjS4bgjcLVg90H21EOLACvtfcHk0lgCIp-SI-Me8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFGntrg%253D&md5=b29ee229721abb97e3661f3bcd61ebcb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.1996.tb01151.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.1996.tb01151.x%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DA.%2BM.%26atitle%3DMembrane%2520transport%2520as%2520a%2520determinant%2520of%2520the%2520hepatic%2520elimination%2520of%2520drugs%2520and%2520metabolites%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D1996%26volume%3D23%26spage%3D970%26epage%3D974%26doi%3D10.1111%2Fj.1440-1681.1996.tb01151.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burckhardt, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burckhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellerich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, V. W.</span></span> <span> </span><span class="NLM_article-title">Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney</span>. <i>Nephrol., Dial., Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1093/ndt/gfm219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1093%2Fndt%2Fgfm219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=17526543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgsb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=2497-2503&author=N.+A.+Wolffauthor=B.+C.+Burckhardtauthor=G.+Burckhardtauthor=M.+Oellerichauthor=V.+W.+Armstrong&title=Mycophenolic+acid+%28MPA%29+and+its+glucuronide+metabolites+interact+with+transport+systems+responsible+for+excretion+of+organic+anions+in+the+basolateral+membrane+of+the+human+kidney&doi=10.1093%2Fndt%2Fgfm219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney</span></div><div class="casAuthors">Wolff, Natascha A.; Burckhardt, Birgitta C.; Burckhardt, Gerhard; Oellerich, Michael; Armstrong, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2497-2503</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">0931-0509</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Mycophenolic acid (MPA), the active moiety of the prodrug mycophenolate mofetil, is widely used in immunosuppressive regimens after kidney, liver or heart transplantation.  MPA is metabolized predominantly to the inactive 7-O-glucuronide (MPAG).  A minor fraction is converted to the pharmacol. active acyl glucuronide (AcMPAG).  All compds. ultimately are eliminated via the kidneys.  Due to their structures, MPA and its metabolites are candidate substrates for the human org. anion transporters 1 (OAT1) and 3 (OAT3) as well as for the Na+-dicarboxylate cotransporter 3 (NaDC3).  Methods: Human (h)OAT1, hOAT3 and hNaDC3 were expressed from in vitro synthesized cRNA in collagenase-defolliculated Xenopus laevis oocytes.  On day 3 post-injection, measurements were made of (i) substrate-assocd. currents using MPA and MPAG (only in hNaDC3-expressing oocytes) and (ii) uptake of [3H]p-aminohippurate (hOAT1) or [3H]estrone sulfate (hOAT3) in the absence or presence of either MPA, MPAG or AcMPAG.  Results: In hNaDC3-expressing oocytes at -60 mV, MPA (0.1 mM) as well as MPAG (0.1 mM) induced inward currents that were 17 and 25% of the currents evoked by succinate (1 mM).  Vice versa, currents induced by succinate (1 mM) were partially inhibited by MPA and MPAG. hOAT1 and hOAT3 were potently inhibited by MPA (IC50 1.24 and 0.52 μM, resp.).  Human OAT3, but not hOAT1, was addnl. inhibited by both glucuronide metabolites of MPA in a concn.-dependent manner (IC50 15.2 μM for MPAG and 2.88 μM for AcMPAG), consistent with a preference of hOAT3 for more bulky substrates compared with hOAT1.  Conclusions: MPA and its metabolites potently interact with renal org. anion transporters hOAT1 and hOAT3, and thereby may interfere with the renal secretion of antiviral drugs, cortisol and other org. anions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFGPolN5is77Vg90H21EOLACvtfcHk0lgacQluxcHMxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgsb3I&md5=71e210520a7dc4bdfc540167fba524f8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfm219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfm219%26sid%3Dliteratum%253Aachs%26aulast%3DWolff%26aufirst%3DN.%2BA.%26aulast%3DBurckhardt%26aufirst%3DB.%2BC.%26aulast%3DBurckhardt%26aufirst%3DG.%26aulast%3DOellerich%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DV.%2BW.%26atitle%3DMycophenolic%2520acid%2520%2528MPA%2529%2520and%2520its%2520glucuronide%2520metabolites%2520interact%2520with%2520transport%2520systems%2520responsible%2520for%2520excretion%2520of%2520organic%2520anions%2520in%2520the%2520basolateral%2520membrane%2520of%2520the%2520human%2520kidney%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2007%26volume%3D22%26spage%3D2497%26epage%3D2503%26doi%3D10.1093%2Fndt%2Fgfm219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putluru, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kole, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandlekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furlong, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marathe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, A. D.</span></span> <span> </span><span class="NLM_article-title">Diclofenac and its acyl glucuronide: Determination of in vivo exposure in human subjects and characterization as human drug transporter substrates in vitro</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.066944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.115.066944" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=320-328&author=Y.+Zhangauthor=Y.+H.+Hanauthor=S.+P.+Putluruauthor=M.+K.+Mattaauthor=P.+Koleauthor=S.+Mandlekarauthor=M.+T.+Furlongauthor=T.+Liuauthor=R.+A.+Iyerauthor=P.+Maratheauthor=Z.+Yangauthor=Y.+Laiauthor=A.+D.+Rodrigues&title=Diclofenac+and+its+acyl+glucuronide%3A+Determination+of+in+vivo+exposure+in+human+subjects+and+characterization+as+human+drug+transporter+substrates+in+vitro&doi=10.1124%2Fdmd.115.066944"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.066944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.066944%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DY.%2BH.%26aulast%3DPutluru%26aufirst%3DS.%2BP.%26aulast%3DMatta%26aufirst%3DM.%2BK.%26aulast%3DKole%26aufirst%3DP.%26aulast%3DMandlekar%26aufirst%3DS.%26aulast%3DFurlong%26aufirst%3DM.%2BT.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DIyer%26aufirst%3DR.%2BA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26atitle%3DDiclofenac%2520and%2520its%2520acyl%2520glucuronide%253A%2520Determination%2520of%2520in%2520vivo%2520exposure%2520in%2520human%2520subjects%2520and%2520characterization%2520as%2520human%2520drug%2520transporter%2520substrates%2520in%2520vitro%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D320%26epage%3D328%26doi%3D10.1124%2Fdmd.115.066944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1124/pr.111.005439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fpr.111.005439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=23406671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVCms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=578-640&author=R.+S.+Obach&title=Pharmacologically+active+drug+metabolites%3A+impact+on+drug+discovery+and+pharmacotherapy&doi=10.1124%2Fpr.111.005439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">578-640</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Metab. represents the most prevalent mechanism for drug clearance.  Many drugs are converted to metabolites that can retain the intrinsic affinity of the parent drug for the pharmacol. target.  Drug metab. redox reactions such as heteroatom dealkylations, hydroxylations, heteroatom oxygenations, redns., and dehydrogenations can yield active metabolites, and in rare cases even conjugation reactions can yield an active metabolite.  To understand the contribution of an active metabolite to efficacy relative to the contribution of the parent drug, the target affinity, functional activity, plasma protein binding, membrane permeability, and pharmacokinetics of the active metabolite and parent drug must be known.  Underlying pharmacokinetic principles and clearance concepts are used to describe the dispositional behavior of metabolites in vivo.  A method to rapidly identify active metabolites in drug research is described.  Finally, over 100 examples of drugs with active metabolites are discussed with regard to the importance of the metabolite(s) in efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-qUngT0My0bVg90H21EOLACvtfcHk0liDYUN9l_VDxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVCms7o%253D&md5=beb38b41325e00d4c03b91b4158a3d6a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fpr.111.005439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.111.005439%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPharmacologically%2520active%2520drug%2520metabolites%253A%2520impact%2520on%2520drug%2520discovery%2520and%2520pharmacotherapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D578%26epage%3D640%26doi%3D10.1124%2Fpr.111.005439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. W.</span></span> <span> </span><span class="NLM_article-title">Morphine-6-glucuronide: actions and mechanisms</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1002/med.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1002%2Fmed.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=15952175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGiurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=521-544&author=G.+J.+Kilpatrickauthor=T.+W.+Smith&title=Morphine-6-glucuronide%3A+actions+and+mechanisms&doi=10.1002%2Fmed.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-6-glucuronide: actions and mechanisms</span></div><div class="casAuthors">Kilpatrick, Gavin J.; Smith, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">521-544</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Morphine-6-glucuronide (M6G) appears to show equiv. analgesia to morphine but to have a superior side-effect profile in terms of reduced liability to induce nausea and vomiting and respiratory depression.  The purpose of this review is to examine the evidence behind this statement and to identify the possible reasons that may contribute to the profile of M6G.  The vast majority of available data supports the notion that both M6G and morphine mediate their effects by activating the μ-opioid receptor.  The differences for which there is a reasonable consensus in the literature can be summarized as: (1) Morphine has a slightly higher affinity for the μ-opioid receptor than M6G, (2) M6G shows a slightly higher efficacy at the μ-opioid receptor, (3) M6G has a lower affinity for the κ-opioid receptor than morphine, and (4) M6G has a very different absorption, distribution, metab., and excretion (ADME) profile from morphine.  However, none of these are adequate alone to explain the clin. differences between M6G and morphine.  The ADME differences are perhaps most likely to explain some of the differences but seem unlikely to be the whole story.  Further work is required to examine further the profile of M6G, notably whether M6G penetrates differentially to areas of the brain involved in pain and those involved in nausea, vomiting, and respiratory control or whether μ-opioid receptors in these brain areas differ in either their regulation or pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBuDnIfESMubVg90H21EOLACvtfcHk0li78708ODi18A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGiurfN&md5=027c9e5903b8109d39116def34f12d9b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fmed.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20035%26sid%3Dliteratum%253Aachs%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DSmith%26aufirst%3DT.%2BW.%26atitle%3DMorphine-6-glucuronide%253A%2520actions%2520and%2520mechanisms%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D521%26epage%3D544%26doi%3D10.1002%2Fmed.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Heek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoos, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sybertz, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. R.,  Jr</span></span> <span> </span><span class="NLM_article-title">Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235 and its glucuronide, SCH60663</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1748</span>– <span class="NLM_lpage">1754</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0703235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1038%2Fsj.bjp.0703235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10780982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2qsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=1748-1754&author=M.+van%0AHeekauthor=C.+Farleyauthor=D.+S.+Comptonauthor=L.+Hoosauthor=K.+B.+Altonauthor=E.+J.+Sybertzauthor=H.+R.+Davis&title=Comparison+of+the+activity+and+disposition+of+the+novel+cholesterol+absorption+inhibitor%2C+SCH58235+and+its+glucuronide%2C+SCH60663&doi=10.1038%2Fsj.bjp.0703235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663</span></div><div class="casAuthors">Van Heek, Margaret; Farley, Constance; Compton, Douglas S.; Hoos, Lizbeth; Alton, Kevin B.; Sybertz, Edmund J.; Davis, Harry R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1748-1754</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 Previous studies described the metab.-based discovery of a potent, selective inhibitor of intestinal absorption of cholesterol, SCH58235 (Ezetimibe).  Here we demonstrate that the phenolic glucuronide (SCH60663) of SCH58235, was more potent at inhibiting cholesterol absorption in rats than SCH58235, when administered by the intraduodenal route.  2 To understand the increased potency of the glucuronide, the metab. and distribution of SCH58235 and SCH60663 were studied in bile duct-cannulated rats.  3 One minute after intraduodenal delivery of SCH58235, significant levels of compd. were detected in portal plasma; >95% was glucuronidated, indicating that the intestine was metabolizing SCH58235 to its glucuronide.  When intraduodenally delivered as SCH58235, the compd. was glucuronidated, moved through the intestinal wall, into portal plasma, through the liver, and into bile.  However, when delivered as SCH60663, >95% of the compd. remained in the intestinal lumen and wall, which may explain its increased potency.  Significant inhibition of cholesterol absorption and glucuronidation of SCH58235 occurred when SCH58235 was i.v. injected into bile duct-cannulated rats.  Autoradiog. anal. demonstrated that drug related material was located throughout the intestinal villi, but concd. in the villus tip.  4 These data indicate that (a) SCH58235 is rapidly metabolized in the intestine to its glucuronide; (b) once glucuronidated, the dose is excreted in the bile, thereby delivering drug related material back to the site of action and (c) the glucuronide is more potent than the parent possibly because it localizes to the intestine.  Taken together, these data may explain the potency of SCH58235 in the rat (ID50=0.0015 mg kg-1) and rhesus monkey (ID50=0.0005 mg kg-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO42lwI-9E0LVg90H21EOLACvtfcHk0lj8JV2O8UC4qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2qsr0%253D&md5=4797b25d860834b0827e8522e1a72eca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703235%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DFarley%26aufirst%3DC.%26aulast%3DCompton%26aufirst%3DD.%2BS.%26aulast%3DHoos%26aufirst%3DL.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26aulast%3DSybertz%26aufirst%3DE.%2BJ.%26aulast%3DDavis%26aufirst%3DH.%2BR.%26atitle%3DComparison%2520of%2520the%2520activity%2520and%2520disposition%2520of%2520the%2520novel%2520cholesterol%2520absorption%2520inhibitor%252C%2520SCH58235%2520and%2520its%2520glucuronide%252C%2520SCH60663%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D129%26spage%3D1748%26epage%3D1754%26doi%3D10.1038%2Fsj.bjp.0703235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Heek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yumibe, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sybertz, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. R.,  Jr</span></span> <span> </span><span class="NLM_article-title">In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=9336320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK2sXmslClt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=157-163&author=M.+van%0AHeekauthor=C.+F.+Franceauthor=D.+S.+Comptonauthor=R.+L.+McLeodauthor=N.+P.+Yumibeauthor=K.+B.+Altonauthor=E.+J.+Sybertzauthor=H.+R.+Davis&title=In+vivo+metabolism-based+discovery+of+a+potent+cholesterol+absorption+inhibitor%2C+SCH58235%2C+in+the+rat+and+rhesus+monkey+through+the+identification+of+the+active+metabolites+of+SCH48461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461</span></div><div class="casAuthors">Van Heek, Margaret; France, Constance F.; Compton, Douglas S.; McLeod, Robbie L.; Yumibe, Nathan P.; Alton, Kevin B.; Sybertz, Edmund J.; Davis, Harry R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-163</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">SCH48461 is a selective and highly potent inhibitor of cholesterol absorption.  In rats, SCH48461 is rapidly and completely metabolized in the first pass through the body.  To compare the activity of the metabolites of SCH48461 with SCH48461 itself, an intestinally cannulated, bile duct-cannulated rat model for cholesterol absorption was developed.  SCH48461 inhibited the absorption of cholesterol by 70%, whereas bile contg. the metabolites of SCH48461 (henceforth, "metabolite bile") inhibited the absorption by greater than 95%.  Very little of the recovered radioactive dose of SCH48461 was located in the intestinal lumen (7%) or wall (4%), whereas 85% appeared in bile.  However, in rats treated with metabolite bile, 62% of the dose remained in the lumen, 13% was assocd. with the wall and only 24% reappeared in bile, which suggests that the activity of the metabolite bile may be related to its higher retention in the intestinal wall.  Rats treated with metabolite bile had 64% and 84% less drug-related radioactivity in their plasma and livers, resp., compared with animals treated with SCH48461, which indicates that the metabolites are systemically less available than SCH48461.  The metabolites in bile were sepd. by high-performance liq. chromatog.; the most active fraction in the bile duct-cannulated rat model was identified by mass spectrometry as the glucuronide of the C4-phenol of SCH48461.  The other fractions had moderate or no activity.  Through the identification of the most active biliary metabolites of SCH48461 in the rat, we have discovered SCH58235, a novel cholesterol absorption inhibitor which is 400 times more potent than SCH48461 in the cholesterol-fed rhesus monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxu8lx3uQuF7Vg90H21EOLACvtfcHk0liyeCtRUDj8tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslClt7g%253D&md5=105ef449955b4f5498f7377135f37cee</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DFrance%26aufirst%3DC.%2BF.%26aulast%3DCompton%26aufirst%3DD.%2BS.%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DYumibe%26aufirst%3DN.%2BP.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26aulast%3DSybertz%26aufirst%3DE.%2BJ.%26aulast%3DDavis%26aufirst%3DH.%2BR.%26atitle%3DIn%2520vivo%2520metabolism-based%2520discovery%2520of%2520a%2520potent%2520cholesterol%2520absorption%2520inhibitor%252C%2520SCH58235%252C%2520in%2520the%2520rat%2520and%2520rhesus%2520monkey%2520through%2520the%2520identification%2520of%2520the%2520active%2520metabolites%2520of%2520SCH48461%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D157%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienen, W.</span></span> <span> </span><span class="NLM_article-title">Dabigatran acylglucuronide, the major human metabolite of dabigatran: in vitro formation, stability, and pharmacological activity</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1567</span>– <span class="NLM_lpage">1575</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.033696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.110.033696" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1567-1575&author=T.+Ebnerauthor=K.+Wagnerauthor=W.+Wienen&title=Dabigatran+acylglucuronide%2C+the+major+human+metabolite+of+dabigatran%3A+in+vitro+formation%2C+stability%2C+and+pharmacological+activity&doi=10.1124%2Fdmd.110.033696"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033696%26sid%3Dliteratum%253Aachs%26aulast%3DEbner%26aufirst%3DT.%26aulast%3DWagner%26aufirst%3DK.%26aulast%3DWienen%26aufirst%3DW.%26atitle%3DDabigatran%2520acylglucuronide%252C%2520the%2520major%2520human%2520metabolite%2520of%2520dabigatran%253A%2520in%2520vitro%2520formation%252C%2520stability%252C%2520and%2520pharmacological%2520activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1567%26epage%3D1575%26doi%3D10.1124%2Fdmd.110.033696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shipkova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niedmann, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellerich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, V. W.</span></span> <span> </span><span class="NLM_article-title">The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes</span>. <i>Transplant. Proc.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1080</span>– <span class="NLM_lpage">1081</span>, <span class="refDoi"> DOI: 10.1016/S0041-1345(00)02424-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2FS0041-1345%2800%2902424-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11267199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2nt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=1080-1081&author=M.+Shipkovaauthor=E.+Wielandauthor=E.+Sch%C3%BCtzauthor=C.+Wieseauthor=P.+D.+Niedmannauthor=M.+Oellerichauthor=V.+W.+Armstrong&title=The+acyl+glucuronide+metabolite+of+mycophenolic+acid+inhibits+the+proliferation+of+human+mononuclear+leukocytes&doi=10.1016%2FS0041-1345%2800%2902424-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes</span></div><div class="casAuthors">Shipkova, M.; Wieland, E.; Schutz, E.; Wiese, C.; Niedmann, P. D.; Oellerich, M.; Armstrong, V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1080-1081</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">It was detd. whether acyl glucuronide (AcMPAG), would inhibit lymphocyte proliferation in vitro.  AcMPAG was generated from mycophenolic acid (MPA) by incubation with human liver microsomes and purified by HPLC.  The addn. of increasing concns. of MPA or AcMPAG to mononuclear leukocytes incubations led to a dose dependent inhibition of cell proliferation.  AcMPAG had an inhibitory effect on lymphocyte proliferation, but this effect was slightly weaker when compared to MPA.  In contrast to MPA, the antiproliferative action of AcMPAG seemed to depend on guanine ribonucleotide depletion and on a further as yet unidentified mechanism.  The characteristic feature of AcMPAG is the irreversible covalent binding to proteins.  The formation of covalent adducts between human albumin and AcMPAG was obsd. both in vivo and in vitro.  The effect of albumin on AcMPAG suppression of leukocyte cell growth was more pronounced than that obsd. for MPA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSjz2AXAkdgLVg90H21EOLACvtfcHk0liCDPZerLcXaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2nt78%253D&md5=e71b2b1c7dee35396f37c10cc29e6bf7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2800%2902424-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252800%252902424-6%26sid%3Dliteratum%253Aachs%26aulast%3DShipkova%26aufirst%3DM.%26aulast%3DWieland%26aufirst%3DE.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DE.%26aulast%3DWiese%26aufirst%3DC.%26aulast%3DNiedmann%26aufirst%3DP.%2BD.%26aulast%3DOellerich%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DV.%2BW.%26atitle%3DThe%2520acyl%2520glucuronide%2520metabolite%2520of%2520mycophenolic%2520acid%2520inhibits%2520the%2520proliferation%2520of%2520human%2520mononuclear%2520leukocytes%26jtitle%3DTransplant.%2520Proc.%26date%3D2001%26volume%3D33%26spage%3D1080%26epage%3D1081%26doi%3D10.1016%2FS0041-1345%2800%2902424-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marbury, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasseter, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stecher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deykin, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of oral tonapofylline and its acyl-glucuronide metabolite in patients with mild and moderate hepatic impairment</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1177/0091270011400413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1177%2F0091270011400413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=21610206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFersLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=543-551&author=Z.+Liauthor=L.+S.+Ganauthor=T.+Marburyauthor=K.+C.+Lasseterauthor=A.+Natarajanauthor=S.+Stecherauthor=D.+Weiauthor=L.+Yangauthor=D.+Freedmanauthor=A.+Deykin&title=Pharmacokinetics+of+oral+tonapofylline+and+its+acyl-glucuronide+metabolite+in+patients+with+mild+and+moderate+hepatic+impairment&doi=10.1177%2F0091270011400413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of oral tonapofylline and its acyl-glucuronide metabolite in patients with mild and moderate hepatic impairment</span></div><div class="casAuthors">Li, Zhaoyang; Gan, Liang-Shang; Marbury, Thomas; Lasseter, Kenneth C.; Natarajan, Amy; Stecher, Scott; Wei, Dong; Yang, Liyu; Freedman, Daniel; Deykin, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-551</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The objective of the study was to evaluate the effect of hepatic impairment on the pharmacokinetics of tonapofylline.  Patients with mild or moderate hepatic impairment were enrolled in parallel with demog. matched healthy subjects.  All study participants received a single 75-mg oral tonapofylline capsule.  The pharmacokinetic parameters for both tonapofylline and its active metabolite, acyl-glucuronide (tonapofylline-AG), were affected by hepatic impairment significantly (P < .1) except for time to peak plasma concn. (tmax), terminal half-life (t1/2), and apparent vol. of distribution based on the terminal phase (Vdz/F).  In the mild group, peak plasma concn. (Cmax), area under the time-concn. curve from time 0 to 48 h postdose (AUC48h), and from time 0 to infinity (AUCinf) of tonapofylline modestly increased as compared with the control healthy subjects (GMR 1.62, 1.57, and 1.53, resp.).  The extent of increase of these parameters for tonapofylline-AG was more profound than tonapofylline with geometric mean ratio (GMR) ranging from 2.02 to 2.08.  Moderate hepatic impairment was also assocd. with modest increases of Cmax, AUC48h, and AUCinf of tonapofylline (GMR 1.41, 1.98, and 2.08, resp.).  Similar to the mild group, the increase of these parameters were higher for tonapofylline-AG with GMR ranging from 2.80 to 3.86.  Single oral 75-mg tonapofylline was safe and well tolerated in patients with mild or moderate hepatic impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXFqe8Pv3i_7Vg90H21EOLACvtfcHk0li5OR7p_p9KOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFersLk%253D&md5=74e7806cc975bbd6ebefd49000516efb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F0091270011400413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270011400413%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGan%26aufirst%3DL.%2BS.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DLasseter%26aufirst%3DK.%2BC.%26aulast%3DNatarajan%26aufirst%3DA.%26aulast%3DStecher%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DFreedman%26aufirst%3DD.%26aulast%3DDeykin%26aufirst%3DA.%26atitle%3DPharmacokinetics%2520of%2520oral%2520tonapofylline%2520and%2520its%2520acyl-glucuronide%2520metabolite%2520in%2520patients%2520with%2520mild%2520and%2520moderate%2520hepatic%2520impairment%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2012%26volume%3D52%26spage%3D543%26epage%3D551%26doi%3D10.1177%2F0091270011400413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8068</span>– <span class="NLM_lpage">8081</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00866</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8068-8081&author=K.+O.+Cameronauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=R.+G.+Kurumbailauthor=R.+Millerauthor=C.+T.+Salattoauthor=J.+Wardauthor=J.+M.+Withkaauthor=S.+K.+Bhattacharyaauthor=M.+Boehmauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+Calabreseauthor=N.+L.+Caspersauthor=E.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=D.+J.+Edmondsauthor=H.+Engauthor=D.+P.+Fernandoauthor=R.+Frisbieauthor=D.+Hepworthauthor=J.+Landroauthor=Y.+Maoauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+R.+Roseauthor=T.+Ryderauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=M.+Tuauthor=A.+C.+Wolfordauthor=J.+Xiao&title=Discovery+and+preclinical+characterization+of+6-chloro-5-%5B4-%281-hydroxycyclobutyl%29phenyl%5D-1H-indole-3-carboxylic+acid+%28PF-06409577%29%2C+a+direct+activator+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29%2C+for+the+potential+treatment+of+diabetic+nephropathy&doi=10.1021%2Facs.jmedchem.6b00866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy</span></div><div class="casAuthors">Cameron, Kimberly O.; Kung, Daniel W.; Kalgutkar, Amit S.; Kurumbail, Ravi G.; Miller, Russell; Salatto, Christopher T.; Ward, Jessica; Withka, Jane M.; Bhattacharya, Samit K.; Boehm, Markus; Borzilleri, Kris A.; Brown, Janice A.; Calabrese, Matthew; Caspers, Nicole L.; Cokorinos, Emily; Conn, Edward L.; Dowling, Matthew S.; Edmonds, David J.; Eng, Heather; Fernando, Dilinie P.; Frisbie, Richard; Hepworth, David; Landro, James; Mao, Yuxia; Rajamohan, Francis; Reyes, Allan R.; Rose, Colin R.; Ryder, Tim; Shavnya, Andre; Smith, Aaron C.; Tu, Meihua; Wolford, Angela C.; Xiao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8068-8081</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells.  On the basis of human genetic assocn. data, AMPK activators were pursued for the treatment of diabetic nephropathy.  Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compd.  Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7).  Compd. 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUC3BGd-8kbVg90H21EOLACvtfcHk0liXoxOHjN0iAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI&md5=0b70014081c86df1cf3d713ab943d39c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00866%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25206-chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2520acid%2520%2528PF-06409577%2529%252C%2520a%2520direct%2520activator%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8068%26epage%3D8081%26doi%3D10.1021%2Facs.jmedchem.6b00866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKintosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span> <span> </span><span class="NLM_article-title">AMP-activated protein kinase: a cellular energy sensor that comes in twelve flavours</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">2987</span>– <span class="NLM_lpage">3001</span>, <span class="refDoi"> DOI: 10.1111/febs.13698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1111%2Ffebs.13698" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=2987-3001&author=F.+A.+Rossauthor=C.+MacKintoshauthor=D.+G.+Hardie&title=AMP-activated+protein+kinase%3A+a+cellular+energy+sensor+that+comes+in+twelve+flavours&doi=10.1111%2Ffebs.13698"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13698%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DF.%2BA.%26aulast%3DMacKintosh%26aufirst%3DC.%26aulast%3DHardie%26aufirst%3DD.%2BG.%26atitle%3DAMP-activated%2520protein%2520kinase%253A%2520a%2520cellular%2520energy%2520sensor%2520that%2520comes%2520in%2520twelve%2520flavours%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26spage%3D2987%26epage%3D3001%26doi%3D10.1111%2Ffebs.13698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riek, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuerk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlattner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallimann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, D.</span></span> <span> </span><span class="NLM_article-title">Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">32207</span>– <span class="NLM_lpage">32216</span>, <span class="refDoi"> DOI: 10.1074/jbc.M606357200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1074%2Fjbc.M606357200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=16943194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSrsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=32207-32216&author=M.+Suterauthor=U.+Riekauthor=R.+Tuerkauthor=U.+Schlattnerauthor=T.+Wallimannauthor=D.+Neumann&title=Dissecting+the+role+of+5%E2%80%B2-AMP+for+allosteric+stimulation%2C+activation%2C+and+deactivation+of+AMP-activated+protein+kinase&doi=10.1074%2Fjbc.M606357200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the Role of 5'-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase</span></div><div class="casAuthors">Suter, Marianne; Riek, Uwe; Tuerk, Roland; Schlattner, Uwe; Wallimann, Theo; Neumann, Dietbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">32207-32216</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a heterotrimeric protein kinase that is crucial for cellular energy homeostasis of eukaryotic cells and organisms.  Here we report on the activation of AMPK α1β1γ1 and α2β2γ1 by their upstream kinases (Ca2+/calmodulin-dependent protein kinase kinase-β and LKB1-MO25α-STRADα), deactivation by protein phosphatase 2Cα (PP2Cα), and the extent of stimulation of AMPK by its allosteric activator AMP, using purified recombinant enzyme prepns.  An accurate high pressure liq. chromatog. (HPLC)-based method for AMPK activity measurements was established, which allowed for direct quantitation of the unphosphorylated and phosphorylated artificial peptide substrate, as well as the adenine nucleotides.  Our results show a 1000-fold activation of AMPK by the combined effects of upstream kinase and satg. concns. of AMP.  The two AMPK isoforms exhibit similar specific activities (6 μmol/min/mg) and do not differ significantly by their responsiveness to AMP.  Due to the inherent instability of ATP and ADP, it proved impossible to assay AMPK activity in the abs. absence of AMP.  However, the half-maximal stimulatory effect of AMP is reached below 2 μM.  AMP does not appear to augment phosphorylation by upstream kinases in the purified in vitro system, but deactivation by dephosphorylation of AMPK α-subunits at Thr-172 by protein phosphatase 2Cα is attenuated by AMP.  Furthermore, it is shown that neither purified NAD+ nor NADH alters the activity of AMPK in a concn. range of 0-300 μM, resp.  Finally, evidence is provided that ZMP, a compd. formed in 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR)-treated cells to activate AMPK in vivo, allosterically activates purified AMPK in vitro, but compared with AMP, maximal activity is not reached.  These data shed new light on physiol. important aspects of AMPK regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrABBO1cst_YrVg90H21EOLACvtfcHk0lhuRpySdEgYAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSrsbnE&md5=d878ffbbd7aa481f314ba8c9b508e0ab</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606357200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606357200%26sid%3Dliteratum%253Aachs%26aulast%3DSuter%26aufirst%3DM.%26aulast%3DRiek%26aufirst%3DU.%26aulast%3DTuerk%26aufirst%3DR.%26aulast%3DSchlattner%26aufirst%3DU.%26aulast%3DWallimann%26aufirst%3DT.%26aulast%3DNeumann%26aufirst%3DD.%26atitle%3DDissecting%2520the%2520role%2520of%25205%25E2%2580%25B2-AMP%2520for%2520allosteric%2520stimulation%252C%2520activation%252C%2520and%2520deactivation%2520of%2520AMP-activated%2520protein%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D32207%26epage%3D32216%26doi%3D10.1074%2Fjbc.M606357200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dugan, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond-Stanic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreyev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhtman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepetan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosius, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naviaux, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">4888</span>– <span class="NLM_lpage">4899</span>, <span class="refDoi"> DOI: 10.1172/JCI66218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1172%2FJCI66218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=24135141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslKksb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4888-4899&author=L.+L.+Duganauthor=Y.+H.+Youauthor=S.+S.+Aliauthor=M.+Diamond-Stanicauthor=S.+Miyamotoauthor=A.+E.+DeClevesauthor=A.+Andreyevauthor=T.+Quachauthor=S.+Lyauthor=G.+Shekhtmanauthor=W.+Nguyenauthor=A.+Chepetanauthor=T.+P.+Leauthor=L.+Wangauthor=M.+Xuauthor=K.+P.+Paikauthor=A.+Fogoauthor=B.+Violletauthor=A.+Murphyauthor=F.+Brosiusauthor=R.+K.+Naviauxauthor=K.+Sharma&title=AMPK+dysregulation+promotes+diabetes-related+reduction+of+superoxide+and+mitochondrial+function&doi=10.1172%2FJCI66218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function</span></div><div class="casAuthors">Dugan, Laura L.; You, Young-Hyun; Ali, Sameh S.; Diamond-Stanic, Maggie; Miyamoto, Satoshi; De Cleves, Anne-Emilie; Andreyev, Aleksander; Quach, Tammy; Ly, San; Shekhtman, Grigory; Nguyen, William; Chepetan, Andre; Le, Thuy P.; Wang, Lin; Xu, Ming; Paik, Kacie P.; Fogo, Agnes; Viollet, Benoit; Murphy, Anne; Brosius, Frank; Naviaux, Robert K.; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4888-4899</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Diabetic microvascular complications have been considered to be mediated by a glucose-driven increase in mitochondrial superoxide anion prodn.  Here, we report that superoxide prodn. was reduced in the kidneys of a steptozotocin-induced mouse model of type 1 diabetes, as assessed by in vivo real-time transcutaneous fluorescence, confocal microscopy, and ESR anal.  Redn. of mitochondrial biogenesis and phosphorylation of pyruvate dehydrogenase (PDH) were obsd. in kidneys from diabetic mice.  These observations were consistent with an overall redn. of mitochondrial glucose oxidn.  Activity of AMPK, the major energy-sensing enzyme, was reduced in kidneys from both diabetic mice and humans.  Mitochondrial biogenesis, PDH activity, and mitochondrial complex activity were rescued by treatment with the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR).  AICAR treatment induced superoxide prodn. and was linked with glomerular matrix and albuminuria redn. in the diabetic kidney.  Furthermore, diabetic heterozygous superoxide dismutase 2 (Sod2+/-) mice had no evidence of increased renal disease, and Ampka2-/- mice had increased albuminuria that was not reduced with AICAR treatment.  Redn. of mitochondrial superoxide prodn. with rotenone was sufficient to reduce AMPK phosphorylation in mouse kidneys.  Taken together, these results demonstrate that diabetic kidneys have reduced superoxide and mitochondrial biogenesis and activation of AMPK enhances superoxide prodn. and mitochondrial function while reducing disease activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqQbY5f3Z-crVg90H21EOLACvtfcHk0lhuRpySdEgYAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslKksb3O&md5=e907941fec351c3da469acc473e24ae6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1172%2FJCI66218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI66218%26sid%3Dliteratum%253Aachs%26aulast%3DDugan%26aufirst%3DL.%2BL.%26aulast%3DYou%26aufirst%3DY.%2BH.%26aulast%3DAli%26aufirst%3DS.%2BS.%26aulast%3DDiamond-Stanic%26aufirst%3DM.%26aulast%3DMiyamoto%26aufirst%3DS.%26aulast%3DDeCleves%26aufirst%3DA.%2BE.%26aulast%3DAndreyev%26aufirst%3DA.%26aulast%3DQuach%26aufirst%3DT.%26aulast%3DLy%26aufirst%3DS.%26aulast%3DShekhtman%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DW.%26aulast%3DChepetan%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DT.%2BP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DPaik%26aufirst%3DK.%2BP.%26aulast%3DFogo%26aufirst%3DA.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DA.%26aulast%3DBrosius%26aufirst%3DF.%26aulast%3DNaviaux%26aufirst%3DR.%2BK.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DAMPK%2520dysregulation%2520promotes%2520diabetes-related%2520reduction%2520of%2520superoxide%2520and%2520mitochondrial%2520function%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4888%26epage%3D4899%26doi%3D10.1172%2FJCI66218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariappan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sataranatarajan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahimainathan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasinath, B. S.</span></span> <span> </span><span class="NLM_article-title">A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy</span>. <i>Am. J. Physiol. Renal Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">F617</span>– <span class="NLM_lpage">F627</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.00278.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1152%2Fajprenal.00278.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=17018841" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=F617-F627&author=M.+J.+Leeauthor=D.+Feliersauthor=M.+M.+Mariappanauthor=K.+Sataranatarajanauthor=L.+Mahimainathanauthor=N.+Musiauthor=M.+Foretzauthor=B.+Violletauthor=J.+M.+Weinbergauthor=G.+G.+Choudhuryauthor=B.+S.+Kasinath&title=A+role+for+AMP-activated+protein+kinase+in+diabetes-induced+renal+hypertrophy&doi=10.1152%2Fajprenal.00278.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00278.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00278.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DFeliers%26aufirst%3DD.%26aulast%3DMariappan%26aufirst%3DM.%2BM.%26aulast%3DSataranatarajan%26aufirst%3DK.%26aulast%3DMahimainathan%26aufirst%3DL.%26aulast%3DMusi%26aufirst%3DN.%26aulast%3DForetz%26aufirst%3DM.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DWeinberg%26aufirst%3DJ.%2BM.%26aulast%3DChoudhury%26aufirst%3DG.%2BG.%26aulast%3DKasinath%26aufirst%3DB.%2BS.%26atitle%3DA%2520role%2520for%2520AMP-activated%2520protein%2520kinase%2520in%2520diabetes-induced%2520renal%2520hypertrophy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DF617%26epage%3DF627%26doi%3D10.1152%2Fajprenal.00278.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">AMPK mediates the initiation of kidney disease induced by a high-fat diet</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1846</span>– <span class="NLM_lpage">1855</span>, <span class="refDoi"> DOI: 10.1681/ASN.2011010026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1681%2FASN.2011010026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=21921143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCls7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1846-1855&author=A.+E.+Declevesauthor=A.+V.+Mathewauthor=R.+Cunardauthor=K.+Sharma&title=AMPK+mediates+the+initiation+of+kidney+disease+induced+by+a+high-fat+diet&doi=10.1681%2FASN.2011010026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK mediates the initiation of kidney disease induced by a high-fat diet</span></div><div class="casAuthors">Decleves, Anne-Emilie; Mathew, Anna V.; Cunard, Robyn; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1846-1855</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The mechanisms underlying the assocn. between obesity and progressive renal disease are not well understood.  Exposure to a high-fat diet decreases levels of the cellular energy sensor AMPK in many organs, including the kidney, but whether AMPK contributes to the pathophysiol. of kidney disease induced by a high-fat diet is unknown.  In this study, we randomly assigned C57BL/6J mice to a std. or high-fat diet.  After 1 wk, mice fed a high-fat diet exhibited an increase in body wt., renal hypertrophy, an increase in urine H2O2 and urine MCP-1, and a decrease in circulating adiponectin levels and renal AMPK activity.  Urine ACR progressively increased after 4 wk of a high-fat diet.  After 12 wk, kidneys of mice fed a high-fat diet demonstrated a marked increase in markers of fibrosis and inflammation, and AMPK activity remained significantly suppressed.  To det. whether inhibition of AMPK activity explained these renal effects, we administered an AMPK activator along with a high-fat diet for 1 wk.  Although AMPK activation did not abrogate the wt. gain, it reduced the renal hypertrophy, urine H2O2, and urine and renal MCP-1.  In vitro, AMPK activation completely inhibited the induction of MCP-1 by palmitic acid in mesangial cells.  In conclusion, these data suggest that the energy sensor AMPK mediates the early renal effects of a high-fat diet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLyy7LBMHJALVg90H21EOLACvtfcHk0lhI4q-tfkZjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCls7nM&md5=7e1ca714e5b6c691934a75df032eda20</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1681%2FASN.2011010026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2011010026%26sid%3Dliteratum%253Aachs%26aulast%3DDecleves%26aufirst%3DA.%2BE.%26aulast%3DMathew%26aufirst%3DA.%2BV.%26aulast%3DCunard%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DAMPK%2520mediates%2520the%2520initiation%2520of%2520kidney%2520disease%2520induced%2520by%2520a%2520high-fat%2520diet%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2011%26volume%3D22%26spage%3D1846%26epage%3D1855%26doi%3D10.1681%2FASN.2011010026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, B. E.</span></span> <span> </span><span class="NLM_article-title">AMPK in health and disease</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1078</span>, <span class="refDoi"> DOI: 10.1152/physrev.00011.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1152%2Fphysrev.00011.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=19584320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpslyjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=1025-1078&author=G.+R.+Steinbergauthor=B.+E.+Kemp&title=AMPK+in+health+and+disease&doi=10.1152%2Fphysrev.00011.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK in health and disease</span></div><div class="casAuthors">Steinberg, Gregory R.; Kemp, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1025-1078</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The function and survival of all organisms is dependent on the dynamic control of energy metab., when energy demand is matched to energy supply.  The AMP-activated protein kinase (AMPK) αβγ heterotrimer has emerged as an important integrator of signals that control energy balance through the regulation of multiple biochem. pathways in all eukaryotes.  In this review, we begin with the discovery of the AMPK family and discuss the recent structural studies that have revealed the mol. basis for AMP binding to the enzyme's γ subunit.  AMPK's regulation involves autoinhibitory features and phosphorylation of both the catalytic α subunit and the β-targeting subunit.  We review the role of AMPK at the cellular level through examn. of its many substrates and discuss how it controls cellular energy balance.  We look at how AMPK integrates stress responses such as exercise as well as nutrient and hormonal signals to control food intake, energy expenditure, and substrate utilization at the whole body level.  Lastly, we review the possible role of AMPK in multiple common diseases and the role of the new age of drugs targeting AMPK signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodloz1gTPHErVg90H21EOLACvtfcHk0lhI4q-tfkZjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpslyjsb4%253D&md5=fbc46b4e8edc695c24da582889bfc9a2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00011.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00011.2008%26sid%3Dliteratum%253Aachs%26aulast%3DSteinberg%26aufirst%3DG.%2BR.%26aulast%3DKemp%26aufirst%3DB.%2BE.%26atitle%3DAMPK%2520in%2520health%2520and%2520disease%26jtitle%3DPhysiol.%2520Rev.%26date%3D2009%26volume%3D89%26spage%3D1025%26epage%3D1078%26doi%3D10.1152%2Fphysrev.00011.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">GTEx
Consortium</span> <span> </span><span class="NLM_article-title">The genotype-tissue
expression (GTEx) project</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/ng.2653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1038%2Fng.2653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=23715323" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=580-585&author=GTEx%0AConsortium&title=The+genotype-tissue%0Aexpression+%28GTEx%29+project&doi=10.1038%2Fng.2653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fng.2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2653%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520genotype-tissue%250Aexpression%2520%2528GTEx%2529%2520project%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D580%26epage%3D585%26doi%3D10.1038%2Fng.2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipski, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebner, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genung, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavergne, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathialagan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panteleev, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polivkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuma, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span> <span> </span><span class="NLM_article-title">Optimization of metabolic and renal clearance in a series of indole acid direct activators of 5′-adenosine monophosphate-activated protein kinase (AMPK)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2372</span>– <span class="NLM_lpage">2383</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01641</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01641" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2372-2383&author=D.+J.+Edmondsauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=K.+J.+Filipskiauthor=D.+C.+Ebnerauthor=S.+Cabralauthor=A.+C.+Smithauthor=G.+E.+Aspnesauthor=S.+K.+Bhattacharyaauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+F.+Calabreseauthor=N.+L.+Caspersauthor=E.+C.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=H.+Engauthor=B.+Fengauthor=D.+P.+Fernandoauthor=N.+E.+Genungauthor=M.+Herrauthor=R.+G.+Kurumbailauthor=S.+Y.+Lavergneauthor=S.+C.-Y.+Leeauthor=Q.+Liauthor=S.+Mathialaganauthor=R.+A.+Millerauthor=J.+Panteleevauthor=J.+Polivkovaauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+T.+Salattoauthor=A.+Shavnyaauthor=B.+A.+Thumaauthor=M.+Tuauthor=J.+Wardauthor=J.+M.+Withkaauthor=J.+Xiaoauthor=K.+O.+Cameron&title=Optimization+of+metabolic+and+renal+clearance+in+a+series+of+indole+acid+direct+activators+of+5%E2%80%B2-adenosine+monophosphate-activated+protein+kinase+%28AMPK%29&doi=10.1021%2Facs.jmedchem.7b01641"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01641%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DEbner%26aufirst%3DD.%2BC.%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%2BC.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DGenung%26aufirst%3DN.%2BE.%26aulast%3DHerr%26aufirst%3DM.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DLavergne%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BC.-Y.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMathialagan%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DPanteleev%26aufirst%3DJ.%26aulast%3DPolivkova%26aufirst%3DJ.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26atitle%3DOptimization%2520of%2520metabolic%2520and%2520renal%2520clearance%2520in%2520a%2520series%2520of%2520indole%2520acid%2520direct%2520activators%2520of%25205%25E2%2580%25B2-adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2372%26epage%3D2383%26doi%3D10.1021%2Facs.jmedchem.7b01641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessire, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, A. E.</span></span> <span> </span><span class="NLM_article-title">A rapid and specific derivatization procedure to identify acyl-glucuronides by mass spectrometry</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2109</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1002/rcm.4621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1002%2Frcm.4621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=20552710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVOgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2109-2121&author=A.+D.+Vazauthor=W.+W.+Wangauthor=A.+J.+Bessireauthor=R.+Sharmaauthor=A.+E.+Hagen&title=A+rapid+and+specific+derivatization+procedure+to+identify+acyl-glucuronides+by+mass+spectrometry&doi=10.1002%2Frcm.4621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and specific derivatization procedure to identify acyl-glucuronides by mass spectrometry</span></div><div class="casAuthors">Vaz, Alfin D. N.; Wang, Wei Wei; Bessire, Andrew J.; Sharma, Raman; Hagen, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2109-2121</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A simple procedure is described to identify acyl-glucuronides by coupled liq. chromatog./mass spectrometry after derivatization to a hydroxamic acid with hydroxylamine.  The reaction specificity obviates the need for isolation of the acyl-glucuronide from an ext.  Glucuronides derived from carbamic acids, and alkyl- and arom. amines, are inert to the derivatization reaction conditions, making the hydroxamic acid deriv. a fingerprint for acyl-glucuronides.  This derivatization procedure provides a key advantage for the quant. anal. of acyl-glucuronide metabolites in a drug discovery setting.  Copyright © 2010 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDR6oEUBtuHbVg90H21EOLACvtfcHk0ljUS1m_b_ok2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVOgurk%253D&md5=1f282304cec298e7db621c9478d14d3e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Frcm.4621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.4621%26sid%3Dliteratum%253Aachs%26aulast%3DVaz%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DW.%2BW.%26aulast%3DBessire%26aufirst%3DA.%2BJ.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DHagen%26aufirst%3DA.%2BE.%26atitle%3DA%2520rapid%2520and%2520specific%2520derivatization%2520procedure%2520to%2520identify%2520acyl-glucuronides%2520by%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2010%26volume%3D24%26spage%3D2109%26epage%3D2121%26doi%3D10.1002%2Frcm.4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauli, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godecke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaki, B. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lankin, D. C.</span></span> <span> </span><span class="NLM_article-title">Quantitative 1H NMR: Development and potential of an analytical method: an update</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1021/np200993k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200993k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=834-851&author=G.+F.+Pauliauthor=T.+Godeckeauthor=B.+U.+Jakiauthor=D.+C.+Lankin&title=Quantitative+1H+NMR%3A+Development+and+potential+of+an+analytical+method%3A+an+update&doi=10.1021%2Fnp200993k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fnp200993k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200993k%26sid%3Dliteratum%253Aachs%26aulast%3DPauli%26aufirst%3DG.%2BF.%26aulast%3DGodecke%26aufirst%3DT.%26aulast%3DJaki%26aufirst%3DB.%2BU.%26aulast%3DLankin%26aufirst%3DD.%2BC.%26atitle%3DQuantitative%25201H%2520NMR%253A%2520Development%2520and%2520potential%2520of%2520an%2520analytical%2520method%253A%2520an%2520update%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D834%26epage%3D851%26doi%3D10.1021%2Fnp200993k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauli, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lankin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godecke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaki, B. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlpine, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napolitano, J. G.</span></span> <span> </span><span class="NLM_article-title">Importance of purity evaluation and the potential of quantitative <sup>1</sup>H NMR as a purity assay</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9220</span>– <span class="NLM_lpage">9231</span>, <span class="refDoi"> DOI: 10.1021/jm500734a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500734a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslahsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9220-9231&author=G.+F.+Pauliauthor=S.+N.+Chenauthor=C.+Simmlerauthor=D.+C.+Lankinauthor=T.+Godeckeauthor=B.+U.+Jakiauthor=J.+B.+Friesenauthor=J.+B.+McAlpineauthor=J.+G.+Napolitano&title=Importance+of+purity+evaluation+and+the+potential+of+quantitative+1H+NMR+as+a+purity+assay&doi=10.1021%2Fjm500734a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of Purity Evaluation and the Potential of Quantitative 1H NMR as a Purity Assay</span></div><div class="casAuthors">Pauli, Guido F.; Chen, Shao-Nong; Simmler, Charlotte; Lankin, David C.; Godecke, Tanja; Jaki, Birgit U.; Friesen, J. Brent; McAlpine, James B.; Napolitano, Jose G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9220-9231</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In any biomedical and chem. context, a truthful description of chem. constitution requires coverage of both structure and purity.  This qualification affects all drug mols., regardless of development stage (early discovery to approved drug) and source (natural product or synthetic).  Purity assessment is particularly crit. in discovery programs and whenever chem. is linked with biol. and/or therapeutic outcome.  Compared with chromatog. and elemental anal., quant. NMR (qNMR) uses nearly universal detection and provides a versatile and orthogonal means of purity evaluation.  Abs. qNMR with flexible calibration captures analytes that frequently escape detection (water, sorbents).  Widely accepted structural NMR workflows require minimal or no adjustments to become practical 1H qNMR (qHNMR) procedures with simultaneous qual. and (abs.) quant. capability.  This study reviews underlying concepts, provides a framework for std. qHNMR purity assays, and shows how adequate accuracy and precision are achieved for the intended use of the material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqquFEu5lLVVrVg90H21EOLACvtfcHk0lglvrtE0s4mfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslahsLzF&md5=78900d0b03e31739e50c04c63c55dba7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm500734a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500734a%26sid%3Dliteratum%253Aachs%26aulast%3DPauli%26aufirst%3DG.%2BF.%26aulast%3DChen%26aufirst%3DS.%2BN.%26aulast%3DSimmler%26aufirst%3DC.%26aulast%3DLankin%26aufirst%3DD.%2BC.%26aulast%3DGodecke%26aufirst%3DT.%26aulast%3DJaki%26aufirst%3DB.%2BU.%26aulast%3DFriesen%26aufirst%3DJ.%2BB.%26aulast%3DMcAlpine%26aufirst%3DJ.%2BB.%26aulast%3DNapolitano%26aufirst%3DJ.%2BG.%26atitle%3DImportance%2520of%2520purity%2520evaluation%2520and%2520the%2520potential%2520of%2520quantitative%25201H%2520NMR%2520as%2520a%2520purity%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9220%26epage%3D9231%26doi%3D10.1021%2Fjm500734a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Espina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vashishtha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.</span></span> <span> </span><span class="NLM_article-title">Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1021/tx800251p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800251p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaiu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=299-310&author=R.+Espinaauthor=L.+Yuauthor=J.+Wangauthor=Z.+Tongauthor=S.+Vashishthaauthor=R.+Talaatauthor=J.+Scatinaauthor=A.+Mutlib&title=Nuclear+magnetic+resonance+spectroscopy+as+a+quantitative+tool+to+determine+the+concentrations+of+biologically+produced+metabolites%3A+implications+in+metabolites+in+safety+testing&doi=10.1021%2Ftx800251p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear Magnetic Resonance Spectroscopy as a Quantitative Tool To Determine the Concentrations of Biologically Produced Metabolites: Implications in Metabolites in Safety Testing</span></div><div class="casAuthors">Espina, Robert; Yu, Linning; Wang, Jianyao; Tong, Zeen; Vashishtha, Sarvesh; Talaat, Rasmy; Scatina, JoAnn; Mutlib, Abdul</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-310</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NMR spectroscopy has traditionally been considered as an indispensable tool in elucidating structures of metabolites.  With the advent of Fourier transform (FT) spectrometers, along with improvements in software and hardware (such as high-field magnets, cryoprobes, versatile pulse sequences, and solvent suppression techniques), NMR is increasingly being considered as a crit. quant. tool, despite its lower sensitivity as compared to mass spectrometry.  A specific quant. application of NMR is in detg. the concns. of biol. isolated metabolites, which could potentially be used as ref. stds. for further quant. work by liq. chromatog./mass spectrometry.  With the recent demands from regulatory agencies on quant. information on metabolites, it is proposed that NMR will play a significant role in strategies aimed at addressing metabolite coverage in toxicol. species.  Traditionally, biol. isolated metabolites have not been considered as a way of generating "ref. stds." for further quant. work.  However, because of the recent FDA guidance on safety testing of metabolites, one has to consider means of authenticating and quantitating biol. or nonbiol. generated metabolites.  1H NMR is being proposed as the method of choice, as it is able to be used as both a qual. and a quant. tool, hence allowing structure detn., purity check, and quant. measurement of the isolated metabolite.  In this publication, the application of NMR as a powerful and robust anal. technique in detg. the concns. of in vitro or in vivo isolated metabolites is discussed.  Furthermore, to demonstrate the reliability and accuracy of metabolite concns. detd. by NMR, validation and cross-validation with gravimetric and mass spectrometric methods were conducted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhv9f79k3pGLVg90H21EOLACvtfcHk0lglvrtE0s4mfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaiu7vL&md5=f509721655fa5d28edada912a2d90841</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Ftx800251p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800251p%26sid%3Dliteratum%253Aachs%26aulast%3DEspina%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DZ.%26aulast%3DVashishtha%26aufirst%3DS.%26aulast%3DTalaat%26aufirst%3DR.%26aulast%3DScatina%26aufirst%3DJ.%26aulast%3DMutlib%26aufirst%3DA.%26atitle%3DNuclear%2520magnetic%2520resonance%2520spectroscopy%2520as%2520a%2520quantitative%2520tool%2520to%2520determine%2520the%2520concentrations%2520of%2520biologically%2520produced%2520metabolites%253A%2520implications%2520in%2520metabolites%2520in%2520safety%2520testing%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2009%26volume%3D22%26spage%3D299%26epage%3D310%26doi%3D10.1021%2Ftx800251p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rundlof, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiasson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekiroglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakkarainen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvidsson, T.</span></span> <span> </span><span class="NLM_article-title">Survey and qualification of internal standards for quantitation by 1H NMR spectroscopy</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2010.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.jpba.2010.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=20207092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jsFertw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=645-651&author=T.+Rundlofauthor=M.+Mathiassonauthor=S.+Bekirogluauthor=B.+Hakkarainenauthor=T.+Bowdenauthor=T.+Arvidsson&title=Survey+and+qualification+of+internal+standards+for+quantitation+by+1H+NMR+spectroscopy&doi=10.1016%2Fj.jpba.2010.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Survey and qualification of internal standards for quantification by 1H NMR spectroscopy</span></div><div class="casAuthors">Rundlof Torgny; Mathiasson Marie; Bekiroglu Somer; Hakkarainen Birgit; Bowden Tim; Arvidsson Torbjorn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutical and biomedical analysis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">645-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In quantitative NMR (qNMR) selection of an appropriate internal standard proves to be crucial.  In this study, 25 candidate compounds considered to be potent internal standards were investigated with respect to the ability of providing unique signal chemical shifts, purity, solubility, and ease of use.  The (1)H chemical shift (delta) values, assignments, multiplicities and number of protons (for each signal), appropriateness (as to be used as internal standards) in four different deuterated solvents (D(2)O, DMSO-d(6), CD(3)OD, CDCl(3)) were studied.  Taking into account the properties of these 25 internal standards, the most versatile eight compounds (2,4,6-triiodophenol, 1,3,5-trichloro-2-nitrobenzene, 3,4,5-trichloropyridine, dimethyl terephthalate, 1,4-dinitrobenzene, 2,3,5-triiodobenzoic acid, maleic acid and fumaric acid) were qualified using both differential scanning calorimetry (DSC) and NMR spectroscopy employing highly pure acetanilide as the reference standard.  The data from these two methods were compared as well as utilized in the quality assessment of the compounds as internal standards.  Finally, the selected internal standards were tested and evaluated in a real case of quantitative NMR analysis of a paracetamol pharmaceutical product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQaSIJzqfbu1SXXDYhVZBdlfW6udTcc2eYRzjictfAzQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jsFertw%253D%253D&md5=97ae3cdb4f4b6ce73c12ce17cd7c031d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2010.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2010.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DRundlof%26aufirst%3DT.%26aulast%3DMathiasson%26aufirst%3DM.%26aulast%3DBekiroglu%26aufirst%3DS.%26aulast%3DHakkarainen%26aufirst%3DB.%26aulast%3DBowden%26aufirst%3DT.%26aulast%3DArvidsson%26aufirst%3DT.%26atitle%3DSurvey%2520and%2520qualification%2520of%2520internal%2520standards%2520for%2520quantitation%2520by%25201H%2520NMR%2520spectroscopy%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2010%26volume%3D52%26spage%3D645%26epage%3D651%26doi%3D10.1016%2Fj.jpba.2010.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwanathan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babalola, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatina, J.</span></span> <span> </span><span class="NLM_article-title">Application of quantitative NMR in pharmacological evaluation of biologically generated metabolites: implications in drug discovery</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.032490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.110.032490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=106-116&author=A.+Mutlibauthor=R.+Espinaauthor=K.+Vishwanathanauthor=K.+Babalolaauthor=Z.+Chenauthor=C.+Dehnhardtauthor=A.+Venkatesanauthor=T.+Mansourauthor=I.+Chaudharyauthor=R.+Talaatauthor=J.+Scatina&title=Application+of+quantitative+NMR+in+pharmacological+evaluation+of+biologically+generated+metabolites%3A+implications+in+drug+discovery&doi=10.1124%2Fdmd.110.032490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.032490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.032490%26sid%3Dliteratum%253Aachs%26aulast%3DMutlib%26aufirst%3DA.%26aulast%3DEspina%26aufirst%3DR.%26aulast%3DVishwanathan%26aufirst%3DK.%26aulast%3DBabalola%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DVenkatesan%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DTalaat%26aufirst%3DR.%26aulast%3DScatina%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520quantitative%2520NMR%2520in%2520pharmacological%2520evaluation%2520of%2520biologically%2520generated%2520metabolites%253A%2520implications%2520in%2520drug%2520discovery%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D106%26epage%3D116%26doi%3D10.1124%2Fdmd.110.032490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.059204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.114.059204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=25053618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yqur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1627-1639&author=G.+S.+Walkerauthor=J.+N.+Baumanauthor=T.+F.+Ryderauthor=E.+B.+Smithauthor=D.+K.+Spracklinauthor=R.+S.+Obach&title=Biosynthesis+of+drug+metabolites+and+quantitation+using+NMR+spectroscopy+for+use+in+pharmacologic+and+drug+metabolism+studies&doi=10.1124%2Fdmd.114.059204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies</span></div><div class="casAuthors">Walker, Gregory S.; Bauman, Jonathan N.; Ryder, Tim F.; Smith, Evan B.; Spracklin, Douglas K.; Scott Obach, R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1627-1639, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The contribution of drug metabolites to the pharmacol. and toxicol. activity of a drug can be important; however, for a variety of reasons metabolites can frequently be difficult to synthesize.  To meet the need of having samples of drug metabolites for further study, we have developed biosynthetic methods coupled with quant. NMR spectroscopy (qNMR) to generate solns. of metabolites of known structure and concn.  These quant. samples can be used in a variety of ways when a synthetic sample is unavailable, including pharmacol. assays, stds. for in vitro work to help establish clearance pathways, and/or as anal. stds. for bioanal. work to ascertain exposure, among others.  We illustrate five examples of metabolite biosynthesis and qNMR.  The types of metabolites include one glucuronide and four oxidative products.  Concns. of the isolated metabolite stock solns. ranged from 0.048 to 8.3 mM, with vols. from approx. 0.04 to 0.150 mL in hexadeutarated dimethylsulfoxide.  These specific quantified isolates were used as stds. in the drug discovery setting as substrates in pharmacol. assays, for bioanal. assays to establish exposure, and in variety of routine absorption, distribution, metab., and excretion assays, such as protein binding and detg. blood-toplasma ratios.  The methods used to generate these materials are described in detail with the objective that these methods can be generally used for metabolite biosynthesis and isolation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIcWqizvGukLVg90H21EOLACvtfcHk0lgNjAOZAu9hjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yqur3N&md5=8d763ea8c23f07f680949c005e2ea7c7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.059204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.059204%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DBiosynthesis%2520of%2520drug%2520metabolites%2520and%2520quantitation%2520using%2520NMR%2520spectroscopy%2520for%2520use%2520in%2520pharmacologic%2520and%2520drug%2520metabolism%2520studies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D1627%26epage%3D1639%26doi%3D10.1124%2Fdmd.114.059204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, A.</span></span> <span> </span><span class="NLM_article-title">Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">433</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.036343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.110.036343" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=433-440&author=G.+S.+Walkerauthor=T.+F.+Ryderauthor=R.+Sharmaauthor=E.+B.+Smithauthor=A.+Freund&title=Validation+of+isolated+metabolites+from+drug+metabolism+studies+as+analytical+standards+by+quantitative+NMR&doi=10.1124%2Fdmd.110.036343"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.036343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.036343%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26aulast%3DFreund%26aufirst%3DA.%26atitle%3DValidation%2520of%2520isolated%2520metabolites%2520from%2520drug%2520metabolism%2520studies%2520as%2520analytical%2520standards%2520by%2520quantitative%2520NMR%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D433%26epage%3D440%26doi%3D10.1124%2Fdmd.110.036343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K.</span>; <span class="NLM_string-name">Edmonds, D. J.</span>; <span class="NLM_string-name">Kalgutkar, A.</span>; <span class="NLM_string-name">Ebner, D.</span>; <span class="NLM_string-name">Thuma, B.</span>; <span class="NLM_string-name">Filipski, K. J.</span>; <span class="NLM_string-name">Kumar, R.</span></span> <span> </span><span class="NLM_article-title">Indole and indazole compounds that activate AMPK</span>. <span class="NLM_patent">WO 2016092413</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+Cameron&author=D.+J.+Edmonds&author=A.+Kalgutkar&author=D.+Ebner&author=B.+Thuma&author=K.+J.+Filipski&author=R.+Kumar&title=Indole+and+indazole+compounds+that+activate+AMPK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%26atitle%3DIndole%2520and%2520indazole%2520compounds%2520that%2520activate%2520AMPK%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span> <span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1410</span>, <span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0ljAewVzXOtQ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spahn-Langguth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutschler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">lin, E. T.</span></span> <span> </span><span class="NLM_article-title">Predictability of the covalent binding of acidic drugs in man</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">PL141</span>– <span class="NLM_lpage">PL146</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(93)90279-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2F0024-3205%2893%2990279-C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=PL141-PL146&author=L.+Z.+Benetauthor=H.+Spahn-Langguthauthor=S.+Iwakawaauthor=C.+Vollandauthor=T.+Mizumaauthor=S.+Mayerauthor=E.+Mutschlerauthor=E.+T.+lin&title=Predictability+of+the+covalent+binding+of+acidic+drugs+in+man&doi=10.1016%2F0024-3205%2893%2990279-C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2893%2990279-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252893%252990279-C%26sid%3Dliteratum%253Aachs%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DSpahn-Langguth%26aufirst%3DH.%26aulast%3DIwakawa%26aufirst%3DS.%26aulast%3DVolland%26aufirst%3DC.%26aulast%3DMizuma%26aufirst%3DT.%26aulast%3DMayer%26aufirst%3DS.%26aulast%3DMutschler%26aufirst%3DE.%26aulast%3Dlin%26aufirst%3DE.%2BT.%26atitle%3DPredictability%2520of%2520the%2520covalent%2520binding%2520of%2520acidic%2520drugs%2520in%2520man%26jtitle%3DLife%2520Sci.%26date%3D1993%26volume%3D53%26spage%3DPL141%26epage%3DPL146%26doi%3D10.1016%2F0024-3205%2893%2990279-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L.</span></span> <span> </span><span class="NLM_article-title">Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies by tandem mass spectrometry</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=246-256&author=Y.+Qiuauthor=A.+L.+Burlingameauthor=L.+Benet&title=Mechanisms+for+covalent+binding+of+benoxaprofen+glucuronide+to+human+serum+albumin.+Studies+by+tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DBurlingame%26aufirst%3DA.%2BL.%26aulast%3DBenet%26aufirst%3DL.%26atitle%3DMechanisms%2520for%2520covalent%2520binding%2520of%2520benoxaprofen%2520glucuronide%2520to%2520human%2520serum%2520albumin.%2520Studies%2520by%2520tandem%2520mass%2520spectrometry%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1998%26volume%3D26%26spage%3D246%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span> </span><span class="NLM_article-title">Safety testing of drug metabolites</span>.  <i>Guidances
(Drugs)</i>; <span class="NLM_publisher-name">US Food and Drug Administration</span>, <span class="NLM_year">2016</span>; <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm" class="extLink">http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm</a> (accessed 31 October, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety+testing+of+drug+metabolites.+Guidances%0A%28Drugs%29%3B+US+Food+and+Drug+Administration%2C+2016%3B+http%3A%2F%2Fwww.fda.gov%2FDrugs%2FGuidanceComplianceRegulatoryInformation%2FGuidances%2Fdefault.htm+%28accessed+31+October%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DSafety%2520testing%2520of%2520drug%2520metabolites%26jtitle%3DGuidances%250A%2528Drugs%2529%26pub%3DUS%2520Food%2520and%2520Drug%2520Administration%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atherton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reily, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.</span></span> <span> </span><span class="NLM_article-title">Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1021/tx600297u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx600297u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVymtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=876-886&author=G.+S.+Walkerauthor=J.+Athertonauthor=J.+Baumanauthor=C.+Kohlauthor=W.+Lamauthor=M.+Reilyauthor=Z.+Louauthor=A.+Mutlib&title=Determination+of+degradation+pathways+and+kinetics+of+acyl+glucuronides+by+NMR+spectroscopy&doi=10.1021%2Ftx600297u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of Degradation Pathways and Kinetics of Acyl Glucuronides by NMR Spectroscopy</span></div><div class="casAuthors">Walker, Gregory S.; Atherton, James; Bauman, Jonathan; Kohl, Christopher; Lam, Wing; Reily, Michael; Lou, Zhen; Mutlib, Abdul</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">876-886</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl glucuronides have been implicated in the toxicity of many xenobiotics and marketed drugs.  These toxicities are hypothesized to be a consequence of covalent binding of the reactive forms of the acyl glucuronide to proteins.  Reactive intermediates of the acyl glucuronide arise from the migration of the aglycon leading to other positional and stereoisomers under physiol. conditions.  In order to screen for the potential liabilities of these metabolites during the early phase of pharmaceutical development, an NMR method based on the disappearance of the anomeric resonance of the O-1-acyl glucuronide was used to monitor the degrdn. kinetics of 11 structurally diverse acyl glucuronides, including those produced from the known nonsteroidal anti-inflammatory drugs (NSAIDs).  The acyl glucuronides were either chem. synthesized or were isolated from biol. matrixes (bile, urine, and liver microsomal exts.).  The half-lives attained utilizing this method were found to be comparable to those reported in the literature.  NMR anal. also enabled the delineation of the two possible pathways of degrdn.: acyl migration and hydrolytic cleavage.  The previously characterized 1H resonances of acyl migrated products are quite distinguishable from those that arise from hydrolysis.  The NMR method described here could be used to rank order acyl glucuronide forming discovery compds. based on the potential reactivity of the conjugates and their routes of decompn. under physiol. conditions.  Furthermore, we have shown that in vitro systems such as liver microsomal prepns. can be used to generate sufficient quantities of acyl glucuronides from early discovery compds. for NMR characterization.  This is particularly important, as we often have limited supply of early discovery compds. to conduct in vivo studies to generate sufficient quantities of acyl glucuronides for further characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3aeMkwVvVErVg90H21EOLACvtfcHk0lhjP_9MDidMrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVymtrw%253D&md5=b0ffe295d85c8a7a6816f3e22eac5bec</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Ftx600297u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx600297u%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DAtherton%26aufirst%3DJ.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLam%26aufirst%3DW.%26aulast%3DReily%26aufirst%3DM.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DMutlib%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520degradation%2520pathways%2520and%2520kinetics%2520of%2520acyl%2520glucuronides%2520by%2520NMR%2520spectroscopy%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D876%26epage%3D886%26doi%3D10.1021%2Ftx600297u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaat, R.</span></span> <span> </span><span class="NLM_article-title">A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1206</span>– <span class="NLM_lpage">1216</span>, <span class="refDoi"> DOI: 10.1021/tx049900+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx049900%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt12qurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=1206-1216&author=J.+Wangauthor=M.+Davisauthor=F.+Liauthor=F.+Azamauthor=J.+Scatinaauthor=R.+Talaat&title=A+novel+approach+for+predicting+acyl+glucuronide+reactivity+via+Schiff+base+formation%3A+development+of+rapidly+formed+peptide+adducts+for+LC%2FMS%2FMS+measurements&doi=10.1021%2Ftx049900%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Approach for Predicting Acyl Glucuronide Reactivity via Schiff Base Formation: Development of Rapidly Formed Peptide Adducts for LC/MS/MS Measurements</span></div><div class="casAuthors">Wang, Jianyao; Davis, Margaret; Li, Fangbiao; Azam, Farooq; Scatina, JoAnn; Talaat, Rasmy</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1206-1216</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel technique to study the reactivity of acyl glucuronide metabolites to protein has been developed and is described herein.  Considered here are acyl glucuronide metabolites, which have undergone the rearrangement of the glucuronic acid moiety at physiol. temp. and pH.  The investigation of the reactivity of these electrophilic metabolites was carried out by measuring the rate of reaction of rearranged AG metabolites in forming the corresponding acyl glucuronide-peptide adduct in the presence of Lys-Phe.  This differs from the parallel technique used in forming AG adducts of proteins that have been previously reported.  In the study described here, the Schiff base adduct, diclofenac acyl glucuronide-Lys-Phe product, was generated and structurally elucidated by liq. chromatog. tandem mass spectrometry (LC/MS/MS) anal.  The product structure was proved to be a Schiff base adduct by chem. derivatization by nucleophilic addn. of HCN and chem. redn. with NaCNBH3, followed by LC/MS/MS anal.  It is proposed here that the degree of reactivity of acyl glucuronides as measured by covalent binding to protein is proportional to the amt. of its peptide adduct generated with the peptide technique described.  The application of this technique to the assessment of the degree of reactivity of acyl glucuronide metabolites was validated by developing a reactivity rank of seven carboxylic acid-contg. drugs.  Consistency was achieved between the ranking of reactivity in the peptide technique for these seven compds. and the rankings found in the literature.  In addn., a correlation (R2 = 0.95) was revealed between the formation of a peptide adduct and the rearrangement rate of the primary acyl glucuronide of seven tested compds.  A structure effect on the degree of reactivity has demonstrated the rate order: acetic acid > propionic acid > benzoic acid derivs.  A rational explanation of this order was proposed, based on the inherent electronic and steric properties of each specific aglycon.  In addn., adaptation of this technique to automation in order to more rapidly assess the ranking of reactivity of acyl glucuronide covalent binding to proteins by new chem. entities is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIzH7J0RPEhrVg90H21EOLACvtfcHk0lhjP_9MDidMrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt12qurg%253D&md5=1cee861849c7acb1ae3fe47d7c1b5d87</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Ftx049900%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx049900%252B%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DAzam%26aufirst%3DF.%26aulast%3DScatina%26aufirst%3DJ.%26aulast%3DTalaat%26aufirst%3DR.%26atitle%3DA%2520novel%2520approach%2520for%2520predicting%2520acyl%2520glucuronide%2520reactivity%2520via%2520Schiff%2520base%2520formation%253A%2520development%2520of%2520rapidly%2520formed%2520peptide%2520adducts%2520for%2520LC%252FMS%252FMS%2520measurements%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D1206%26epage%3D1216%26doi%3D10.1021%2Ftx049900%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, T.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for the degradation reaction of 1-beta-O-acyl glucuronides. Part 3: Electronic and steric descriptors predicting the reactivity of aralkyl carboxylic acid 1-beta-O-acyl glucuronides</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1998</span>– <span class="NLM_lpage">2008</span>, <span class="refDoi"> DOI: 10.1021/tx9002963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx9002963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2qu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=1998-2008&author=A.+Babaauthor=T.+Yoshioka&title=Structure-activity+relationships+for+the+degradation+reaction+of+1-beta-O-acyl+glucuronides.+Part+3%3A+Electronic+and+steric+descriptors+predicting+the+reactivity+of+aralkyl+carboxylic+acid+1-beta-O-acyl+glucuronides&doi=10.1021%2Ftx9002963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships for the Degradation Reaction of 1-β-O-Acyl Glucuronides. Part 3: Electronic and Steric Descriptors Predicting the Reactivity of Aralkyl Carboxylic Acid 1-β-O-Acyl Glucuronides</span></div><div class="casAuthors">Baba, Akiko; Yoshioka, Tadao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1998-2008</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since 1-β-O-acyl glucuronides (βGAs) are thought to be chem. reactive metabolites capable of binding to tissue proteins, possibly leading to adverse drug reactions of the parent carboxylic acid drugs, we have initiated research efforts to derive structure-activity relationships (SARs) of βGAs, with a focus on finding appropriate descriptors that predict their intrinsic electrophilic reactivity or degrdn. rate consts. (k values).  Our previous SAR studies on the k values of βGAs derived from o-, m-, and p-substituted benzoic acids demonstrated that the diversity and complexity of the k values were controlled by the electronic and/or steric effects of the parent carboxylic acids.  In the present study, we performed further SAR studies on the k values of 13 βGAs derived from aralkyl carboxylic acids, focusing on the substituents and stereochem. at the α-position of the parent carboxylic acids.  In single regression analyses, the pKa and 1H NMR chem. shifts (δCOOH) of the parent carboxylic acids correlated well with the log k values of seven βGAs derived from five arylacetic and two (R)-2-arylpropionic acids, whereas the 13C NMR chem. shifts [δC=O and δ(C=O)OH] correlated with the log k values of another seven βGAs derived from the five arylacetic and two (S)-2-arylpropionic acids.  Excellent correlations were also obtained between the log k values of four βGAs with a common 4-phenylbenzyl moiety and the partial at. charges (natural type) of the corresponding carboxylic hydrogen atoms (Hpac), the molar volume (MV), and the molar refractivity (MR).  In multiple regression analyses, appropriate combinations of electronic (δCOOH or pKa) and steric [Taft's steric const. (Es) or δ(C=O)OH] descriptors could predict the log k values of βGAs; electron-withdrawing 1-β-O-acyl groups increased the k values, while increasing steric hindrance around the linkages decreased them.  The std. partial regression coeffs. indicated that the steric effects of the 1-β-O-acyl groups of βGAs affected the k values as strongly as the electronic effects.  External validation of the derived SAR models is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMRVLPvP_JALVg90H21EOLACvtfcHk0lhjP_9MDidMrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2qu77F&md5=5b25cd783fa5597dff4183ed56474dd3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Ftx9002963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9002963%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DA.%26aulast%3DYoshioka%26aufirst%3DT.%26atitle%3DStructure-activity%2520relationships%2520for%2520the%2520degradation%2520reaction%2520of%25201-beta-O-acyl%2520glucuronides.%2520Part%25203%253A%2520Electronic%2520and%2520steric%2520descriptors%2520predicting%2520the%2520reactivity%2520of%2520aralkyl%2520carboxylic%2520acid%25201-beta-O-acyl%2520glucuronides%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2009%26volume%3D22%26spage%3D1998%26epage%3D2008%26doi%3D10.1021%2Ftx9002963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolkipli, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satriano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogac, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nortier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farquhar, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naviaux, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1038/ki.2013.462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1038%2Fki.2013.462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=24304883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCqsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=611-623&author=A.+E.+Declevesauthor=Z.+Zolkipliauthor=J.+Satrianoauthor=L.+Wangauthor=T.+Nakayamaauthor=M.+Rogacauthor=T.+P.+Leauthor=J.+L.+Nortierauthor=M.+G.+Farquharauthor=R.+K.+Naviauxauthor=K.+Sharma&title=Regulation+of+lipid+accumulation+by+AMP-activated+kinase+%5Bcorrected%5D+in+high+fat+diet-induced+kidney+injury&doi=10.1038%2Fki.2013.462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury</span></div><div class="casAuthors">Decleves, Anne-Emilie; Zolkipli, Zarazuela; Satriano, Joseph; Wang, Lin; Nakayama, Tomohiro; Rogac, Mihael; Le, Thuy P.; Nortier, Joelle L.; Farquhar, Marilyn G.; Naviaux, Robert K.; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">611-623</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is an important energy sensor that may be crit. in regulating renal lipid accumulation.  To evaluate the role of AMPK in mediating renal lipid accumulation, C57BL/6J mice were randomized to a std. diet, a high-fat diet, or a high-fat diet plus AICAR (an AMPK activator) for 14 wk.  Renal functional and structural studies along with electron microscopy were performed.  Mice given the high-fat diet had proximal tubule injury with the presence of enlarged clear vacuoles, and multilaminar inclusions concurrent with an increase of tissue lipid and overloading of the lysosomal system.  The margins of the clear vacuoles were pos. for the endolysosomal marker, LAMP1, suggesting lysosome accumulation.  Characterization of vesicles by special stains (Oil Red O, Nile Red, Luxol Fast Blue) and by electron microscopy showed they contained onion skin-like accumulations consistent with phospholipids.  Moreover, cholesteryl esters and phosphatidylcholine-contg. phospholipids were significantly increased in the kidneys of mice on a high-fat diet.  AMPK activation with chronic AICAR treatment prevented the clin. and structural effects of high-fat diet.  Thus, high-fat diet contributes to a dysfunction of the lysosomal system and altered lipid metab. characterized by cholesterol and phospholipid accumulation in the kidney.  AMPK activation normalizes the changes in renal lipid content despite chronic exposure to lipid challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVVBeeRcEQSbVg90H21EOLACvtfcHk0liy6oY2XhX3xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqsLvJ&md5=64ea7fda54ac5822f19081d2d96c8846</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fki.2013.462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2013.462%26sid%3Dliteratum%253Aachs%26aulast%3DDecleves%26aufirst%3DA.%2BE.%26aulast%3DZolkipli%26aufirst%3DZ.%26aulast%3DSatriano%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DRogac%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DT.%2BP.%26aulast%3DNortier%26aufirst%3DJ.%2BL.%26aulast%3DFarquhar%26aufirst%3DM.%2BG.%26aulast%3DNaviaux%26aufirst%3DR.%2BK.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DRegulation%2520of%2520lipid%2520accumulation%2520by%2520AMP-activated%2520kinase%2520%255Bcorrected%255D%2520in%2520high%2520fat%2520diet-induced%2520kidney%2520injury%26jtitle%3DKidney%2520Int.%26date%3D2014%26volume%3D85%26spage%3D611%26epage%3D623%26doi%3D10.1038%2Fki.2013.462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0liy6oY2XhX3xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClean, S.</span></span> <span> </span><span class="NLM_article-title">An improved method for the determination of distribution coefficients</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">144</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.1990.tb05373.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1111%2Fj.2042-7158.1990.tb05373.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1972404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=144&author=D.+Stopherauthor=S.+McClean&title=An+improved+method+for+the+determination+of+distribution+coefficients&doi=10.1111%2Fj.2042-7158.1990.tb05373.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for the determination of distribution coefficients</span></div><div class="casAuthors">Stopher, David; McClean, Siobhan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The traditional shake flash method for measuring the distribution coeff. (D) of drugs (Leo et al., 1971) was modified to minimize the amt. of compd. required by employing HPLC to detn. the concn. of the compd. in the octanol and buffer phases.  The HPLC employed a reverse-phase Spherisorb octyl column with a mobile phase of MeOH-ammonium phosphate 0.01 M, pH 7.  The method was validated using drugs with a range of log D values of -2 to 4.  The method is suitable for rapid evaluation of the compds. since it decreases errors due to any impurities present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodB1AZ9RwrrLVg90H21EOLACvtfcHk0liy6oY2XhX3xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D&md5=4d4ab2e9a04d54dbb868cb1b212e8e55</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1990.tb05373.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1990.tb05373.x%26sid%3Dliteratum%253Aachs%26aulast%3DStopher%26aufirst%3DD.%26aulast%3DMcClean%26aufirst%3DS.%26atitle%3DAn%2520improved%2520method%2520for%2520the%2520determination%2520of%2520distribution%2520coefficients%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1990%26volume%3D42%26spage%3D144%26doi%3D10.1111%2Fj.2042-7158.1990.tb05373.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genung, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jatkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhok, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cialdea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreeger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coskran, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opsahl, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolph, T.</span></span> <span> </span><span class="NLM_article-title">Selective activation of AMPK β1-containing isoforms improves kidney function in a rat model of diabetic nephropathy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.237925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fjpet.116.237925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=28289077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOqtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2017&pages=303-311&author=C.+T.+Salattoauthor=R.+A.+Millerauthor=K.+O.+Cameronauthor=E.+Cokorinosauthor=A.+Reyesauthor=J.+Wardauthor=M.+F.+Calabreseauthor=R.+G.+Kurumbailauthor=F.+Rajamohanauthor=A.+S.+Kalgutkarauthor=D.+A.+Tessauthor=A.+Shavnyaauthor=N.+E.+Genungauthor=D.+J.+Edmondsauthor=A.+Jatkarauthor=B.+S.+Maciejewskiauthor=M.+Amaroauthor=H.+Gandhokauthor=M.+Monettiauthor=K.+Cialdeaauthor=E.+Bollingerauthor=J.+M.+Kreegerauthor=T.+M.+Coskranauthor=A.+C.+Opsahlauthor=G.+G.+Boucherauthor=M.+J.+Birnbaumauthor=P.+DaSilva-Jardineauthor=T.+Rolph&title=Selective+activation+of+AMPK+%CE%B21-containing+isoforms+improves+kidney+function+in+a+rat+model+of+diabetic+nephropathy&doi=10.1124%2Fjpet.116.237925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of AMPK β1-containing isoforms improves kidney function in a rat model of diabetic nephropathy</span></div><div class="casAuthors">Salatto, Christopher T.; Miller, Russell A.; Cameron, Kimberly O.; Cokorinos, Emily; Reyes, Allan; Ward, Jessica; Calabrese, Matthew F.; Kurumbail, Ravi G.; Rajamohan, Francis; Kalgutkar, Amit S.; Tess, David A.; Shavnya, Andre; Genung, Nathan E.; Edmonds, David J.; Jatkar, Aditi; Maciejewski, Benjamin S.; Amaro, Marina; Gandhok, Harmeet; Monetti, Mara; Cialdea, Katherine; Bollinger, Eliza; Kreeger, John M.; Coskran, Timothy M.; Opsahl, Alan C.; Boucher, Germaine G.; Birnbaum, Morris J.; Da Silva-Jardine, Paul; Rolph, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-311, S1-S33</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Diabetic nephropathy remains an area of high unmet medical need, with current therapies that slow down, but do not prevent, the progression of disease.  A reduced phosphorylation state of adenosine monophosphate-activated protein kinase (AMPK) has been correlated with diminished kidney function in both humans and animal models of renal disease.  Here, we describe the identification of novel, potent, small mol. activators of AMPK that selectively activate AMPK heterotrimers contg. the β1 subunit.  After confirming that human and rodent kidney predominately express AMPK β1, we explore the effects of pharmacol. activation of AMPK in the ZSF1 rat model of diabetic nephropathy.  Chronic administration of these direct activators elevates the phosphorylation of AMPK in the kidney, without impacting blood glucose levels, and reduces the progression of proteinuria to a greater degree than the current std. of care, angiotensin-converting enzyme inhibitor ramipril.  Further analyses of urine biomarkers and kidney tissue gene expression reveal AMPK activation leads to the modulation of multiple pathways implicated in kidney injury, including cellular hypertrophy, fibrosis, and oxidative stress.  These results support the need for further investigation into the potential beneficial effects of AMPK activation in kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps8STmG-nZsrVg90H21EOLACvtfcHk0lhwwEDqBbWIjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOqtb3E&md5=808a4036f5c55486c3d8f61beeb2faa4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237925%26sid%3Dliteratum%253Aachs%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DReyes%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DGenung%26aufirst%3DN.%2BE.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DJatkar%26aufirst%3DA.%26aulast%3DMaciejewski%26aufirst%3DB.%2BS.%26aulast%3DAmaro%26aufirst%3DM.%26aulast%3DGandhok%26aufirst%3DH.%26aulast%3DMonetti%26aufirst%3DM.%26aulast%3DCialdea%26aufirst%3DK.%26aulast%3DBollinger%26aufirst%3DE.%26aulast%3DKreeger%26aufirst%3DJ.%2BM.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DOpsahl%26aufirst%3DA.%2BC.%26aulast%3DBoucher%26aufirst%3DG.%2BG.%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DRolph%26aufirst%3DT.%26atitle%3DSelective%2520activation%2520of%2520AMPK%2520%25CE%25B21-containing%2520isoforms%2520improves%2520kidney%2520function%2520in%2520a%2520rat%2520model%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D361%26spage%3D303%26epage%3D311%26doi%3D10.1124%2Fjpet.116.237925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahasrabudhe, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoth, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subashi, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londregan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span> <span> </span><span class="NLM_article-title">Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1016/j.str.2014.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.str.2014.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=25066137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ags7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1161-1172&author=M.+F.+Calabreseauthor=F.+Rajamohanauthor=M.+S.+Harrisauthor=N.+L.+Caspersauthor=R.+Magyarauthor=J.+M.+Withkaauthor=H.+Wangauthor=K.+A.+Borzilleriauthor=P.+V.+Sahasrabudheauthor=L.+R.+Hothauthor=K.+F.+Geogheganauthor=S.+Hanauthor=J.+Brownauthor=T.+A.+Subashiauthor=A.+R.+Reyesauthor=R.+K.+Frisbieauthor=J.+Wardauthor=R.+A.+Millerauthor=J.+A.+Landroauthor=A.+T.+Londreganauthor=P.+A.+Carpinoauthor=S.+Cabralauthor=A.+C.+Smithauthor=E.+L.+Connauthor=K.+O.+Cameronauthor=X.+Qiuauthor=R.+G.+Kurumbail&title=Structural+basis+for+AMPK+activation%3A+natural+and+synthetic+ligands+regulate+kinase+activity+from+opposite+poles+by+different+molecular+mechanisms&doi=10.1016%2Fj.str.2014.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms</span></div><div class="casAuthors">Calabrese, Matthew F.; Rajamohan, Francis; Harris, Melissa S.; Caspers, Nicole L.; Magyar, Rachelle; Withka, Jane M.; Wang, Hong; Borzilleri, Kris A.; Sahasrabudhe, Parag V.; Hoth, Lise R.; Geoghegan, Kieran F.; Han, Seungil; Brown, Janice; Subashi, Timothy A.; Reyes, Allan R.; Frisbie, Richard K.; Ward, Jessica; Miller, Russell A.; Landro, James A.; Londregan, Allyn T.; Carpino, Philip A.; Cabral, Shawn; Smith, Aaron C.; Conn, Edward L.; Cameron, Kimberly O.; Qiu, Xiayang; Kurumbail, Ravi G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1161-1172</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a principal metabolic regulator affecting growth and response to cellular stress.  Comprised of catalytic and regulatory subunits, each present in multiple forms, AMPK is best described as a family of related enzymes.  In recent years, AMPK has emerged as a desirable target for modulation of numerous diseases, yet clin. therapies remain elusive.  Challenges result, in part, from an incomplete understanding of the structure and function of full-length heterotrimeric complexes.  In this work, we provide the full-length structure of the widely expressed α1β1γ1 isoform of mammalian AMPK, along with detailed kinetic and biophys. characterization.  We characterize binding of the broadly studied synthetic activator A769662 and its analogs.  Our studies follow on the heels of the recent disclosure of the α2β1γ1 structure and provide insight into the distinct mol. mechanisms of AMPK regulation by AMP and A769662.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFqyeOwFToerVg90H21EOLACvtfcHk0ljz5itLDA1iKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ags7bM&md5=8a4edd6c5ff990d9e4c7e0cb16b7b873</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2014.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2014.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DM.%2BS.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DMagyar%26aufirst%3DR.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DSahasrabudhe%26aufirst%3DP.%2BV.%26aulast%3DHoth%26aufirst%3DL.%2BR.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DSubashi%26aufirst%3DT.%2BA.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DLandro%26aufirst%3DJ.%2BA.%26aulast%3DLondregan%26aufirst%3DA.%2BT.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26atitle%3DStructural%2520basis%2520for%2520AMPK%2520activation%253A%2520natural%2520and%2520synthetic%2520ligands%2520regulate%2520kinase%2520activity%2520from%2520opposite%2520poles%2520by%2520different%2520molecular%2520mechanisms%26jtitle%3DStructure%26date%3D2014%26volume%3D22%26spage%3D1161%26epage%3D1172%26doi%3D10.1016%2Fj.str.2014.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haire, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of AMPK regulation by small molecule activators</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3017</span>, <span class="refDoi"> DOI: 10.1038/ncomms4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1038%2Fncomms4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=24352254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=3017&author=B.+Xiaoauthor=M.+J.+Sandersauthor=D.+Carmenaauthor=N.+J.+Brightauthor=L.+F.+Haireauthor=E.+Underwoodauthor=B.+R.+Patelauthor=R.+B.+Heathauthor=P.+A.+Walkerauthor=S.+Hallenauthor=F.+Giordanettoauthor=S.+R.+Martinauthor=D.+Carlingauthor=S.+J.+Gamblin&title=Structural+basis+of+AMPK+regulation+by+small+molecule+activators&doi=10.1038%2Fncomms4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of AMPK regulation by small molecule activators</span></div><div class="casAuthors">Xiao Bing; Sanders Matthew J; Heath Richard B; Carmena David; Bright Nicola J; Patel Bhakti R; Carling David; Haire Lesley F; Underwood Elizabeth; Walker Philip A; Martin Stephen R; Gamblin Steven J; Hallen Stefan; Giordanetto Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP.  Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase.  AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer.  A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK.  Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components.  The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK.  Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp1w2ofyr07jXfW6udTcc2ebASq3M031NRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D&md5=b261b7498514e258ea6ec99a34d04794</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fncomms4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4017%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DM.%2BJ.%26aulast%3DCarmena%26aufirst%3DD.%26aulast%3DBright%26aufirst%3DN.%2BJ.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DB.%2BR.%26aulast%3DHeath%26aufirst%3DR.%2BB.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DHallen%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520AMPK%2520regulation%2520by%2520small%2520molecule%2520activators%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D3017%26doi%3D10.1038%2Fncomms4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckett, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liljevald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohlooly-Y, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span> <span> </span><span class="NLM_article-title">Liver-specific activation of AMPK prevents steatosis on a high-fructose diet</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3043</span>– <span class="NLM_lpage">3051</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2017.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.celrep.2017.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=28355557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt12ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=3043-3051&author=A.+Woodsauthor=J.+R.+Williamsauthor=P.+J.+Muckettauthor=F.+V.+Mayerauthor=M.+Liljevaldauthor=M.+Bohlooly-Yauthor=D.+Carling&title=Liver-specific+activation+of+AMPK+prevents+steatosis+on+a+high-fructose+diet&doi=10.1016%2Fj.celrep.2017.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet</span></div><div class="casAuthors">Woods, Angela; Williams, Jennet R.; Muckett, Phillip J.; Mayer, Faith V.; Liljevald, Maria; Bohlooly-Y, Mohammad; Carling, David</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3043-3051</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a key role in integrating metabolic pathways in response to energy demand.  We identified a mutation in the γ1 subunit (γ1D316A) that leads to activation of AMPK.  We generated mice with this mutation to study the effect of chronic liver-specific activation of AMPK in vivo.  Primary hepatocytes isolated from these mice have reduced gluconeogenesis and fatty acid synthesis, but there is no effect on fatty acid oxidn. compared to cells from wild-type mice.  Liver-specific activation of AMPK decreases lipogenesis in vivo and completely protects against hepatic steatosis when mice are fed a high-fructose diet.  Our findings demonstrate that liver-specific activation of AMPK is sufficient to protect against hepatic triglyceride accumulation, a hallmark of non-alc. fatty liver disease (NAFLD).  These results emphasize the clin. relevance of activating AMPK in the liver to combat NAFLD and potentially other assocd. complications (e.g., cirrhosis and hepatocellular carcinoma).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgaNUehVkO_bVg90H21EOLACvtfcHk0lhdChq56-IyXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt12ru7k%253D&md5=5ebec7dea0a82251bcc4f120e1e8ff03</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2017.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2017.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DJ.%2BR.%26aulast%3DMuckett%26aufirst%3DP.%2BJ.%26aulast%3DMayer%26aufirst%3DF.%2BV.%26aulast%3DLiljevald%26aufirst%3DM.%26aulast%3DBohlooly-Y%26aufirst%3DM.%26aulast%3DCarling%26aufirst%3DD.%26atitle%3DLiver-specific%2520activation%2520of%2520AMPK%2520prevents%2520steatosis%2520on%2520a%2520high-fructose%2520diet%26jtitle%3DCell%2520Rep.%26date%3D2017%26volume%3D18%26spage%3D3043%26epage%3D3051%26doi%3D10.1016%2Fj.celrep.2017.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esquejo, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moccia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peloquin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barricklow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreeger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opsahl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span> <span> </span><span class="NLM_article-title">Activation of liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2018.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.ebiom.2018.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=29673898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADC%252BC1MjksFCquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=122-132&author=R.+M.+Esquejoauthor=C.+T.+Salattoauthor=J.+Delmoreauthor=B.+Albuquerqueauthor=A.+Reyesauthor=Y.+Shiauthor=R.+Mocciaauthor=E.+Cokorinosauthor=M.+Peloquinauthor=M.+Monettiauthor=J.+Barricklowauthor=E.+Bollingerauthor=B.+K.+Smithauthor=E.+A.+Dayauthor=C.+Nguyenauthor=K.+F.+Geogheganauthor=J.+M.+Kreegerauthor=A.+Opsahlauthor=J.+Wardauthor=A.+S.+Kalgutkarauthor=D.+Tessauthor=L.+Butlerauthor=N.+Shiraiauthor=T.+F.+Osborneauthor=G.+R.+Steinbergauthor=M.+J.+Birnbaumauthor=K.+O.+Cameronauthor=R.+A.+Miller&title=Activation+of+liver+AMPK+with+PF-06409577+corrects+NAFLD+and+lowers+cholesterol+in+rodent+and+primate+preclinical+models&doi=10.1016%2Fj.ebiom.2018.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models</span></div><div class="casAuthors">Esquejo Ryan M; Salatto Christopher T; Delmore Jake; Albuquerque Bina; Reyes Allan; Shi Yuji; Cokorinos Emily; Peloquin Matthew; Monetti Mara; Bollinger Eliza; Ward Jessica; Birnbaum Morris J; Moccia Rob; Barricklow Jason; Smith Brennan K; Day Emily A; Steinberg Gregory R; Nguyen Chuong; Geoghegan Kieran F; Kreeger John M; Opsahl Alan; Butler Lynne; Shirai Norimitsu; Kalgutkar Amit S; Tess David; Osborne Timothy F; Cameron Kimberly O; Miller Russell A</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">122-132</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dysregulation of hepatic lipid and cholesterol metabolism is a significant contributor to cardiometabolic health, resulting in excessive liver lipid accumulation and ultimately non-alcoholic steatohepatitis (NASH).  Therapeutic activators of the AMP-Activated Protein Kinase (AMPK) have been proposed as a treatment for metabolic diseases; we show that the AMPK β1-biased activator PF-06409577 is capable of lowering hepatic and systemic lipid and cholesterol levels in both rodent and monkey preclinical models.  PF-06409577 is able to inhibit de novo lipid and cholesterol synthesis pathways, and causes a reduction in hepatic lipids and mRNA expression of markers of hepatic fibrosis.  These effects require AMPK activity in the hepatocytes.  Treatment of hyperlipidemic rats or cynomolgus monkeys with PF-06409577 for 6weeks resulted in a reduction in circulating cholesterol.  Together these data suggest that activation of AMPK β1 complexes with PF-06409577 is capable of impacting multiple facets of liver disease and represents a promising strategy for the treatment of NAFLD and NASH in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKwo8-BMi-wmxpATR2EQURfW6udTcc2eZ0UVMSLvzSgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MjksFCquw%253D%253D&md5=b566de696f76e623975433c49ea94ddf</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2018.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2018.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DEsquejo%26aufirst%3DR.%2BM.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DDelmore%26aufirst%3DJ.%26aulast%3DAlbuquerque%26aufirst%3DB.%26aulast%3DReyes%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DMoccia%26aufirst%3DR.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DPeloquin%26aufirst%3DM.%26aulast%3DMonetti%26aufirst%3DM.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DBollinger%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DB.%2BK.%26aulast%3DDay%26aufirst%3DE.%2BA.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DKreeger%26aufirst%3DJ.%2BM.%26aulast%3DOpsahl%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DTess%26aufirst%3DD.%26aulast%3DButler%26aufirst%3DL.%26aulast%3DShirai%26aufirst%3DN.%26aulast%3DOsborne%26aufirst%3DT.%2BF.%26aulast%3DSteinberg%26aufirst%3DG.%2BR.%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26atitle%3DActivation%2520of%2520liver%2520AMPK%2520with%2520PF-06409577%2520corrects%2520NAFLD%2520and%2520lowers%2520cholesterol%2520in%2520rodent%2520and%2520primate%2520preclinical%2520models%26jtitle%3DEBioMedicine%26date%3D2018%26volume%3D31%26spage%3D122%26epage%3D132%26doi%3D10.1016%2Fj.ebiom.2018.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malik, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lal, J.</span></span> <span> </span><span class="NLM_article-title">Role of enterohepatic recirculation in drug disposition: cooperation and complications</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.3109/03602532.2016.1157600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.3109%2F03602532.2016.1157600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=26987379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVeksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=281-327&author=M.+Y.+Malikauthor=S.+Jaiswalauthor=A.+Sharmaauthor=M.+Shuklaauthor=J.+Lal&title=Role+of+enterohepatic+recirculation+in+drug+disposition%3A+cooperation+and+complications&doi=10.3109%2F03602532.2016.1157600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Role of enterohepatic recirculation in drug disposition: cooperation and complications</span></div><div class="casAuthors">Malik, Mohd Yaseen; Jaiswal, Swati; Sharma, Abhisheak; Shukla, Mahendra; Lal, Jawahar</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-327</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Enterohepatic recirculation (EHC) concerns many physiol. processes and notably affects pharmacokinetic parameters such as plasma half-life and AUC as well as ests. of bioavailability of drugs.  Also, EHC plays a detrimental role as the compds./drugs are allowed to recycle.  An in-depth comprehension of this phenomenon and its consequences on the pharmacol. effects of affected drugs is important and decisive in the design and development of new candidate drugs.  EHC of a compd./drug occurs by biliary excretion and intestinal reabsorption, sometimes with hepatic conjugation and intestinal deconjugation.  EHC leads to prolonged elimination half-life of the drugs, altered pharmacokinetics and pharmacodynamics.  Study of the EHC of any drug is complicated due to unavailability of the apposite model, sophisticated procedures and ethical concerns.  Different in vitro and in vivo methods for studies in exptl. animals and humans have been devised, each having its own merits and demerits.  Involvement of the different transporters in biliary excretion, intra- and inter-species, pathol. and biochem. variabilities obscure the study of the phenomenon.  Modeling of drugs undergoing EHC has always been intricate and exigent models have been exploited to interpret the pharmacokinetic profiles of drugs witnessing multiple peaks due to EHC.  Here, we critically appraise the mechanisms of bile formation, factors affecting biliary drug elimination, methods to est. biliary excretion of drugs, EHC, multiple peak phenomenon and its modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAGytBPJXE3bVg90H21EOLACvtfcHk0lhY_tIqNZ2d4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVeksbc%253D&md5=35a26554595b10c65b4533da62c02e92</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.3109%2F03602532.2016.1157600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602532.2016.1157600%26sid%3Dliteratum%253Aachs%26aulast%3DMalik%26aufirst%3DM.%2BY.%26aulast%3DJaiswal%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DShukla%26aufirst%3DM.%26aulast%3DLal%26aufirst%3DJ.%26atitle%3DRole%2520of%2520enterohepatic%2520recirculation%2520in%2520drug%2520disposition%253A%2520cooperation%2520and%2520complications%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2016%26volume%3D48%26spage%3D281%26epage%3D327%26doi%3D10.3109%2F03602532.2016.1157600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fagerholm, U.</span></span> <span> </span><span class="NLM_article-title">Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1211/jpp.60.5.0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1211%2Fjpp.60.5.0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=18416932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlemsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=535-542&author=U.+Fagerholm&title=Prediction+of+human+pharmacokinetics-biliary+and+intestinal+clearance+and+enterohepatic+circulation&doi=10.1211%2Fjpp.60.5.0001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation</span></div><div class="casAuthors">Fagerholm, Urban</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">535-542</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review.  The main objective was to evaluate and propose methods for predicting biliary clearance (CLbile) and enterohepatic circulation (EHC) of intact drugs in man.  Another aim was to evaluate to role of intestinal drug secretion and propose a method for prediction of intestinal secretion CL (CLi).  Animal data poorly predict the CL and CLbile of biliary excreted drugs, and the suggested mol. wt. threshold for bile excretion as the dominant elimination route does not seem to hold.  Active transport, low metabolic intrinsic CL (CLint) and, as an approxn., permeability (Pe) less than that of metoprolol is required for substantial CLbile to occur.  The typical EHC plasma concn. vs time profile (multiple peaks) is demonstrated for many low metabolic CLint-compds. with efflux and moderate to high intestinal Pe and fraction absorbed.  Physiol.-based in-vitro to in-vivo (PB-IVIV) methodol. with in-vitro intrinsic CLbile-data obtained with sandwich-cultured human hepatocytes has generated 2- and 5-fold underpredictions for two compds. with intermediate to high CLbile.  This is despite not considering the unbound fraction.  Possible explanations include low transporter activity and diffusion limitations in the in-vitro expts.  Intestinal resorption and EHC were also neglected in these predictions and in-vivo CLbile estns.  The sandwich model and these ref. data are still very useful.  Consideration of an empirical scaling factor and a newly developed approach that accounts for intestinal resorption and EHC could potentially lead to improved PB-IVIV predictions of CLbile.  Apparently, no attempts have been made to predict CLi.  Elimination via the intestinal route does not appear to be of great importance for the few compds. with available data, but could be equally as important as bile excretion.  Net secretion in-vitro Pe and newly estd. in-vivo intrinsic CLi data for digoxin and rosuvastatin could be useful for approxn. of CLi of other compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppqKJMNxNjALVg90H21EOLACvtfcHk0lhY_tIqNZ2d4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlemsbc%253D&md5=d51f46d7d87d64e6c4f4479821895526</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1211%2Fjpp.60.5.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.60.5.0001%26sid%3Dliteratum%253Aachs%26aulast%3DFagerholm%26aufirst%3DU.%26atitle%3DPrediction%2520of%2520human%2520pharmacokinetics-biliary%2520and%2520intestinal%2520clearance%2520and%2520enterohepatic%2520circulation%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2008%26volume%3D60%26spage%3D535%26epage%3D542%26doi%3D10.1211%2Fjpp.60.5.0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagas, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparidans, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagenaar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1124/mol.109.062364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fmol.109.062364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=20086033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVyku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=687-694&author=J.+S.+Lagasauthor=R.+W.+Sparidansauthor=E.+Wagenaarauthor=J.+H.+Beijnenauthor=A.+H.+Schinkel&title=Hepatic+clearance+of+reactive+glucuronide+metabolites+of+diclofenac+in+the+mouse+is+dependent+on+multiple+ATP-binding+cassette+efflux+transporters&doi=10.1124%2Fmol.109.062364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters</span></div><div class="casAuthors">Lagas, Jurjen S.; Sparidans, Rolf W.; Wagenaar, Els; Beijnen, Jos H.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-694</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Diclofenac is an important analgesic and anti-inflammatory drug that is widely used for the treatment of postoperative pain, rheumatoid arthritis, and chronic pain assocd. with cancer.  Diclofenac is extensively metabolized in the liver, and the main metabolites are hydroxylated and/or glucuronidated conjugates.  We show here that loss of multidrug resistance protein 2 (MRP2/ABCC2) and breast cancer resistance protein (BCRP/ABCG2) in mice results in highly increased plasma levels of diclofenac acyl glucuronide, after both oral and i.v. administration.  The absence of Mrp2 and Bcrp1, localized at the canalicular membrane of hepatocytes, leads to impaired biliary excretion of acyl glucuronides and consequently to elevated liver and plasma levels.  Mrp2 also mediates the biliary excretion of two hydroxylated diclofenac metabolites, 4'-hydroxydiclofenac and 5-hydroxydiclofenac.  We further show that the sinusoidal efflux of diclofenac acyl glucuronide, from liver to blood, is largely dependent on multidrug resistance protein 3 (MRP3/ABCC3).  Diclofenac acyl glucuronides are chem. instable and reactive, and in patients, these metabolites are assocd. with rare but serious idiosyncratic liver toxicity.  This might explain why Mrp2/Mrp3/Bcrp1(-/-) mice, which have markedly elevated levels of diclofenac acyl glucuronides in their liver, display acute, albeit very mild, hepatotoxicity.  We believe that the handling of diclofenac acyl glucuronides by ATP binding cassette transporters may be representative for the handling of acyl glucuronide metabolites of many other clin. relevant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7hz__m1sE7LVg90H21EOLACvtfcHk0lhY_tIqNZ2d4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVyku7o%253D&md5=3f943eaaded06e34a7c3ccf0a3c09a5f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.062364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.062364%26sid%3Dliteratum%253Aachs%26aulast%3DLagas%26aufirst%3DJ.%2BS.%26aulast%3DSparidans%26aufirst%3DR.%2BW.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DHepatic%2520clearance%2520of%2520reactive%2520glucuronide%2520metabolites%2520of%2520diclofenac%2520in%2520the%2520mouse%2520is%2520dependent%2520on%2520multiple%2520ATP-binding%2520cassette%2520efflux%2520transporters%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D687%26epage%3D694%26doi%3D10.1124%2Fmol.109.062364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, J.</span></span> <span> </span><span class="NLM_article-title">Hepatic secretion of conjugated drugs and endogenous substances</span>. <i>Semin. Liver Dis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1055/s-2000-9391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1055%2Fs-2000-9391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11076395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVOmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=265-272&author=D.+Kepplerauthor=J.+K%C3%B6nig&title=Hepatic+secretion+of+conjugated+drugs+and+endogenous+substances&doi=10.1055%2Fs-2000-9391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic secretion of conjugated drugs and endogenous substances</span></div><div class="casAuthors">Keppler, Dietrich; Konig, Jorg</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Liver Disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-272</span>CODEN:
                <span class="NLM_cas:coden">SLDIEE</span>;
        ISSN:<span class="NLM_cas:issn">0272-8087</span>.
    
            (<span class="NLM_cas:orgname">Thieme Medical Publishers, Inc.</span>)
        </div><div class="casAbstract">A review is given with 81 refs. on the role of multidrug resistance protein (MRP) family members in the hepatocellular secretion of anionic substances formed in the conjugation phase.  Xenobiotic and endogenous lipophilic substances may be conjugated with glutathione, glucuronate, sulfate, or other neg. charged groups and thus become substrates for export pumps of the MRP family.  The apical isoform, MRP2 (gene symbol ABCC2), was localized to the apical membrane of several polarized epithelia and particularly to the canalicular membrane of hepatocytes.  Absence of functionally active MRP2 glycoprotein from this membrane domain prevents the secretion of many anionic conjugates into bile.  Prototypic endogenous substrates of high affinity for recombinant human MRP2 include bisglucuronosyl bilirubin, monoglucuronosyl bilirubin, and the glutathione S-conjugate leukotriene C4.  Several mutations in the human MRP2 gene were identified that lead to the absence of MRP2 from the canalicular membrane and to the conjugated hyperbilirubinemia of Dubin-Johnson syndrome.  MRP2-mediated conjugate export represents a decisive final step in the detoxification of drugs, toxins, and endogenous substances.  The basolateral isoform, MRP3 (gene symbol ABCC3), is upregulated in MRP2 deficiency and in extrahepatic cholestasis.  MRP3 mediates the ATP-dependent transport of anionic conjugates, particularly of glucuronides and sulfoconjugates, across the basolateral hepatocyte membrane into sinusoidal blood.  The inverse regulation of MRP3 and MRP2 expression under many conditions is consistent with their distinct localization and with a compensatory role of MRP3 in the hepatic secretion of anionic conjugates during impaired transport into bile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfEeDwhncV47Vg90H21EOLACvtfcHk0ljXULxhaoU0dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVOmurw%253D&md5=e6512080940457af12f15b03ecfcdfb1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-9391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-9391%26sid%3Dliteratum%253Aachs%26aulast%3DKeppler%26aufirst%3DD.%26aulast%3DK%25C3%25B6nig%26aufirst%3DJ.%26atitle%3DHepatic%2520secretion%2520of%2520conjugated%2520drugs%2520and%2520endogenous%2520substances%26jtitle%3DSemin.%2520Liver%2520Dis.%26date%3D2000%26volume%3D20%26spage%3D265%26epage%3D272%26doi%3D10.1055%2Fs-2000-9391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stachulski, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindon, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. D.</span></span> <span> </span><span class="NLM_article-title">Acyl glucuronides: biological activity, chemical reactivity, and chemical synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6931</span>– <span class="NLM_lpage">6945</span>, <span class="refDoi"> DOI: 10.1021/jm060599z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060599z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Gls7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6931-6945&author=A.+V.+Stachulskiauthor=J.+R.+Hardingauthor=J.+C.+Lindonauthor=J.+L.+Maggsauthor=B.+K.+Parkauthor=I.+D.+Wilson&title=Acyl+glucuronides%3A+biological+activity%2C+chemical+reactivity%2C+and+chemical+synthesis&doi=10.1021%2Fjm060599z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Acyl Glucuronides: Biological Activity, Chemical Reactivity, and Chemical Synthesis</span></div><div class="casAuthors">Stachulski, Andrew V.; Harding, John R.; Lindon, John C.; Maggs, James L.; Park, B. Kevin; Wilson, Ian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6931-6945</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the synthesis, chem. reactivity with biomols. and anal. technol. for their detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGPGlj0fHykrVg90H21EOLACvtfcHk0ljXULxhaoU0dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Gls7jP&md5=b5bc088699cbd60c78ac52d79c634f59</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm060599z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060599z%26sid%3Dliteratum%253Aachs%26aulast%3DStachulski%26aufirst%3DA.%2BV.%26aulast%3DHarding%26aufirst%3DJ.%2BR.%26aulast%3DLindon%26aufirst%3DJ.%2BC.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26atitle%3DAcyl%2520glucuronides%253A%2520biological%2520activity%252C%2520chemical%2520reactivity%252C%2520and%2520chemical%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6931%26epage%3D6945%26doi%3D10.1021%2Fjm060599z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stachulski, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span> <span> </span><span class="NLM_article-title">Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">806</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1039/c3np70003h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1039%2Fc3np70003h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=23648894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1ahsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=806-848&author=A.+V.+Stachulskiauthor=X.+Meng&title=Glucuronides+from+metabolites+to+medicines%3A+a+survey+of+the+in+vivo+generation%2C+chemical+synthesis+and+properties+of+glucuronides&doi=10.1039%2Fc3np70003h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides</span></div><div class="casAuthors">Stachulski, Andrew V.; Meng, Xiaoli</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">806-848</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The fourteen years that have passed since the previous review on this topic have seen a significant increase of interest in many aspects of glucuronide chem. and biol.  Glucuronides are the most important class of phase 2 xenobiotic metabolites and typically act in a detoxifying role.  While this is generally true for O-alkyl and O-aryl glucuronides, a no. of glucuronides are known to be pharmacol. active per se.  Addnl. the use of glucuronide prodrugs, notably to ameliorate the cytotoxicity of anticancer agents, has markedly increased.  Whereas the previous review covered only the synthesis of O-glucuronides, we now include N-, S- and C-glucuronides also and discuss both synthetic and biol. aspects.  Synthetic methods for all classes of glucuronides are reviewed and updated, together with advances in the enzymic synthesis of glucuronides and methods for their detection.  Finally we discuss the biol. reactivity of glucuronides where known, including the important morphine-6-glucuronide.  A lively debate has continued for several years on whether O-acyl glucuronide metabolites of carboxylic acids are toxic, affecting both the safety assessment of well-used drugs and new drug development programs.  We summarise the current understanding, together with other known examples of interaction between glucuronides and macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwzUgkR4b3vLVg90H21EOLACvtfcHk0ljXULxhaoU0dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1ahsrg%253D&md5=ff61864421447aaf55fec7ffec1e9ee2</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1039%2Fc3np70003h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3np70003h%26sid%3Dliteratum%253Aachs%26aulast%3DStachulski%26aufirst%3DA.%2BV.%26aulast%3DMeng%26aufirst%3DX.%26atitle%3DGlucuronides%2520from%2520metabolites%2520to%2520medicines%253A%2520a%2520survey%2520of%2520the%2520in%2520vivo%2520generation%252C%2520chemical%2520synthesis%2520and%2520properties%2520of%2520glucuronides%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2013%26volume%3D30%26spage%3D806%26epage%3D848%26doi%3D10.1039%2Fc3np70003h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, T.</span></span> <span> </span><span class="NLM_article-title">Physiological parameters in laboratory animals and humans</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1093</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1023/A:1018943613122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1023%2FA%3A1018943613122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=8378254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=1093-1095&author=B.+Daviesauthor=T.+Morris&title=Physiological+parameters+in+laboratory+animals+and+humans&doi=10.1023%2FA%3A1018943613122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological parameters in laboratory animals and humans</span></div><div class="casAuthors">Davies B; Morris T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-5</span>
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDDwka3A6hEYYPsCkJIw00fW6udTcc2eYm8t4NBSnbnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D&md5=094cdd17306b58cc17c8cf4fd5db9927</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018943613122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018943613122%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%26atitle%3DPhysiological%2520parameters%2520in%2520laboratory%2520animals%2520and%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D1093%26epage%3D1095%26doi%3D10.1023%2FA%3A1018943613122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Safety assessment of acyl glucuronides – A simplified paradigm</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">912</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.080515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.118.080515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=29559442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWltrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=908-912&author=D.+A.+Smithauthor=T.+Hammondauthor=T.+A.+Baillie&title=Safety+assessment+of+acyl+glucuronides+%E2%80%93+A+simplified+paradigm&doi=10.1124%2Fdmd.118.080515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Safety assessment of acyl glucuronides-a simplified paradigm</span></div><div class="casAuthors">Smith, Dennis A.; Hammond, Timothy; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">908-912</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">While simple O-(ether-linked) and N-glucuronide drug conjugates generally are unreactive and considered benign from a safety perspective, the acyl glucuronides that derive from metab. of carboxylic acid-contg. xenobiotics can exhibit a degree of chem. reactivity that is dependent upon their mol. structure.  As a result, concerns have arisen over the safety of acyl glucuronides as a class, several members of which have been implicated in the toxicity of their resp. parent drugs.  However, direct evidence in support of these claims remains sparse, and due to frequently encountered species differences in the systemic exposure to acyl glucuronides (both of the parent drug and oxidized derivs. thereof), coupled with their instability in aq. media and potential to undergo chem. rearrangement (acyl migration), qualification of these conjugates by traditional safety assessment methods can be very challenging.  In this Commentary, we discuss alternative (non-acyl glucuronide)mechanisms by which carboxylic acids may cause serious adverse reactions, and propose a novel, practical approach to compare systemic exposure to acyl glucuronide metabolites in humans to that in animal species used in preclin. safety assessment based on relative ests. of the total body burden of these circulating conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEevJPQ6waKbVg90H21EOLACvtfcHk0liJzPKTchYxoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWltrnK&md5=bb4d99cdc5bf87751b6d796366ed7e46</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.080515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.080515%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DHammond%26aufirst%3DT.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DSafety%2520assessment%2520of%2520acyl%2520glucuronides%2520%25E2%2580%2593%2520A%2520simplified%2520paradigm%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26spage%3D908%26epage%3D912%26doi%3D10.1124%2Fdmd.118.080515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prueksaritanont, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Complicating factors in safety testing of drug metabolites: kinetic differences between generated and preformed metabolites</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2006.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.taap.2006.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=17055014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SmsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2006&pages=143-152&author=T.+Prueksaritanontauthor=J.+H.+Linauthor=T.+A.+Baillie&title=Complicating+factors+in+safety+testing+of+drug+metabolites%3A+kinetic+differences+between+generated+and+preformed+metabolites&doi=10.1016%2Fj.taap.2006.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Complicating factors in safety testing of drug metabolites: Kinetic differences between generated and preformed metabolites</span></div><div class="casAuthors">Prueksaritanont, Thomayant; Lin, Jiunn H.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-152</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  This paper aims to provide a scientifically based perspective on issues surrounding the proposed toxicol. testing of synthetic drug metabolites as a means of ensuring adequate nonclin. safety evaluation of drug candidates that generate metabolites considered either to be unique to humans or are present at much higher levels in humans than in preclin. species.  We put forward a no. of theor. considerations and present several specific examples where the kinetic behavior of a preformed metabolite given to animals or humans differs from that of the corresponding metabolite generated endogenously from its parent.  The potential ramifications of this phenomenon are that the results of toxicity testing of the preformed metabolite may be misleading and fail to characterize the true toxicol. contribution of the metabolite when formed from the parent.  It is anticipated that such complications would be evident in situations where (a) differences exist in the accumulation of the preformed vs. generated metabolites in specific tissues, and (b) the metabolite undergoes sequential metab. to a downstream product that is toxic, leading to differences in tissue-specific toxicity.  Owing to the complex nature of this subject, there is a need to treat drug metabolite issues in safety assessment on a case-by-case basis, in which a knowledge of metabolite kinetics is employed to validate exptl. paradigms that entail administration of preformed metabolites to animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS61bFOTELG7Vg90H21EOLACvtfcHk0liJzPKTchYxoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SmsLbP&md5=e5482de97034be7ca31f884a7dd4aded</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2006.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2006.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DComplicating%2520factors%2520in%2520safety%2520testing%2520of%2520drug%2520metabolites%253A%2520kinetic%2520differences%2520between%2520generated%2520and%2520preformed%2520metabolites%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2006%26volume%3D217%26spage%3D143%26epage%3D152%26doi%3D10.1016%2Fj.taap.2006.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodnar, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inturrisi, C. E.</span></span> <span> </span><span class="NLM_article-title">Morphine-6-glucuroinde, a potent mu agonist</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2845</span>– <span class="NLM_lpage">2849</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(87)90431-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2F0024-3205%2887%2990431-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1987&pages=2845-2849&author=G.+W.+Pasternakauthor=R.+J.+Bodnarauthor=J.+A.+Clarkauthor=C.+E.+Inturrisi&title=Morphine-6-glucuroinde%2C+a+potent+mu+agonist&doi=10.1016%2F0024-3205%2887%2990431-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2887%2990431-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252887%252990431-0%26sid%3Dliteratum%253Aachs%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26aulast%3DBodnar%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DJ.%2BA.%26aulast%3DInturrisi%26aufirst%3DC.%2BE.%26atitle%3DMorphine-6-glucuroinde%252C%2520a%2520potent%2520mu%2520agonist%26jtitle%3DLife%2520Sci.%26date%3D1987%26volume%3D41%26spage%3D2845%26epage%3D2849%26doi%3D10.1016%2F0024-3205%2887%2990431-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standifer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inturrisi, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>251</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=2810109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK3cXmvFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1989&pages=477-483&author=D.+Paulauthor=K.+M.+Standiferauthor=C.+E.+Inturrisiauthor=G.+W.+Pasternak&title=Pharmacological+characterization+of+morphine-6+beta-glucuronide%2C+a+very+potent+morphine+metabolite"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite</span></div><div class="casAuthors">Paul, Dennis; Standifer, Kelly M.; Inturrisi, Charles E.; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">477-83</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Morphine 6β-glucuronide is a major metabolite of morphine with potent analgesic actions.  The analgesic actions of morphine and its 6β-glucuronide metabolite were compared in mice after peripheral and central administration.  Given s.c., morphine 6β-glucuronide elicited analgesia with an effect approx. twice that of morphine due to its long duration of action and also inhibited gastrointestinal motility.  Both actions were easily reversed by s.c. naloxone.  When injected intracerebroventricularly (i.c.v.) or intrathecally, morphine 6β-glucuronide was ∼90- and 650-fold more potent analgesic than morphine, resp.  Whereas morphine was equipotent at both levels of the central nervous system as an analgesic, the 6β-glucuronide was ∼5-fold more effective at the level of the spinal cord than supraspinally.  The μ1-selective antagonist naloxonazine blocked the analgesic effect of s.c. and i.c.v. morphine 6β-glucuronide much as it blocked morphine, implying a role for μ1-receptors in these actions.  Like morphine, morphine 6β-glucuronide analgesia after intrathecal injection was not sensitive to naloxonazine, suggesting a μ2 mechanism within the spinal cord.  Thus, morphine 6β-glucuronide elicited its analgesic actions through the same receptor mechanisms as morphine.  Mice highly tolerant to morphine after implantation of morphine pellets showed cross-tolerance to s.c. morphine 6β-glucuronide.  The high potency of morphine 6β-glucuronide strongly suggests that this metabolite plays an important role in morphine actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiGi1lWpdrPbVg90H21EOLACvtfcHk0lijf1XS7o8rFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmvFOktA%253D%253D&md5=a2397ae055be55ea31410dce506b966f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DStandifer%26aufirst%3DK.%2BM.%26aulast%3DInturrisi%26aufirst%3DC.%2BE.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DPharmacological%2520characterization%2520of%2520morphine-6%2520beta-glucuronide%252C%2520a%2520very%2520potent%2520morphine%2520metabolite%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D251%26spage%3D477%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lotsch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span> <span> </span><span class="NLM_article-title">Morphine-6-glucuronideL an analgesis of the future?</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.2165/00003088-200140070-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.2165%2F00003088-200140070-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11510626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms1arsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=485-499&author=J.+Lotschauthor=G.+Geisslinger&title=Morphine-6-glucuronideL+an+analgesis+of+the+future%3F&doi=10.2165%2F00003088-200140070-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-6-glucuronide. An analgesic of the future?</span></div><div class="casAuthors">Lotsch, Jorn; Geisslinger, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">485-499</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Morphine-6-β-glucuronide (M6G) is an opioid agonist that plays a role in the clin. effects of morphine.  Although M6G probably crosses the blood-brain barrier with difficulty, during long-term morphine administration it may reach sufficiently high CNS concns. to exert clin. relevant opioid effects.  As a consequence of its almost exclusive renal elimination, M6G may accumulate in the body of patients with impaired renal function and cause severe opioid adverse effects with insidious onset and long persistence.  Its profile of receptor affinities, however, gives reason to speculate that M6G may exhibit analgesic effects while causing fewer adverse effects than morphine.  This is supported by reports of the good tolerability of intrathecal and i.v. injections of M6G in humans with intact renal function.  M6G may thus be contemplated as an analgesic for short-term postoperative analgesia, esp. for intrathecal analgesic therapy.  In addn., its possibly higher potency than morphine makes M6G a candidate opioid for local or peripheral analgesic therapy.  However, current knowledge is too incomplete to finally judge the clin. usefulness of M6G.  The next topics for clin. research on M6G should include: (1) a comparison of the potencies of M6G and morphine to cause wanted and unwanted clin. effects; (2) development of a predictive population pharmacokinetic-pharmacodynamic model of M6G with calcn. of the transfer half-life between plasma and effect site; and (3) identification of cofactors influencing the action of M6G that can serve as predictors for the clin. outcome of morphine/M6G therapy in an individual including the pharmacogenetics of M6G.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZmW_qkNVkbVg90H21EOLACvtfcHk0lgnvLakTdyAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms1arsrc%253D&md5=8a32f45bbd7fdd65f4db19817160548a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2165%2F00003088-200140070-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200140070-00001%26sid%3Dliteratum%253Aachs%26aulast%3DLotsch%26aufirst%3DJ.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DMorphine-6-glucuronideL%2520an%2520analgesis%2520of%2520the%2520future%253F%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2001%26volume%3D40%26spage%3D485%26epage%3D499%26doi%3D10.2165%2F00003088-200140070-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klimas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikus, G.</span></span> <span> </span><span class="NLM_article-title">Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">944</span>, <span class="refDoi"> DOI: 10.1093/bja/aeu186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1093%2Fbja%2Faeu186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=24985077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Chtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2014&pages=935-944&author=R.+Klimasauthor=G.+Mikus&title=Morphine-6-glucuronide+is+responsible+for+the+analgesic+effect+after+morphine+administration%3A+a+quantitative+review+of+morphine%2C+morphine-6-glucuronide%2C+and+morphine-3-glucuronide&doi=10.1093%2Fbja%2Faeu186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6 glucuronide, and morphine-3-glucuronide</span></div><div class="casAuthors">Klimas, R.; Mikus, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">935-944</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">0007-0912</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Morphine-6-glucuronide (M6G) is a strong μ-receptor agonist with higher affinity than morphine itself.  It has been suggested that M6G contributes to the analgesic effect after administration of morphine, but the extent of its contribution remains unclear.  Methods: In order to elucidate the relative contribution of both drugs to the overall analgesic effect mediated by the μ-receptor, published data on μ-receptor binding, plasma protein binding, concns. [preferably area under the concn.-time curve (AUC)] of morphine and M6G in blood or cerebrospinal fluid (CSF), or concn. ratios were used to calc. free CSF concn. cor. for receptor binding for each compd.  To compare different routes of administration, free CSF concns. of M and M6G cor. for potency were added and compared with oral administration.  Results: Based on AUC data, there is a major contribution of M6G to the overall analgesic effect; the mean contributions being estd. as 96.6%, 85.6%, 85.4%, and 91.3% after oral, s.c., i.v., and rectal administration of morphine, resp.  In patients with renal insufficiency, 97.6% of the analgesic effect is caused by M6G when morphine is given orally.  Owing to accumulation of M6G over time in these patients, morphine may be regarded as a prodrug.  Conclusions: When administering morphine to patients, the analgesic effect is mainly caused by M6G instead of morphine itself, irresp. of the route of administration.  Therefore, the patient's kidney function plays a key role in detg. the optimal daily dose of morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7VNCqIHZXq7Vg90H21EOLACvtfcHk0lgnvLakTdyAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Chtb8%253D&md5=293e3a2a1782649fa747d941a141cacc</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1093%2Fbja%2Faeu186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbja%252Faeu186%26sid%3Dliteratum%253Aachs%26aulast%3DKlimas%26aufirst%3DR.%26aulast%3DMikus%26aufirst%3DG.%26atitle%3DMorphine-6-glucuronide%2520is%2520responsible%2520for%2520the%2520analgesic%2520effect%2520after%2520morphine%2520administration%253A%2520a%2520quantitative%2520review%2520of%2520morphine%252C%2520morphine-6-glucuronide%252C%2520and%2520morphine-3-glucuronide%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2014%26volume%3D113%26spage%3D935%26epage%3D944%26doi%3D10.1093%2Fbja%2Faeu186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luffer-Atlas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrakchi, A.</span></span> <span> </span><span class="NLM_article-title">A decade of drug metabolite safety testing: industry and regulatory shared learning</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1364362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1080%2F17425255.2017.1364362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=28797172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADC%252BC1cfmsVyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=897-900&author=D.+Luffer-Atlasauthor=A.+Atrakchi&title=A+decade+of+drug+metabolite+safety+testing%3A+industry+and+regulatory+shared+learning&doi=10.1080%2F17425255.2017.1364362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of drug metabolite safety testing: industry and regulatory shared learning</span></div><div class="casAuthors">Luffer-Atlas Debra; Atrakchi Aisar</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug metabolism & toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">897-900</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvghRhWF_WzhdUSIfHIn4FfW6udTcc2eb8TGwKgBCgjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfmsVyhsg%253D%253D&md5=fa9aacec75b7772338c9863d413bb093</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1364362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1364362%26sid%3Dliteratum%253Aachs%26aulast%3DLuffer-Atlas%26aufirst%3DD.%26aulast%3DAtrakchi%26aufirst%3DA.%26atitle%3DA%2520decade%2520of%2520drug%2520metabolite%2520safety%2520testing%253A%2520industry%2520and%2520regulatory%2520shared%2520learning%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26spage%3D897%26epage%3D900%26doi%3D10.1080%2F17425255.2017.1364362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roversi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2221</span>, <span class="refDoi"> DOI: 10.1107/S0907444904016427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1107%2FS0907444904016427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=15572774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2210-2221&author=E.+Blancauthor=P.+Roversiauthor=C.+Vonrheinauthor=C.+Flensburgauthor=S.+M.+Leaauthor=G.+Bricogne&title=Refinement+of+severely+incomplete+structures+with+maximum+likelihood+in+BUSTER-TNT&doi=10.1107%2FS0907444904016427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT</span></div><div class="casAuthors">Blanc, E.; Roversi, P.; Vonrhein, C.; Flensburg, C.; Lea, S. M.; Bricogne, G.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2210-2221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">BUSTER-TNT is a max.-likelihood macromol. refinement package.  BUSTER assembles the structural model, scales obsd. and calcd. structure-factor amplitudes and computes the model likelihood, while TNT handles the stereochem. and NCS restraints/constraints and shifts the at. coordinates, B factors and occupancies.  In real space, in addn. to the traditional at. and bulk-solvent models, BUSTER models the parts of the structure for which an at. model is not yet available ('missing structure') as low-resoln. probability distributions for the random positions of the missing atoms.  In reciprocal space, the BUSTER structure-factor distribution in the complex plane is a two-dimensional Gaussian centered around the structure factor calcd. from the at., bulk-solvent and missing-structure models.  The errors assocd. with these three structural components are added to compute the overall spread of the Gaussian.  When the at. model is very incomplete, modeling of the missing structure and the consistency of the BUSTER statistical model help structure building and completion because (i) the accuracy of the overall scale factors is increased, (ii) the bias affecting at. model refinement is reduced by accounting for some of the scattering from the missing structure, (iii) the addn. of a spatial definition to the source of incompleteness improves on traditional Luzzati and σA-based error models and (iv) the program can perform selective d. modification in the regions of unbuilt structure alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0psykpyEUoLVg90H21EOLACvtfcHk0lg_TwVkEIDAnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars7rO&md5=6ea77dcafccd3e87facac18928469bfa</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444904016427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904016427%26sid%3Dliteratum%253Aachs%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DRoversi%26aufirst%3DP.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DLea%26aufirst%3DS.%2BM.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DRefinement%2520of%2520severely%2520incomplete%2520structures%2520with%2520maximum%2520likelihood%2520in%2520BUSTER-TNT%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2210%26epage%3D2221%26doi%3D10.1107%2FS0907444904016427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lj5DuJ3zAAO8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Julia Shanu-Wilson, Liam Evans, Stephen Wrigley, Jonathan Steele, James Atherton, <span class="NLM_string-name hlFld-ContribAuthor">Jason Boer</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation: Impact and Application of Metabolism in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2087-2107. <a href="https://doi.org/10.1021/acsmedchemlett.0c00202" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00202%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBiotransformation%25253A%252BImpact%252Band%252BApplication%252Bof%252BMetabolism%252Bin%252BDrug%252BDiscovery%26aulast%3DShanu-Wilson%26aufirst%3DJulia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D13082020%26date%3D28082020%26volume%3D11%26issue%3D11%26spage%3D2087%26epage%3D2107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew A. Cerny, Amit S. Kalgutkar, R. Scott Obach, Raman Sharma, Douglas K. Spracklin, <span class="NLM_string-name hlFld-ContribAuthor">Gregory S. Walker</span>. </span><span class="cited-content_cbyCitation_article-title">Effective Application of Metabolite Profiling in Drug Design and Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6387-6406. <a href="https://doi.org/10.1021/acs.jmedchem.9b01840" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01840%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffective%252BApplication%252Bof%252BMetabolite%252BProfiling%252Bin%252BDrug%252BDesign%252Band%252BDiscovery%26aulast%3DCerny%26aufirst%3DMatthew%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D06112019%26date%3D06032020%26date%3D25022020%26volume%3D63%26issue%3D12%26spage%3D6387%26epage%3D6406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuqian  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinran  Zhao</span>, <span class="hlFld-ContribAuthor ">Longbiao  Luo</span>, <span class="hlFld-ContribAuthor ">Yang  Gao</span>, <span class="hlFld-ContribAuthor ">He  Bao</span>, <span class="hlFld-ContribAuthor ">Pengfei  Li</span>, <span class="hlFld-ContribAuthor ">Hailong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress of indole compounds with potential antidiabetic activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113665. <a href="https://doi.org/10.1016/j.ejmech.2021.113665" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113665%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bof%252Bindole%252Bcompounds%252Bwith%252Bpotential%252Bantidiabetic%252Bactivity%26aulast%3DZhu%26aufirst%3DYuqian%26date%3D2021%26volume%3D223%26spage%3D113665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamie I.  van der Vaart</span>, <span class="hlFld-ContribAuthor ">Mariëtte R.  Boon</span>, <span class="hlFld-ContribAuthor ">Riekelt H.  Houtkooper</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of AMPK Signaling in Brown Adipose Tissue Activation. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 1122. <a href="https://doi.org/10.3390/cells10051122" title="DOI URL">https://doi.org/10.3390/cells10051122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10051122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10051122%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DThe%252BRole%252Bof%252BAMPK%252BSignaling%252Bin%252BBrown%252BAdipose%252BTissue%252BActivation%26aulast%3Dvan%2Bder%2BVaart%26aufirst%3DJamie%2BI.%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John O.  Miners</span>, <span class="hlFld-ContribAuthor ">Andrew  Rowland</span>, <span class="hlFld-ContribAuthor ">Jonathan J.  Novak</span>, <span class="hlFld-ContribAuthor ">Kimberly  Lapham</span>, <span class="hlFld-ContribAuthor ">Theunis C.  Goosen</span>. </span><span class="cited-content_cbyCitation_article-title">Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>218 </em>, 107689. <a href="https://doi.org/10.1016/j.pharmthera.2020.107689" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107689%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DEvidence-based%252Bstrategies%252Bfor%252Bthe%252Bcharacterisation%252Bof%252Bhuman%252Bdrug%252Band%252Bchemical%252Bglucuronidation%252Bin%252Bvitro%252Band%252BUDP-glucuronosyltransferase%252Breaction%252Bphenotyping%26aulast%3DMiners%26aufirst%3DJohn%2BO.%26date%3D2021%26volume%3D218%26spage%3D107689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter R.  Bradshaw</span>, <span class="hlFld-ContribAuthor ">Toby J.  Athersuch</span>, <span class="hlFld-ContribAuthor ">Andrew V.  Stachulski</span>, <span class="hlFld-ContribAuthor ">Ian D.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Acyl glucuronide reactivity in perspective. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 1639-1650. <a href="https://doi.org/10.1016/j.drudis.2020.07.009" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAcyl%252Bglucuronide%252Breactivity%252Bin%252Bperspective%26aulast%3DBradshaw%26aufirst%3DPeter%2BR.%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D1639%26epage%3D1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liai  Lan</span>, <span class="hlFld-ContribAuthor ">Shengyuan  Wu</span>, <span class="hlFld-ContribAuthor ">Shidan  Yu</span>, <span class="hlFld-ContribAuthor ">Jingjing  Jiang</span>, <span class="hlFld-ContribAuthor ">Honghong  Chen</span>, <span class="hlFld-ContribAuthor ">Yuefen  Lou</span>, <span class="hlFld-ContribAuthor ">Guorong  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Fast and direct determination of catechol-3, 6-bis(methyleiminodiacetic acid) prototype in beagle dog plasma using liquid chromatography tandem mass spectrometry: A simplified and high throughput in-vivo method for the metal chelator. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography A</span><span> <strong>2019,</strong> <em>1596 </em>, 84-95. <a href="https://doi.org/10.1016/j.chroma.2019.03.002" title="DOI URL">https://doi.org/10.1016/j.chroma.2019.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chroma.2019.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chroma.2019.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520A%26atitle%3DFast%252Band%252Bdirect%252Bdetermination%252Bof%252Bcatechol-3%25252C%252B6-bis%252528methyleiminodiacetic%252Bacid%252529%252Bprototype%252Bin%252Bbeagle%252Bdog%252Bplasma%252Busing%252Bliquid%252Bchromatography%252Btandem%252Bmass%252Bspectrometry%25253A%252BA%252Bsimplified%252Band%252Bhigh%252Bthroughput%252Bin-vivo%252Bmethod%252Bfor%252Bthe%252Bmetal%252Bchelator%26aulast%3DLan%26aufirst%3DLiai%26date%3D2019%26volume%3D1596%26spage%3D84%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kimberly  Lapham</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Jonathan  Novak</span>, <span class="hlFld-ContribAuthor ">Christine  Orozco</span>, <span class="hlFld-ContribAuthor ">Mark  Niosi</span>, <span class="hlFld-ContribAuthor ">Li  Di</span>, <span class="hlFld-ContribAuthor ">Theunis C.  Goosen</span>, <span class="hlFld-ContribAuthor ">Sangwoo  Ryu</span>, <span class="hlFld-ContribAuthor ">Keith  Riccardi</span>, <span class="hlFld-ContribAuthor ">Heather  Eng</span>, <span class="hlFld-ContribAuthor ">Kimberly O.  Cameron</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">6-Chloro-5-[4-(1-Hydroxycyclobutyl)Phenyl]-1
              H
              -Indole-3-Carboxylic Acid is a Highly Selective Substrate for Glucuronidation by UGT1A1, Relative to
              β
              -Estradiol. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2018,</strong> <em>46 </em>
                                    (12)
                                     , 1836-1846. <a href="https://doi.org/10.1124/dmd.118.083709" title="DOI URL">https://doi.org/10.1124/dmd.118.083709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.118.083709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.118.083709%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3D6-Chloro-5-%25255B4-%2525281-Hydroxycyclobutyl%252529Phenyl%25255D-1%252BH%252B-Indole-3-Carboxylic%252BAcid%252Bis%252Ba%252BHighly%252BSelective%252BSubstrate%252Bfor%252BGlucuronidation%252Bby%252BUGT1A1%25252C%252BRelative%252Bto%252B%2525CE%2525B2%252B-Estradiol%26aulast%3DLapham%26aufirst%3DKimberly%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D12%26spage%3D1836%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of indole-3-carboxylic acid-based α1β1γ1 AMPK activators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HPLC-UV chromatograms of reaction mixtures of <b>1</b> (A), <b>2</b> (B), and <b>3</b> (C) in cryopreserved human hepatocytes incubated at 37 °C for 4 h. The final concentration of <b>1</b>–<b>3</b> in the hepatocyte incubations was 10 μM. Earlier eluting peaks (<i>t</i><sub>R</sub> ∼ 3.0–4.0 min) were also observed in hepatocyte incubations at <i>t</i> = 0 h and are background noise.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. HPLC-UV chromatograms (<i>t</i> = 0 h, A, and <i>t</i> = 24 h, B) of human hepatocytes extract of <b>1</b> treated with hydroxylamine at room temperature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <sup>1</sup>H NMR spectra of <b>1</b> and biochemically synthesized glucuronide M1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <sup>1</sup>H–<sup>13</sup>C HMBC spectra of biosynthesized M1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <sup>1</sup>H NMR spectra of <b>2</b> (A) and biochemically synthesized M2 (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <sup>1</sup>H NMR spectra of <b>3</b> (A) and biosynthesized M3 (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <sup>1</sup>H–<sup>13</sup>C HMBC spectra of biosynthesized M3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. TR-FRET data (90% confidence intervals) for α1β1γ1 AMPK activation by <b>1</b> and M1 (A), <b>2</b> and M2 (B), and <b>3</b> and M3 (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Crystal structures of AMPK α1β1γ1 with acyl glucuronide conjugates M1–M3. (A) Overall topology of AMPK α1β1γ1 illustrating compound <b>1</b> bound to the ADaM site. Structure derived from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5">5KQ5</a>.pdb.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (B) Overlay of bound pose of compounds <b>1</b> and M1 (top) together with a surface representation of the ADaM site from the M1 structure (gray surface). (C) Overlay of bound poses of M1, M2, and M3 along with electron density over ligand from each crystal structure (2<i>f</i><sub>o</sub> – <i>f</i><sub>c</sub> map contoured at 1σ).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/medium/jm-2018-00807r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Increase in Ser79 phosphorylation of the specific AMPK substrate ACC in primary human hepatocytes following treatment with compounds <b>1</b>, <b>2</b>, M1, and M2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00807/20180816/images/large/jm-2018-00807r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00807&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 69 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Acyl glucuronides: the good, the bad and the ugly</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1002/bdd.720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1002%2Fbdd.720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=20830700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=367-395&author=S.+L.+Reganauthor=J.+L.+Maggsauthor=T.+G.+Hammondauthor=T.+G.+Lambertauthor=D.+P.+Williamsauthor=B.+K.+Park&title=Acyl+glucuronides%3A+the+good%2C+the+bad+and+the+ugly&doi=10.1002%2Fbdd.720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Acyl glucuronides: the good, the bad and the ugly</span></div><div class="casAuthors">Regan, Sophie L.; Maggs, James L.; Hammond, Thomas G.; Lambert, Craig; Williams, Dominic P.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">367-395</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Acyl glucuronidation is the major metabolic conjugation reaction of most carboxylic acid drugs in mammals.  The physiol. consequences of this biotransformation have been investigated incompletely but include effects on drug metab., protein binding, distribution and clearance that impact upon pharmacol. and toxicol. outcomes.  In marked contrast, the exceptional but widely disparate chem. reactivity of acyl glucuronides has attracted far greater attention.  Specifically, the complex transacylation and glycation reactions with proteins have provoked much inconclusive debate over the safety of drugs metabolised to acyl glucuronides.  It has been hypothesised that these covalent modifications could initiate idiosyncratic adverse drug reactions.  However, despite a large body of in vitro data on the reactions of acyl glucuronides with protein, evidence for adduct formation from acyl glucuronides in vivo is limited and potentially ambiguous.  The causal connection of protein adduction to adverse drug reactions remains uncertain.  This review has assessed the intrinsic reactivity, metabolic stability and pharmacokinetic properties of acyl glucuronides in the context of physiol., pharmacol. and toxicol. perspectives.  Although numerous expts. have characterised the reactions of acyl glucuronides with proteins, these might be attenuated substantially in vivo by rapid clearance of the conjugates.  Consequently, to delineate a relationship between acyl glucuronide formation and toxicol. phenomena, detailed pharmacokinetic anal. of systemic exposure to the acyl glucuronide should be undertaken adjacent to detg. protein adduct concns. in vivo.  Further investigation is required to ascertain whether acyl glucuronide clearance is sufficient to prevent covalent modification of endogenous proteins and consequentially a potential immunol. response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ1hIcbM_oZ7Vg90H21EOLACvtfcHk0liQyJHVyonXHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3L&md5=8c45d4dbb68c12bd128af1dba7a08c16</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fbdd.720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.720%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DS.%2BL.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DLambert%26aufirst%3DT.%2BG.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAcyl%2520glucuronides%253A%2520the%2520good%252C%2520the%2520bad%2520and%2520the%2520ugly%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2010%26volume%3D31%26spage%3D367%26epage%3D395%26doi%3D10.1002%2Fbdd.720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reger, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C.</span></span> <span> </span><span class="NLM_article-title">Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2004.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.abb.2004.02.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2004&pages=219-225&author=K.+Sakaguchiauthor=M.+Greenauthor=N.+Stockauthor=T.+S.+Regerauthor=J.+Zunicauthor=C.+King&title=Glucuronidation+of+carboxylic+acid+containing+compounds+by+UDP-glucuronosyltransferase+isoforms&doi=10.1016%2Fj.abb.2004.02.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2004.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2004.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DSakaguchi%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DStock%26aufirst%3DN.%26aulast%3DReger%26aufirst%3DT.%2BS.%26aulast%3DZunic%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26atitle%3DGlucuronidation%2520of%2520carboxylic%2520acid%2520containing%2520compounds%2520by%2520UDP-glucuronosyltransferase%2520isoforms%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D424%26spage%3D219%26epage%3D225%26doi%3D10.1016%2Fj.abb.2004.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miners, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, P. I.</span></span> <span> </span><span class="NLM_article-title">Drug glucuronidation in humans</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(91)90065-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2F0163-7258%2891%2990065-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1792239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK38Xht1ShsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=347-369&author=J.+O.+Minersauthor=P.+I.+Mackenzie&title=Drug+glucuronidation+in+humans&doi=10.1016%2F0163-7258%2891%2990065-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drug glucuronidation in humans</span></div><div class="casAuthors">Miners, John O.; Mackenzie, Peter I.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-69</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ∼270 refs.  Glucuronidation is a major metabolic pathway for a large no. of drugs in humans.  Conjugation of drugs and other chems. with glucuronic acid is catalyzed by the multigene UDP-glucuronosyltransferase family.  It is believed that a no. (unspecified at present) of glucuronosyltransferase isoenzymes, which probably differ in terms of substrate specificity and regulation, contribute to drug glucuronidation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpydPex6hIr_rVg90H21EOLACvtfcHk0ljsJIJoxdjnBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1ShsL8%253D&md5=2a01262fbd35772f7bbcb37e29cc1797</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2891%2990065-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252891%252990065-T%26sid%3Dliteratum%253Aachs%26aulast%3DMiners%26aufirst%3DJ.%2BO.%26aulast%3DMackenzie%26aufirst%3DP.%2BI.%26atitle%3DDrug%2520glucuronidation%2520in%2520humans%26jtitle%3DPharmacol.%2520Ther.%26date%3D1991%26volume%3D51%26spage%3D347%26epage%3D369%26doi%3D10.1016%2F0163-7258%2891%2990065-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faed, E. M.</span></span> <span> </span><span class="NLM_article-title">Properties of acyl glucuronides. Implications for studies of the pharmacokinetics and metabolism of acidic drugs</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.3109/03602538409033562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.3109%2F03602538409033562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=6396057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaL2MXnt1Wktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1984&pages=1213-1249&author=E.+M.+Faed&title=Properties+of+acyl+glucuronides.+Implications+for+studies+of+the+pharmacokinetics+and+metabolism+of+acidic+drugs&doi=10.3109%2F03602538409033562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of acyl glucuronides:  implications for studies of the pharmacokinetics and metabolism of acidic drugs</span></div><div class="casAuthors">Faed, Ellen M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">1213-49</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    </div><div class="casAbstract">A review with 168 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo4GdIX4n_frVg90H21EOLACvtfcHk0ljsJIJoxdjnBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXnt1Wktw%253D%253D&md5=4527f2890ac2410f7fdf7816c69d68b3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3109%2F03602538409033562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602538409033562%26sid%3Dliteratum%253Aachs%26aulast%3DFaed%26aufirst%3DE.%2BM.%26atitle%3DProperties%2520of%2520acyl%2520glucuronides.%2520Implications%2520for%2520studies%2520of%2520the%2520pharmacokinetics%2520and%2520metabolism%2520of%2520acidic%2520drugs%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D1984%26volume%3D15%26spage%3D1213%26epage%3D1249%26doi%3D10.3109%2F03602538409033562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span> <span> </span><span class="NLM_article-title">Unusual glucuronides</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1239</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.045096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.112.045096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1239-1251&author=U.+A.+Argikar&title=Unusual+glucuronides&doi=10.1124%2Fdmd.112.045096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.045096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.045096%26sid%3Dliteratum%253Aachs%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26atitle%3DUnusual%2520glucuronides%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1239%26epage%3D1251%26doi%3D10.1124%2Fdmd.112.045096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paine, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrighton, S. A.</span></span> <span> </span><span class="NLM_article-title">The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1081/DMR-120000653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1081%2FDMR-120000653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11768770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=273-297&author=M.+B.+Fisherauthor=M.+F.+Paineauthor=T.+J.+Strelevitzauthor=S.+A.+Wrighton&title=The+role+of+hepatic+and+extrahepatic+UDP-glucuronosyltransferases+in+human+drug+metabolism&doi=10.1081%2FDMR-120000653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism</span></div><div class="casAuthors">Fisher, Michael B.; Paine, Mary F.; Strelevitz, Timothy J.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">273-297</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  At present, the methods and enzymol. of the UDP-glucuronosyltransferases (UGTs) lag behind that of the cytochromes P 450 (CYPs).  About 15 human UGTs have been identified, and knowledge about their regulation, substrate selectivity, and tissue distribution has progressed recently.  Alamethicin has been characterized as a treatment to remove the latency of microsomal glucuronidations.  Most UGT isoforms appear to have a distinct hepatic and/or extrahepatic expression, resulting in significant expression in kidney, intestine, and steroid target tissues.  The gastrointestinal tract possesses a complex expression pattern largely contg. members of the UGT1A subfamily.  Thus, these forms are poised to participate in the first pass metab. of oral drugs.  The authors and others have identified a significant expression of UGT1A1 in human small intestine, an enzyme possessing considerable allelic variability and a polymorphic expression pattern in intestine.  Intestinal glucuronidation therefore plays a major role not only in first pass metab., but also in the degree of interindividual variation in overall oral bioavailability.  Due to issues such as significant genetic variability and tissue localization in first-pass organs, clearance due to UGT1A1 should be minimized for new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrThMjjbeI-nbVg90H21EOLACvtfcHk0lj8deQ3WIy-JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVGqsg%253D%253D&md5=7a35a3d8dcba636ac4bcac54a13f47b1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1081%2FDMR-120000653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120000653%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DPaine%26aufirst%3DM.%2BF.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520role%2520of%2520hepatic%2520and%2520extrahepatic%2520UDP-glucuronosyltransferases%2520in%2520human%2520drug%2520metabolism%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2001%26volume%3D33%26spage%3D273%26epage%3D297%26doi%3D10.1081%2FDMR-120000653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tukey, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strassburg, C. P.</span></span> <span> </span><span class="NLM_article-title">Human UDP-glucuronosyltransferases: metabolism, expression and disease</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.40.1.581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1146%2Fannurev.pharmtox.40.1.581" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2000&pages=581-616&author=R.+H.+Tukeyauthor=C.+P.+Strassburg&title=Human+UDP-glucuronosyltransferases%3A+metabolism%2C+expression+and+disease&doi=10.1146%2Fannurev.pharmtox.40.1.581"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.40.1.581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.40.1.581%26sid%3Dliteratum%253Aachs%26aulast%3DTukey%26aufirst%3DR.%2BH.%26aulast%3DStrassburg%26aufirst%3DC.%2BP.%26atitle%3DHuman%2520UDP-glucuronosyltransferases%253A%2520metabolism%252C%2520expression%2520and%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2000%26volume%3D40%26spage%3D581%26epage%3D616%26doi%3D10.1146%2Fannurev.pharmtox.40.1.581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, J. K.</span></span> <span> </span><span class="NLM_article-title">Roles of glucuronidation and UDPglucuronosyltransferases in xenobiotic bioactivation reactions</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/S0009-2797(00)00198-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2FS0009-2797%2800%2900198-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11154740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=171-193&author=J.+K.+Ritter&title=Roles+of+glucuronidation+and+UDPglucuronosyltransferases+in+xenobiotic+bioactivation+reactions&doi=10.1016%2FS0009-2797%2800%2900198-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions</span></div><div class="casAuthors">Ritter, J. K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">171-193</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 121 refs.  Glucuronide conjugates represent one of the major types of naturally occurring phase 2 metabolites of xenobiotics and endobiotics.  The process underlying their formation, glucuronidation, is normally considered detoxifying, because glucuronides usually possess less intrinsic biol. or chem. activity than their parent aglycons and they are rapid excreted.  However, a no. of glucuronide conjugates are known that are active and may contribute to pharmacol. activities or toxicities assocd. with their parent compds.  These include two classes of glucuronides with electrophilic chem. reactivity (N-O-glucuronides of hydroxamic acids and acyl glucuronides of carboxylic acids) and several types of glucuronides that impart biol. effects through non-covalent interactions (morphine 6-O-glucuronide, retinoid glucuronides, and D-ring glucuronides of estrogens).  Glucuronides may thus contribute to clin. significant effects, including environmental arylamine-induced carcinogenesis, drug hypersensitivity and other toxicities assocd. with carboxylic acid drugs, morphine analgesia, and cholestasis from estrogens.  This review summarizes the rat and human UDP-glucuronosyltransferases that may be involved in the formation of bioactive glucuronides, including their substrate- and tissue-specificity and genetic and environmental influences on their activity.  This knowledge may be useful for enhancing the therapeutic efficacy and minimizing the risk of adverse effects assocd. with xenobiotics that undergo bioactivating glucuronidation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1oYTW1Dg3VLVg90H21EOLACvtfcHk0lgr6890U-nLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlOmsw%253D%253D&md5=ef694b6d692a426a695de41d37199ec3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900198-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900198-8%26sid%3Dliteratum%253Aachs%26aulast%3DRitter%26aufirst%3DJ.%2BK.%26atitle%3DRoles%2520of%2520glucuronidation%2520and%2520UDPglucuronosyltransferases%2520in%2520xenobiotic%2520bioactivation%2520reactions%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D129%26spage%3D171%26epage%3D193%26doi%3D10.1016%2FS0009-2797%2800%2900198-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sallustio, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabordo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nation, R. L.</span></span> <span> </span><span class="NLM_article-title">Hepatic disposition of electrophilic acyl glucuronide conjugates</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.2174/1389200003339153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.2174%2F1389200003339153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11465081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlOrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=163-180&author=B.+C.+Sallustioauthor=L.+Sabordoauthor=A.+M.+Evansauthor=R.+L.+Nation&title=Hepatic+disposition+of+electrophilic+acyl+glucuronide+conjugates&doi=10.2174%2F1389200003339153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic disposition of electrophilic acyl glucuronide conjugates</span></div><div class="casAuthors">Sallustio, B. C.; Sabordo, L.; Evans, A. M.; Nation, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-180</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 148 refs.  Acyl glucuronides are a unique class of electrophilic metabolites, capable of non-enzymic reactions including acylation and/or glycation of endogenous macromols., hydrolysis to reform the parent aglycon, and intra-mol. rearrangement.  Three human UDP-glucuronosyltransferases (UGTs) catalyzing the hepatic glucuronidation of carboxylic acid drugs have been identified, UGT1A3, UGT1A9 and a UGT2B7 variant.  Within the liver, acyl glucuronides also undergo enzymic hydrolysis by β-glucuronidase and esterases which, like the UGTs, are located in the endoplasmic reticulum.  In addn., the liver also transports acyl glucuronides between the sinusoidal circulation and bile.  Due to their polarity, membrane transport of acyl glucuronides is carrier-mediated, resulting in the establishment of significant concn. gradients between sinusoidal circulation, hepatocyte and bile, in the order of 1:50:5000 in these compartments, resp.  As a result of exposure to high acyl glucuronide concns., the liver is a major target of protein adduct formation.  Dipeptidylpeptidase IV, UGTs and tubulin have been identified as intra-hepatic targets of adduct formation by acyl glucuronides.  Adduct formation results in altered protein activity and potentially contributes to hepatotoxicity.  Hepatic protein adducts are also immunogenic and may cause immune mediated cytotoxicity.  Both intra- and extra-hepatic exposure to acyl glucuronides depends not only on the efficiency of glucuronidation and hydrolysis by the liver, but also on the efficiency of the hepatic membrane transport systems.  Thus, changes in membrane transporter activities, as may occur due to satn. or drug-drug interactions, can significantly affect acyl glucuronide disposition, adduct formation and the disposition of parent aglycon, thereby affecting clin. efficacy and toxicity of acyl glucuronide forming drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-AkLxhuBjD7Vg90H21EOLACvtfcHk0lgr6890U-nLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlOrs7o%253D&md5=dee87ae191547acf3e8b2e87fb87a013</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F1389200003339153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200003339153%26sid%3Dliteratum%253Aachs%26aulast%3DSallustio%26aufirst%3DB.%2BC.%26aulast%3DSabordo%26aufirst%3DL.%26aulast%3DEvans%26aufirst%3DA.%2BM.%26aulast%3DNation%26aufirst%3DR.%2BL.%26atitle%3DHepatic%2520disposition%2520of%2520electrophilic%2520acyl%2520glucuronide%2520conjugates%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2000%26volume%3D1%26spage%3D163%26epage%3D180%26doi%3D10.2174%2F1389200003339153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scialis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span> <span> </span><span class="NLM_article-title">Hepatic disposition of gemfibrozil and its major metabolite gemfibrozil 1-O-β-glucuronide</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3943</span>– <span class="NLM_lpage">3952</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWhs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=3943-3952&author=E.+Kimotoauthor=R.+Liauthor=R.+J.+Scialisauthor=Y.+Laiauthor=M.+V.+Varma&title=Hepatic+disposition+of+gemfibrozil+and+its+major+metabolite+gemfibrozil+1-O-%CE%B2-glucuronide&doi=10.1021%2Facs.molpharmaceut.5b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide</span></div><div class="casAuthors">Kimoto, Emi; Li, Rui; Scialis, Renato J.; Lai, Yurong; Varma, Manthena V. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3943-3952</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gemfibrozil (GEM), which decreases serum triglycerides and low d. lipoprotein, perpetrates drug-drug interactions (DDIs) with several drugs.  These DDIs are primarily attributed to the inhibition of drug transporters and metabolic enzymes, particularly cytochrome P 450 (CYP) 2C8 by the major circulating metabolite gemfibrozil 1-O-β-glucuronide (GG).  Here, we characterized the transporter-mediated hepatic disposition of GEM and GG using sandwich-cultured human hepatocytes (SCHH) and transporter-transfect systems.  Significant active uptake was noted in SCHH for the metabolite.  GG, but not GEM, showed substrate affinity to org. anion transporting polypeptide (OATP) 1B1, 1B3, and 2B1.  In SCHH, glucuronidation was characterized affinity consts. (Km) of 7.9 and 61.4 μM, and biliary excretion of GG was obsd.  Furthermore, GG showed active basolateral efflux from preloaded SCHH and ATP-dependent uptake into membrane vesicles overexpressing multidrug resistance-assocd. protein (MRP) 2, MRP3, and MRP4.  A math. model was developed to est. hepatic uptake and efflux kinetics of GEM and GG based on SCHH studies.  Collectively, the hepatic transporters play a key role in the disposition and thus det. the local concns. of GEM and more so for GG, which is the predominant inhibitory species against CYP2C8 and OATP1B1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooA1I3axUaVLVg90H21EOLACvtfcHk0lgr6890U-nLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWhs7jP&md5=2000815ba3930a0f8f4dbbeb15dd444e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00411%26sid%3Dliteratum%253Aachs%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26atitle%3DHepatic%2520disposition%2520of%2520gemfibrozil%2520and%2520its%2520major%2520metabolite%2520gemfibrozil%25201-O-%25CE%25B2-glucuronide%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D3943%26epage%3D3952%26doi%3D10.1021%2Facs.molpharmaceut.5b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, A. M.</span></span> <span> </span><span class="NLM_article-title">Membrane transport as a determinant of the hepatic elimination of drugs and metabolites</span>. <i>Clin. Exp. Pharmacol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">970</span>– <span class="NLM_lpage">974</span>, <span class="refDoi"> DOI: 10.1111/j.1440-1681.1996.tb01151.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1111%2Fj.1440-1681.1996.tb01151.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=8911743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK28XmsFGntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=970-974&author=A.+M.+Evans&title=Membrane+transport+as+a+determinant+of+the+hepatic+elimination+of+drugs+and+metabolites&doi=10.1111%2Fj.1440-1681.1996.tb01151.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane transport as a determinant of the hepatic elimination of drugs and metabolites</span></div><div class="casAuthors">Evans, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10/11</span>),
    <span class="NLM_cas:pages">970-974</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">A review, with 32 refs.  The liver is ideally suited for the efficient uptake of drugs from sinusoidal blood.  For most drugs, uptake into hepatocytes across the basolateral membrane occurs via passive diffusion, with minimal reliance on carrier-mediated transport systems.  Often, this passive diffusion is so efficient that uptake is rate-limited by the delivery of the drug to the liver (i.e. blood flow) rather than membrane transport per se.  For highly polar mols., passive diffusion no longer represents an efficient mode of hepatocellular uptake and there is an increased reliance on carrier-mediated transport systems.  For these compds., membrane transport may dictate the overall efficiency of hepatic elimination.  Drug metabolites, particularly conjugated metabolites, such as sulfates and glucuronides, are invariably more polar than their precursors and are more likely to experience hepatocyte membranes as diffusional barriers.  In the presence of such a barrier, the hepatocellular disposal of a locally formed metabolite will depend critically on the presence and activity of carrier-mediated transport systems for sinusoidal efflux and biliary excretion.  Transporters of current interest include P-glycoproteins, which are responsible for the biliary excretion of a range of org. cations, and the canalicular multispecific org. anion transporter.  Intracellular trapping of hepatically formed metabolites, secondary to low membrane permeability, is clin. important as many metabolites are potentially hepatotoxic and/or capable of interfering with the hepatic transport of endogenous compds. or other drugs and metabolites.  In addn., if the metabolite is unstable, intracellular accumulation can lead to the regeneration of the precursor and 'futile cycling' within hepatocytes.  An increased understanding of the factors influencing the intracellular concns. of drugs and hepatically formed metabolites in the liver will improve our ability to specifically treat liver disorders, such as hepatocellular carcinoma and malaria, and minimize the risk of hepatotoxicity from drugs and other xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGdJjS4bgjcLVg90H21EOLACvtfcHk0ljWegifQpPbmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFGntrg%253D&md5=b29ee229721abb97e3661f3bcd61ebcb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.1996.tb01151.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.1996.tb01151.x%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DA.%2BM.%26atitle%3DMembrane%2520transport%2520as%2520a%2520determinant%2520of%2520the%2520hepatic%2520elimination%2520of%2520drugs%2520and%2520metabolites%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D1996%26volume%3D23%26spage%3D970%26epage%3D974%26doi%3D10.1111%2Fj.1440-1681.1996.tb01151.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burckhardt, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burckhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellerich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, V. W.</span></span> <span> </span><span class="NLM_article-title">Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney</span>. <i>Nephrol., Dial., Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1093/ndt/gfm219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1093%2Fndt%2Fgfm219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=17526543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgsb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=2497-2503&author=N.+A.+Wolffauthor=B.+C.+Burckhardtauthor=G.+Burckhardtauthor=M.+Oellerichauthor=V.+W.+Armstrong&title=Mycophenolic+acid+%28MPA%29+and+its+glucuronide+metabolites+interact+with+transport+systems+responsible+for+excretion+of+organic+anions+in+the+basolateral+membrane+of+the+human+kidney&doi=10.1093%2Fndt%2Fgfm219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney</span></div><div class="casAuthors">Wolff, Natascha A.; Burckhardt, Birgitta C.; Burckhardt, Gerhard; Oellerich, Michael; Armstrong, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2497-2503</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">0931-0509</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Mycophenolic acid (MPA), the active moiety of the prodrug mycophenolate mofetil, is widely used in immunosuppressive regimens after kidney, liver or heart transplantation.  MPA is metabolized predominantly to the inactive 7-O-glucuronide (MPAG).  A minor fraction is converted to the pharmacol. active acyl glucuronide (AcMPAG).  All compds. ultimately are eliminated via the kidneys.  Due to their structures, MPA and its metabolites are candidate substrates for the human org. anion transporters 1 (OAT1) and 3 (OAT3) as well as for the Na+-dicarboxylate cotransporter 3 (NaDC3).  Methods: Human (h)OAT1, hOAT3 and hNaDC3 were expressed from in vitro synthesized cRNA in collagenase-defolliculated Xenopus laevis oocytes.  On day 3 post-injection, measurements were made of (i) substrate-assocd. currents using MPA and MPAG (only in hNaDC3-expressing oocytes) and (ii) uptake of [3H]p-aminohippurate (hOAT1) or [3H]estrone sulfate (hOAT3) in the absence or presence of either MPA, MPAG or AcMPAG.  Results: In hNaDC3-expressing oocytes at -60 mV, MPA (0.1 mM) as well as MPAG (0.1 mM) induced inward currents that were 17 and 25% of the currents evoked by succinate (1 mM).  Vice versa, currents induced by succinate (1 mM) were partially inhibited by MPA and MPAG. hOAT1 and hOAT3 were potently inhibited by MPA (IC50 1.24 and 0.52 μM, resp.).  Human OAT3, but not hOAT1, was addnl. inhibited by both glucuronide metabolites of MPA in a concn.-dependent manner (IC50 15.2 μM for MPAG and 2.88 μM for AcMPAG), consistent with a preference of hOAT3 for more bulky substrates compared with hOAT1.  Conclusions: MPA and its metabolites potently interact with renal org. anion transporters hOAT1 and hOAT3, and thereby may interfere with the renal secretion of antiviral drugs, cortisol and other org. anions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFGPolN5is77Vg90H21EOLACvtfcHk0ljWegifQpPbmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgsb3I&md5=71e210520a7dc4bdfc540167fba524f8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfm219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfm219%26sid%3Dliteratum%253Aachs%26aulast%3DWolff%26aufirst%3DN.%2BA.%26aulast%3DBurckhardt%26aufirst%3DB.%2BC.%26aulast%3DBurckhardt%26aufirst%3DG.%26aulast%3DOellerich%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DV.%2BW.%26atitle%3DMycophenolic%2520acid%2520%2528MPA%2529%2520and%2520its%2520glucuronide%2520metabolites%2520interact%2520with%2520transport%2520systems%2520responsible%2520for%2520excretion%2520of%2520organic%2520anions%2520in%2520the%2520basolateral%2520membrane%2520of%2520the%2520human%2520kidney%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2007%26volume%3D22%26spage%3D2497%26epage%3D2503%26doi%3D10.1093%2Fndt%2Fgfm219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putluru, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kole, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandlekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furlong, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marathe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, A. D.</span></span> <span> </span><span class="NLM_article-title">Diclofenac and its acyl glucuronide: Determination of in vivo exposure in human subjects and characterization as human drug transporter substrates in vitro</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.066944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.115.066944" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=320-328&author=Y.+Zhangauthor=Y.+H.+Hanauthor=S.+P.+Putluruauthor=M.+K.+Mattaauthor=P.+Koleauthor=S.+Mandlekarauthor=M.+T.+Furlongauthor=T.+Liuauthor=R.+A.+Iyerauthor=P.+Maratheauthor=Z.+Yangauthor=Y.+Laiauthor=A.+D.+Rodrigues&title=Diclofenac+and+its+acyl+glucuronide%3A+Determination+of+in+vivo+exposure+in+human+subjects+and+characterization+as+human+drug+transporter+substrates+in+vitro&doi=10.1124%2Fdmd.115.066944"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.066944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.066944%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DY.%2BH.%26aulast%3DPutluru%26aufirst%3DS.%2BP.%26aulast%3DMatta%26aufirst%3DM.%2BK.%26aulast%3DKole%26aufirst%3DP.%26aulast%3DMandlekar%26aufirst%3DS.%26aulast%3DFurlong%26aufirst%3DM.%2BT.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DIyer%26aufirst%3DR.%2BA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26atitle%3DDiclofenac%2520and%2520its%2520acyl%2520glucuronide%253A%2520Determination%2520of%2520in%2520vivo%2520exposure%2520in%2520human%2520subjects%2520and%2520characterization%2520as%2520human%2520drug%2520transporter%2520substrates%2520in%2520vitro%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D320%26epage%3D328%26doi%3D10.1124%2Fdmd.115.066944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1124/pr.111.005439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fpr.111.005439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=23406671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVCms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=578-640&author=R.+S.+Obach&title=Pharmacologically+active+drug+metabolites%3A+impact+on+drug+discovery+and+pharmacotherapy&doi=10.1124%2Fpr.111.005439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">578-640</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Metab. represents the most prevalent mechanism for drug clearance.  Many drugs are converted to metabolites that can retain the intrinsic affinity of the parent drug for the pharmacol. target.  Drug metab. redox reactions such as heteroatom dealkylations, hydroxylations, heteroatom oxygenations, redns., and dehydrogenations can yield active metabolites, and in rare cases even conjugation reactions can yield an active metabolite.  To understand the contribution of an active metabolite to efficacy relative to the contribution of the parent drug, the target affinity, functional activity, plasma protein binding, membrane permeability, and pharmacokinetics of the active metabolite and parent drug must be known.  Underlying pharmacokinetic principles and clearance concepts are used to describe the dispositional behavior of metabolites in vivo.  A method to rapidly identify active metabolites in drug research is described.  Finally, over 100 examples of drugs with active metabolites are discussed with regard to the importance of the metabolite(s) in efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-qUngT0My0bVg90H21EOLACvtfcHk0lj-wQZvAcyRhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVCms7o%253D&md5=beb38b41325e00d4c03b91b4158a3d6a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fpr.111.005439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.111.005439%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPharmacologically%2520active%2520drug%2520metabolites%253A%2520impact%2520on%2520drug%2520discovery%2520and%2520pharmacotherapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D578%26epage%3D640%26doi%3D10.1124%2Fpr.111.005439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. W.</span></span> <span> </span><span class="NLM_article-title">Morphine-6-glucuronide: actions and mechanisms</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1002/med.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1002%2Fmed.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=15952175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGiurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=521-544&author=G.+J.+Kilpatrickauthor=T.+W.+Smith&title=Morphine-6-glucuronide%3A+actions+and+mechanisms&doi=10.1002%2Fmed.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-6-glucuronide: actions and mechanisms</span></div><div class="casAuthors">Kilpatrick, Gavin J.; Smith, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">521-544</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Morphine-6-glucuronide (M6G) appears to show equiv. analgesia to morphine but to have a superior side-effect profile in terms of reduced liability to induce nausea and vomiting and respiratory depression.  The purpose of this review is to examine the evidence behind this statement and to identify the possible reasons that may contribute to the profile of M6G.  The vast majority of available data supports the notion that both M6G and morphine mediate their effects by activating the μ-opioid receptor.  The differences for which there is a reasonable consensus in the literature can be summarized as: (1) Morphine has a slightly higher affinity for the μ-opioid receptor than M6G, (2) M6G shows a slightly higher efficacy at the μ-opioid receptor, (3) M6G has a lower affinity for the κ-opioid receptor than morphine, and (4) M6G has a very different absorption, distribution, metab., and excretion (ADME) profile from morphine.  However, none of these are adequate alone to explain the clin. differences between M6G and morphine.  The ADME differences are perhaps most likely to explain some of the differences but seem unlikely to be the whole story.  Further work is required to examine further the profile of M6G, notably whether M6G penetrates differentially to areas of the brain involved in pain and those involved in nausea, vomiting, and respiratory control or whether μ-opioid receptors in these brain areas differ in either their regulation or pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBuDnIfESMubVg90H21EOLACvtfcHk0lj-wQZvAcyRhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGiurfN&md5=027c9e5903b8109d39116def34f12d9b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fmed.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20035%26sid%3Dliteratum%253Aachs%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DSmith%26aufirst%3DT.%2BW.%26atitle%3DMorphine-6-glucuronide%253A%2520actions%2520and%2520mechanisms%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D521%26epage%3D544%26doi%3D10.1002%2Fmed.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Heek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoos, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sybertz, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. R.,  Jr</span></span> <span> </span><span class="NLM_article-title">Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235 and its glucuronide, SCH60663</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1748</span>– <span class="NLM_lpage">1754</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0703235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1038%2Fsj.bjp.0703235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10780982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2qsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=1748-1754&author=M.+van%0AHeekauthor=C.+Farleyauthor=D.+S.+Comptonauthor=L.+Hoosauthor=K.+B.+Altonauthor=E.+J.+Sybertzauthor=H.+R.+Davis&title=Comparison+of+the+activity+and+disposition+of+the+novel+cholesterol+absorption+inhibitor%2C+SCH58235+and+its+glucuronide%2C+SCH60663&doi=10.1038%2Fsj.bjp.0703235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663</span></div><div class="casAuthors">Van Heek, Margaret; Farley, Constance; Compton, Douglas S.; Hoos, Lizbeth; Alton, Kevin B.; Sybertz, Edmund J.; Davis, Harry R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1748-1754</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 Previous studies described the metab.-based discovery of a potent, selective inhibitor of intestinal absorption of cholesterol, SCH58235 (Ezetimibe).  Here we demonstrate that the phenolic glucuronide (SCH60663) of SCH58235, was more potent at inhibiting cholesterol absorption in rats than SCH58235, when administered by the intraduodenal route.  2 To understand the increased potency of the glucuronide, the metab. and distribution of SCH58235 and SCH60663 were studied in bile duct-cannulated rats.  3 One minute after intraduodenal delivery of SCH58235, significant levels of compd. were detected in portal plasma; >95% was glucuronidated, indicating that the intestine was metabolizing SCH58235 to its glucuronide.  When intraduodenally delivered as SCH58235, the compd. was glucuronidated, moved through the intestinal wall, into portal plasma, through the liver, and into bile.  However, when delivered as SCH60663, >95% of the compd. remained in the intestinal lumen and wall, which may explain its increased potency.  Significant inhibition of cholesterol absorption and glucuronidation of SCH58235 occurred when SCH58235 was i.v. injected into bile duct-cannulated rats.  Autoradiog. anal. demonstrated that drug related material was located throughout the intestinal villi, but concd. in the villus tip.  4 These data indicate that (a) SCH58235 is rapidly metabolized in the intestine to its glucuronide; (b) once glucuronidated, the dose is excreted in the bile, thereby delivering drug related material back to the site of action and (c) the glucuronide is more potent than the parent possibly because it localizes to the intestine.  Taken together, these data may explain the potency of SCH58235 in the rat (ID50=0.0015 mg kg-1) and rhesus monkey (ID50=0.0005 mg kg-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO42lwI-9E0LVg90H21EOLACvtfcHk0ljzxL94_Nvnzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2qsr0%253D&md5=4797b25d860834b0827e8522e1a72eca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703235%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DFarley%26aufirst%3DC.%26aulast%3DCompton%26aufirst%3DD.%2BS.%26aulast%3DHoos%26aufirst%3DL.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26aulast%3DSybertz%26aufirst%3DE.%2BJ.%26aulast%3DDavis%26aufirst%3DH.%2BR.%26atitle%3DComparison%2520of%2520the%2520activity%2520and%2520disposition%2520of%2520the%2520novel%2520cholesterol%2520absorption%2520inhibitor%252C%2520SCH58235%2520and%2520its%2520glucuronide%252C%2520SCH60663%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D129%26spage%3D1748%26epage%3D1754%26doi%3D10.1038%2Fsj.bjp.0703235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Heek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yumibe, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sybertz, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. R.,  Jr</span></span> <span> </span><span class="NLM_article-title">In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=9336320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK2sXmslClt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=157-163&author=M.+van%0AHeekauthor=C.+F.+Franceauthor=D.+S.+Comptonauthor=R.+L.+McLeodauthor=N.+P.+Yumibeauthor=K.+B.+Altonauthor=E.+J.+Sybertzauthor=H.+R.+Davis&title=In+vivo+metabolism-based+discovery+of+a+potent+cholesterol+absorption+inhibitor%2C+SCH58235%2C+in+the+rat+and+rhesus+monkey+through+the+identification+of+the+active+metabolites+of+SCH48461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461</span></div><div class="casAuthors">Van Heek, Margaret; France, Constance F.; Compton, Douglas S.; McLeod, Robbie L.; Yumibe, Nathan P.; Alton, Kevin B.; Sybertz, Edmund J.; Davis, Harry R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-163</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">SCH48461 is a selective and highly potent inhibitor of cholesterol absorption.  In rats, SCH48461 is rapidly and completely metabolized in the first pass through the body.  To compare the activity of the metabolites of SCH48461 with SCH48461 itself, an intestinally cannulated, bile duct-cannulated rat model for cholesterol absorption was developed.  SCH48461 inhibited the absorption of cholesterol by 70%, whereas bile contg. the metabolites of SCH48461 (henceforth, "metabolite bile") inhibited the absorption by greater than 95%.  Very little of the recovered radioactive dose of SCH48461 was located in the intestinal lumen (7%) or wall (4%), whereas 85% appeared in bile.  However, in rats treated with metabolite bile, 62% of the dose remained in the lumen, 13% was assocd. with the wall and only 24% reappeared in bile, which suggests that the activity of the metabolite bile may be related to its higher retention in the intestinal wall.  Rats treated with metabolite bile had 64% and 84% less drug-related radioactivity in their plasma and livers, resp., compared with animals treated with SCH48461, which indicates that the metabolites are systemically less available than SCH48461.  The metabolites in bile were sepd. by high-performance liq. chromatog.; the most active fraction in the bile duct-cannulated rat model was identified by mass spectrometry as the glucuronide of the C4-phenol of SCH48461.  The other fractions had moderate or no activity.  Through the identification of the most active biliary metabolites of SCH48461 in the rat, we have discovered SCH58235, a novel cholesterol absorption inhibitor which is 400 times more potent than SCH48461 in the cholesterol-fed rhesus monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxu8lx3uQuF7Vg90H21EOLACvtfcHk0lgnytkObbVw1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslClt7g%253D&md5=105ef449955b4f5498f7377135f37cee</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DFrance%26aufirst%3DC.%2BF.%26aulast%3DCompton%26aufirst%3DD.%2BS.%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DYumibe%26aufirst%3DN.%2BP.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26aulast%3DSybertz%26aufirst%3DE.%2BJ.%26aulast%3DDavis%26aufirst%3DH.%2BR.%26atitle%3DIn%2520vivo%2520metabolism-based%2520discovery%2520of%2520a%2520potent%2520cholesterol%2520absorption%2520inhibitor%252C%2520SCH58235%252C%2520in%2520the%2520rat%2520and%2520rhesus%2520monkey%2520through%2520the%2520identification%2520of%2520the%2520active%2520metabolites%2520of%2520SCH48461%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D157%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienen, W.</span></span> <span> </span><span class="NLM_article-title">Dabigatran acylglucuronide, the major human metabolite of dabigatran: in vitro formation, stability, and pharmacological activity</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1567</span>– <span class="NLM_lpage">1575</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.033696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.110.033696" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1567-1575&author=T.+Ebnerauthor=K.+Wagnerauthor=W.+Wienen&title=Dabigatran+acylglucuronide%2C+the+major+human+metabolite+of+dabigatran%3A+in+vitro+formation%2C+stability%2C+and+pharmacological+activity&doi=10.1124%2Fdmd.110.033696"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033696%26sid%3Dliteratum%253Aachs%26aulast%3DEbner%26aufirst%3DT.%26aulast%3DWagner%26aufirst%3DK.%26aulast%3DWienen%26aufirst%3DW.%26atitle%3DDabigatran%2520acylglucuronide%252C%2520the%2520major%2520human%2520metabolite%2520of%2520dabigatran%253A%2520in%2520vitro%2520formation%252C%2520stability%252C%2520and%2520pharmacological%2520activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1567%26epage%3D1575%26doi%3D10.1124%2Fdmd.110.033696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shipkova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niedmann, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oellerich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, V. W.</span></span> <span> </span><span class="NLM_article-title">The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes</span>. <i>Transplant. Proc.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1080</span>– <span class="NLM_lpage">1081</span>, <span class="refDoi"> DOI: 10.1016/S0041-1345(00)02424-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2FS0041-1345%2800%2902424-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11267199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2nt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=1080-1081&author=M.+Shipkovaauthor=E.+Wielandauthor=E.+Sch%C3%BCtzauthor=C.+Wieseauthor=P.+D.+Niedmannauthor=M.+Oellerichauthor=V.+W.+Armstrong&title=The+acyl+glucuronide+metabolite+of+mycophenolic+acid+inhibits+the+proliferation+of+human+mononuclear+leukocytes&doi=10.1016%2FS0041-1345%2800%2902424-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes</span></div><div class="casAuthors">Shipkova, M.; Wieland, E.; Schutz, E.; Wiese, C.; Niedmann, P. D.; Oellerich, M.; Armstrong, V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1080-1081</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">It was detd. whether acyl glucuronide (AcMPAG), would inhibit lymphocyte proliferation in vitro.  AcMPAG was generated from mycophenolic acid (MPA) by incubation with human liver microsomes and purified by HPLC.  The addn. of increasing concns. of MPA or AcMPAG to mononuclear leukocytes incubations led to a dose dependent inhibition of cell proliferation.  AcMPAG had an inhibitory effect on lymphocyte proliferation, but this effect was slightly weaker when compared to MPA.  In contrast to MPA, the antiproliferative action of AcMPAG seemed to depend on guanine ribonucleotide depletion and on a further as yet unidentified mechanism.  The characteristic feature of AcMPAG is the irreversible covalent binding to proteins.  The formation of covalent adducts between human albumin and AcMPAG was obsd. both in vivo and in vitro.  The effect of albumin on AcMPAG suppression of leukocyte cell growth was more pronounced than that obsd. for MPA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSjz2AXAkdgLVg90H21EOLACvtfcHk0lgnytkObbVw1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2nt78%253D&md5=e71b2b1c7dee35396f37c10cc29e6bf7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2800%2902424-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252800%252902424-6%26sid%3Dliteratum%253Aachs%26aulast%3DShipkova%26aufirst%3DM.%26aulast%3DWieland%26aufirst%3DE.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DE.%26aulast%3DWiese%26aufirst%3DC.%26aulast%3DNiedmann%26aufirst%3DP.%2BD.%26aulast%3DOellerich%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DV.%2BW.%26atitle%3DThe%2520acyl%2520glucuronide%2520metabolite%2520of%2520mycophenolic%2520acid%2520inhibits%2520the%2520proliferation%2520of%2520human%2520mononuclear%2520leukocytes%26jtitle%3DTransplant.%2520Proc.%26date%3D2001%26volume%3D33%26spage%3D1080%26epage%3D1081%26doi%3D10.1016%2FS0041-1345%2800%2902424-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marbury, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasseter, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stecher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deykin, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of oral tonapofylline and its acyl-glucuronide metabolite in patients with mild and moderate hepatic impairment</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1177/0091270011400413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1177%2F0091270011400413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=21610206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFersLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=543-551&author=Z.+Liauthor=L.+S.+Ganauthor=T.+Marburyauthor=K.+C.+Lasseterauthor=A.+Natarajanauthor=S.+Stecherauthor=D.+Weiauthor=L.+Yangauthor=D.+Freedmanauthor=A.+Deykin&title=Pharmacokinetics+of+oral+tonapofylline+and+its+acyl-glucuronide+metabolite+in+patients+with+mild+and+moderate+hepatic+impairment&doi=10.1177%2F0091270011400413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of oral tonapofylline and its acyl-glucuronide metabolite in patients with mild and moderate hepatic impairment</span></div><div class="casAuthors">Li, Zhaoyang; Gan, Liang-Shang; Marbury, Thomas; Lasseter, Kenneth C.; Natarajan, Amy; Stecher, Scott; Wei, Dong; Yang, Liyu; Freedman, Daniel; Deykin, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-551</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The objective of the study was to evaluate the effect of hepatic impairment on the pharmacokinetics of tonapofylline.  Patients with mild or moderate hepatic impairment were enrolled in parallel with demog. matched healthy subjects.  All study participants received a single 75-mg oral tonapofylline capsule.  The pharmacokinetic parameters for both tonapofylline and its active metabolite, acyl-glucuronide (tonapofylline-AG), were affected by hepatic impairment significantly (P < .1) except for time to peak plasma concn. (tmax), terminal half-life (t1/2), and apparent vol. of distribution based on the terminal phase (Vdz/F).  In the mild group, peak plasma concn. (Cmax), area under the time-concn. curve from time 0 to 48 h postdose (AUC48h), and from time 0 to infinity (AUCinf) of tonapofylline modestly increased as compared with the control healthy subjects (GMR 1.62, 1.57, and 1.53, resp.).  The extent of increase of these parameters for tonapofylline-AG was more profound than tonapofylline with geometric mean ratio (GMR) ranging from 2.02 to 2.08.  Moderate hepatic impairment was also assocd. with modest increases of Cmax, AUC48h, and AUCinf of tonapofylline (GMR 1.41, 1.98, and 2.08, resp.).  Similar to the mild group, the increase of these parameters were higher for tonapofylline-AG with GMR ranging from 2.80 to 3.86.  Single oral 75-mg tonapofylline was safe and well tolerated in patients with mild or moderate hepatic impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXFqe8Pv3i_7Vg90H21EOLACvtfcHk0ljjHWIxZvjrJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFersLk%253D&md5=74e7806cc975bbd6ebefd49000516efb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F0091270011400413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270011400413%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGan%26aufirst%3DL.%2BS.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DLasseter%26aufirst%3DK.%2BC.%26aulast%3DNatarajan%26aufirst%3DA.%26aulast%3DStecher%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DFreedman%26aufirst%3DD.%26aulast%3DDeykin%26aufirst%3DA.%26atitle%3DPharmacokinetics%2520of%2520oral%2520tonapofylline%2520and%2520its%2520acyl-glucuronide%2520metabolite%2520in%2520patients%2520with%2520mild%2520and%2520moderate%2520hepatic%2520impairment%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2012%26volume%3D52%26spage%3D543%26epage%3D551%26doi%3D10.1177%2F0091270011400413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8068</span>– <span class="NLM_lpage">8081</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00866</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8068-8081&author=K.+O.+Cameronauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=R.+G.+Kurumbailauthor=R.+Millerauthor=C.+T.+Salattoauthor=J.+Wardauthor=J.+M.+Withkaauthor=S.+K.+Bhattacharyaauthor=M.+Boehmauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+Calabreseauthor=N.+L.+Caspersauthor=E.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=D.+J.+Edmondsauthor=H.+Engauthor=D.+P.+Fernandoauthor=R.+Frisbieauthor=D.+Hepworthauthor=J.+Landroauthor=Y.+Maoauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+R.+Roseauthor=T.+Ryderauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=M.+Tuauthor=A.+C.+Wolfordauthor=J.+Xiao&title=Discovery+and+preclinical+characterization+of+6-chloro-5-%5B4-%281-hydroxycyclobutyl%29phenyl%5D-1H-indole-3-carboxylic+acid+%28PF-06409577%29%2C+a+direct+activator+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29%2C+for+the+potential+treatment+of+diabetic+nephropathy&doi=10.1021%2Facs.jmedchem.6b00866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy</span></div><div class="casAuthors">Cameron, Kimberly O.; Kung, Daniel W.; Kalgutkar, Amit S.; Kurumbail, Ravi G.; Miller, Russell; Salatto, Christopher T.; Ward, Jessica; Withka, Jane M.; Bhattacharya, Samit K.; Boehm, Markus; Borzilleri, Kris A.; Brown, Janice A.; Calabrese, Matthew; Caspers, Nicole L.; Cokorinos, Emily; Conn, Edward L.; Dowling, Matthew S.; Edmonds, David J.; Eng, Heather; Fernando, Dilinie P.; Frisbie, Richard; Hepworth, David; Landro, James; Mao, Yuxia; Rajamohan, Francis; Reyes, Allan R.; Rose, Colin R.; Ryder, Tim; Shavnya, Andre; Smith, Aaron C.; Tu, Meihua; Wolford, Angela C.; Xiao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8068-8081</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells.  On the basis of human genetic assocn. data, AMPK activators were pursued for the treatment of diabetic nephropathy.  Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compd.  Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7).  Compd. 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUC3BGd-8kbVg90H21EOLACvtfcHk0linybyAj1Sjdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI&md5=0b70014081c86df1cf3d713ab943d39c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00866%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25206-chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2520acid%2520%2528PF-06409577%2529%252C%2520a%2520direct%2520activator%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8068%26epage%3D8081%26doi%3D10.1021%2Facs.jmedchem.6b00866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKintosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span> <span> </span><span class="NLM_article-title">AMP-activated protein kinase: a cellular energy sensor that comes in twelve flavours</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">2987</span>– <span class="NLM_lpage">3001</span>, <span class="refDoi"> DOI: 10.1111/febs.13698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1111%2Ffebs.13698" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=2987-3001&author=F.+A.+Rossauthor=C.+MacKintoshauthor=D.+G.+Hardie&title=AMP-activated+protein+kinase%3A+a+cellular+energy+sensor+that+comes+in+twelve+flavours&doi=10.1111%2Ffebs.13698"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13698%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DF.%2BA.%26aulast%3DMacKintosh%26aufirst%3DC.%26aulast%3DHardie%26aufirst%3DD.%2BG.%26atitle%3DAMP-activated%2520protein%2520kinase%253A%2520a%2520cellular%2520energy%2520sensor%2520that%2520comes%2520in%2520twelve%2520flavours%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26spage%3D2987%26epage%3D3001%26doi%3D10.1111%2Ffebs.13698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riek, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuerk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlattner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallimann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, D.</span></span> <span> </span><span class="NLM_article-title">Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">32207</span>– <span class="NLM_lpage">32216</span>, <span class="refDoi"> DOI: 10.1074/jbc.M606357200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1074%2Fjbc.M606357200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=16943194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSrsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=32207-32216&author=M.+Suterauthor=U.+Riekauthor=R.+Tuerkauthor=U.+Schlattnerauthor=T.+Wallimannauthor=D.+Neumann&title=Dissecting+the+role+of+5%E2%80%B2-AMP+for+allosteric+stimulation%2C+activation%2C+and+deactivation+of+AMP-activated+protein+kinase&doi=10.1074%2Fjbc.M606357200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the Role of 5'-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase</span></div><div class="casAuthors">Suter, Marianne; Riek, Uwe; Tuerk, Roland; Schlattner, Uwe; Wallimann, Theo; Neumann, Dietbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">32207-32216</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a heterotrimeric protein kinase that is crucial for cellular energy homeostasis of eukaryotic cells and organisms.  Here we report on the activation of AMPK α1β1γ1 and α2β2γ1 by their upstream kinases (Ca2+/calmodulin-dependent protein kinase kinase-β and LKB1-MO25α-STRADα), deactivation by protein phosphatase 2Cα (PP2Cα), and the extent of stimulation of AMPK by its allosteric activator AMP, using purified recombinant enzyme prepns.  An accurate high pressure liq. chromatog. (HPLC)-based method for AMPK activity measurements was established, which allowed for direct quantitation of the unphosphorylated and phosphorylated artificial peptide substrate, as well as the adenine nucleotides.  Our results show a 1000-fold activation of AMPK by the combined effects of upstream kinase and satg. concns. of AMP.  The two AMPK isoforms exhibit similar specific activities (6 μmol/min/mg) and do not differ significantly by their responsiveness to AMP.  Due to the inherent instability of ATP and ADP, it proved impossible to assay AMPK activity in the abs. absence of AMP.  However, the half-maximal stimulatory effect of AMP is reached below 2 μM.  AMP does not appear to augment phosphorylation by upstream kinases in the purified in vitro system, but deactivation by dephosphorylation of AMPK α-subunits at Thr-172 by protein phosphatase 2Cα is attenuated by AMP.  Furthermore, it is shown that neither purified NAD+ nor NADH alters the activity of AMPK in a concn. range of 0-300 μM, resp.  Finally, evidence is provided that ZMP, a compd. formed in 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR)-treated cells to activate AMPK in vivo, allosterically activates purified AMPK in vitro, but compared with AMP, maximal activity is not reached.  These data shed new light on physiol. important aspects of AMPK regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrABBO1cst_YrVg90H21EOLACvtfcHk0linybyAj1Sjdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSrsbnE&md5=d878ffbbd7aa481f314ba8c9b508e0ab</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606357200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606357200%26sid%3Dliteratum%253Aachs%26aulast%3DSuter%26aufirst%3DM.%26aulast%3DRiek%26aufirst%3DU.%26aulast%3DTuerk%26aufirst%3DR.%26aulast%3DSchlattner%26aufirst%3DU.%26aulast%3DWallimann%26aufirst%3DT.%26aulast%3DNeumann%26aufirst%3DD.%26atitle%3DDissecting%2520the%2520role%2520of%25205%25E2%2580%25B2-AMP%2520for%2520allosteric%2520stimulation%252C%2520activation%252C%2520and%2520deactivation%2520of%2520AMP-activated%2520protein%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D32207%26epage%3D32216%26doi%3D10.1074%2Fjbc.M606357200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dugan, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond-Stanic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreyev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhtman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepetan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosius, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naviaux, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">4888</span>– <span class="NLM_lpage">4899</span>, <span class="refDoi"> DOI: 10.1172/JCI66218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1172%2FJCI66218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=24135141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslKksb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4888-4899&author=L.+L.+Duganauthor=Y.+H.+Youauthor=S.+S.+Aliauthor=M.+Diamond-Stanicauthor=S.+Miyamotoauthor=A.+E.+DeClevesauthor=A.+Andreyevauthor=T.+Quachauthor=S.+Lyauthor=G.+Shekhtmanauthor=W.+Nguyenauthor=A.+Chepetanauthor=T.+P.+Leauthor=L.+Wangauthor=M.+Xuauthor=K.+P.+Paikauthor=A.+Fogoauthor=B.+Violletauthor=A.+Murphyauthor=F.+Brosiusauthor=R.+K.+Naviauxauthor=K.+Sharma&title=AMPK+dysregulation+promotes+diabetes-related+reduction+of+superoxide+and+mitochondrial+function&doi=10.1172%2FJCI66218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function</span></div><div class="casAuthors">Dugan, Laura L.; You, Young-Hyun; Ali, Sameh S.; Diamond-Stanic, Maggie; Miyamoto, Satoshi; De Cleves, Anne-Emilie; Andreyev, Aleksander; Quach, Tammy; Ly, San; Shekhtman, Grigory; Nguyen, William; Chepetan, Andre; Le, Thuy P.; Wang, Lin; Xu, Ming; Paik, Kacie P.; Fogo, Agnes; Viollet, Benoit; Murphy, Anne; Brosius, Frank; Naviaux, Robert K.; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4888-4899</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Diabetic microvascular complications have been considered to be mediated by a glucose-driven increase in mitochondrial superoxide anion prodn.  Here, we report that superoxide prodn. was reduced in the kidneys of a steptozotocin-induced mouse model of type 1 diabetes, as assessed by in vivo real-time transcutaneous fluorescence, confocal microscopy, and ESR anal.  Redn. of mitochondrial biogenesis and phosphorylation of pyruvate dehydrogenase (PDH) were obsd. in kidneys from diabetic mice.  These observations were consistent with an overall redn. of mitochondrial glucose oxidn.  Activity of AMPK, the major energy-sensing enzyme, was reduced in kidneys from both diabetic mice and humans.  Mitochondrial biogenesis, PDH activity, and mitochondrial complex activity were rescued by treatment with the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR).  AICAR treatment induced superoxide prodn. and was linked with glomerular matrix and albuminuria redn. in the diabetic kidney.  Furthermore, diabetic heterozygous superoxide dismutase 2 (Sod2+/-) mice had no evidence of increased renal disease, and Ampka2-/- mice had increased albuminuria that was not reduced with AICAR treatment.  Redn. of mitochondrial superoxide prodn. with rotenone was sufficient to reduce AMPK phosphorylation in mouse kidneys.  Taken together, these results demonstrate that diabetic kidneys have reduced superoxide and mitochondrial biogenesis and activation of AMPK enhances superoxide prodn. and mitochondrial function while reducing disease activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqQbY5f3Z-crVg90H21EOLACvtfcHk0lj4gQ5qYGgtyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslKksb3O&md5=e907941fec351c3da469acc473e24ae6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1172%2FJCI66218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI66218%26sid%3Dliteratum%253Aachs%26aulast%3DDugan%26aufirst%3DL.%2BL.%26aulast%3DYou%26aufirst%3DY.%2BH.%26aulast%3DAli%26aufirst%3DS.%2BS.%26aulast%3DDiamond-Stanic%26aufirst%3DM.%26aulast%3DMiyamoto%26aufirst%3DS.%26aulast%3DDeCleves%26aufirst%3DA.%2BE.%26aulast%3DAndreyev%26aufirst%3DA.%26aulast%3DQuach%26aufirst%3DT.%26aulast%3DLy%26aufirst%3DS.%26aulast%3DShekhtman%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DW.%26aulast%3DChepetan%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DT.%2BP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DPaik%26aufirst%3DK.%2BP.%26aulast%3DFogo%26aufirst%3DA.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DA.%26aulast%3DBrosius%26aufirst%3DF.%26aulast%3DNaviaux%26aufirst%3DR.%2BK.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DAMPK%2520dysregulation%2520promotes%2520diabetes-related%2520reduction%2520of%2520superoxide%2520and%2520mitochondrial%2520function%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4888%26epage%3D4899%26doi%3D10.1172%2FJCI66218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariappan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sataranatarajan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahimainathan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasinath, B. S.</span></span> <span> </span><span class="NLM_article-title">A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy</span>. <i>Am. J. Physiol. Renal Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">F617</span>– <span class="NLM_lpage">F627</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.00278.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1152%2Fajprenal.00278.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=17018841" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=F617-F627&author=M.+J.+Leeauthor=D.+Feliersauthor=M.+M.+Mariappanauthor=K.+Sataranatarajanauthor=L.+Mahimainathanauthor=N.+Musiauthor=M.+Foretzauthor=B.+Violletauthor=J.+M.+Weinbergauthor=G.+G.+Choudhuryauthor=B.+S.+Kasinath&title=A+role+for+AMP-activated+protein+kinase+in+diabetes-induced+renal+hypertrophy&doi=10.1152%2Fajprenal.00278.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00278.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00278.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DFeliers%26aufirst%3DD.%26aulast%3DMariappan%26aufirst%3DM.%2BM.%26aulast%3DSataranatarajan%26aufirst%3DK.%26aulast%3DMahimainathan%26aufirst%3DL.%26aulast%3DMusi%26aufirst%3DN.%26aulast%3DForetz%26aufirst%3DM.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DWeinberg%26aufirst%3DJ.%2BM.%26aulast%3DChoudhury%26aufirst%3DG.%2BG.%26aulast%3DKasinath%26aufirst%3DB.%2BS.%26atitle%3DA%2520role%2520for%2520AMP-activated%2520protein%2520kinase%2520in%2520diabetes-induced%2520renal%2520hypertrophy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DF617%26epage%3DF627%26doi%3D10.1152%2Fajprenal.00278.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">AMPK mediates the initiation of kidney disease induced by a high-fat diet</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1846</span>– <span class="NLM_lpage">1855</span>, <span class="refDoi"> DOI: 10.1681/ASN.2011010026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1681%2FASN.2011010026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=21921143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCls7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1846-1855&author=A.+E.+Declevesauthor=A.+V.+Mathewauthor=R.+Cunardauthor=K.+Sharma&title=AMPK+mediates+the+initiation+of+kidney+disease+induced+by+a+high-fat+diet&doi=10.1681%2FASN.2011010026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK mediates the initiation of kidney disease induced by a high-fat diet</span></div><div class="casAuthors">Decleves, Anne-Emilie; Mathew, Anna V.; Cunard, Robyn; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1846-1855</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The mechanisms underlying the assocn. between obesity and progressive renal disease are not well understood.  Exposure to a high-fat diet decreases levels of the cellular energy sensor AMPK in many organs, including the kidney, but whether AMPK contributes to the pathophysiol. of kidney disease induced by a high-fat diet is unknown.  In this study, we randomly assigned C57BL/6J mice to a std. or high-fat diet.  After 1 wk, mice fed a high-fat diet exhibited an increase in body wt., renal hypertrophy, an increase in urine H2O2 and urine MCP-1, and a decrease in circulating adiponectin levels and renal AMPK activity.  Urine ACR progressively increased after 4 wk of a high-fat diet.  After 12 wk, kidneys of mice fed a high-fat diet demonstrated a marked increase in markers of fibrosis and inflammation, and AMPK activity remained significantly suppressed.  To det. whether inhibition of AMPK activity explained these renal effects, we administered an AMPK activator along with a high-fat diet for 1 wk.  Although AMPK activation did not abrogate the wt. gain, it reduced the renal hypertrophy, urine H2O2, and urine and renal MCP-1.  In vitro, AMPK activation completely inhibited the induction of MCP-1 by palmitic acid in mesangial cells.  In conclusion, these data suggest that the energy sensor AMPK mediates the early renal effects of a high-fat diet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLyy7LBMHJALVg90H21EOLACvtfcHk0liF5Vj-0ZBMWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCls7nM&md5=7e1ca714e5b6c691934a75df032eda20</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1681%2FASN.2011010026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2011010026%26sid%3Dliteratum%253Aachs%26aulast%3DDecleves%26aufirst%3DA.%2BE.%26aulast%3DMathew%26aufirst%3DA.%2BV.%26aulast%3DCunard%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DAMPK%2520mediates%2520the%2520initiation%2520of%2520kidney%2520disease%2520induced%2520by%2520a%2520high-fat%2520diet%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2011%26volume%3D22%26spage%3D1846%26epage%3D1855%26doi%3D10.1681%2FASN.2011010026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, B. E.</span></span> <span> </span><span class="NLM_article-title">AMPK in health and disease</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1078</span>, <span class="refDoi"> DOI: 10.1152/physrev.00011.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1152%2Fphysrev.00011.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=19584320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpslyjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=1025-1078&author=G.+R.+Steinbergauthor=B.+E.+Kemp&title=AMPK+in+health+and+disease&doi=10.1152%2Fphysrev.00011.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK in health and disease</span></div><div class="casAuthors">Steinberg, Gregory R.; Kemp, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1025-1078</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The function and survival of all organisms is dependent on the dynamic control of energy metab., when energy demand is matched to energy supply.  The AMP-activated protein kinase (AMPK) αβγ heterotrimer has emerged as an important integrator of signals that control energy balance through the regulation of multiple biochem. pathways in all eukaryotes.  In this review, we begin with the discovery of the AMPK family and discuss the recent structural studies that have revealed the mol. basis for AMP binding to the enzyme's γ subunit.  AMPK's regulation involves autoinhibitory features and phosphorylation of both the catalytic α subunit and the β-targeting subunit.  We review the role of AMPK at the cellular level through examn. of its many substrates and discuss how it controls cellular energy balance.  We look at how AMPK integrates stress responses such as exercise as well as nutrient and hormonal signals to control food intake, energy expenditure, and substrate utilization at the whole body level.  Lastly, we review the possible role of AMPK in multiple common diseases and the role of the new age of drugs targeting AMPK signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodloz1gTPHErVg90H21EOLACvtfcHk0liF5Vj-0ZBMWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpslyjsb4%253D&md5=fbc46b4e8edc695c24da582889bfc9a2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00011.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00011.2008%26sid%3Dliteratum%253Aachs%26aulast%3DSteinberg%26aufirst%3DG.%2BR.%26aulast%3DKemp%26aufirst%3DB.%2BE.%26atitle%3DAMPK%2520in%2520health%2520and%2520disease%26jtitle%3DPhysiol.%2520Rev.%26date%3D2009%26volume%3D89%26spage%3D1025%26epage%3D1078%26doi%3D10.1152%2Fphysrev.00011.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">GTEx
Consortium</span> <span> </span><span class="NLM_article-title">The genotype-tissue
expression (GTEx) project</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/ng.2653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1038%2Fng.2653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=23715323" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=580-585&author=GTEx%0AConsortium&title=The+genotype-tissue%0Aexpression+%28GTEx%29+project&doi=10.1038%2Fng.2653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fng.2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2653%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520genotype-tissue%250Aexpression%2520%2528GTEx%2529%2520project%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D580%26epage%3D585%26doi%3D10.1038%2Fng.2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipski, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebner, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genung, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavergne, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathialagan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panteleev, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polivkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuma, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span> <span> </span><span class="NLM_article-title">Optimization of metabolic and renal clearance in a series of indole acid direct activators of 5′-adenosine monophosphate-activated protein kinase (AMPK)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2372</span>– <span class="NLM_lpage">2383</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01641</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01641" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2372-2383&author=D.+J.+Edmondsauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=K.+J.+Filipskiauthor=D.+C.+Ebnerauthor=S.+Cabralauthor=A.+C.+Smithauthor=G.+E.+Aspnesauthor=S.+K.+Bhattacharyaauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+F.+Calabreseauthor=N.+L.+Caspersauthor=E.+C.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=H.+Engauthor=B.+Fengauthor=D.+P.+Fernandoauthor=N.+E.+Genungauthor=M.+Herrauthor=R.+G.+Kurumbailauthor=S.+Y.+Lavergneauthor=S.+C.-Y.+Leeauthor=Q.+Liauthor=S.+Mathialaganauthor=R.+A.+Millerauthor=J.+Panteleevauthor=J.+Polivkovaauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+T.+Salattoauthor=A.+Shavnyaauthor=B.+A.+Thumaauthor=M.+Tuauthor=J.+Wardauthor=J.+M.+Withkaauthor=J.+Xiaoauthor=K.+O.+Cameron&title=Optimization+of+metabolic+and+renal+clearance+in+a+series+of+indole+acid+direct+activators+of+5%E2%80%B2-adenosine+monophosphate-activated+protein+kinase+%28AMPK%29&doi=10.1021%2Facs.jmedchem.7b01641"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01641%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DEbner%26aufirst%3DD.%2BC.%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%2BC.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DGenung%26aufirst%3DN.%2BE.%26aulast%3DHerr%26aufirst%3DM.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DLavergne%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BC.-Y.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMathialagan%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DPanteleev%26aufirst%3DJ.%26aulast%3DPolivkova%26aufirst%3DJ.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26atitle%3DOptimization%2520of%2520metabolic%2520and%2520renal%2520clearance%2520in%2520a%2520series%2520of%2520indole%2520acid%2520direct%2520activators%2520of%25205%25E2%2580%25B2-adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2372%26epage%3D2383%26doi%3D10.1021%2Facs.jmedchem.7b01641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessire, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, A. E.</span></span> <span> </span><span class="NLM_article-title">A rapid and specific derivatization procedure to identify acyl-glucuronides by mass spectrometry</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2109</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1002/rcm.4621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1002%2Frcm.4621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=20552710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVOgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2109-2121&author=A.+D.+Vazauthor=W.+W.+Wangauthor=A.+J.+Bessireauthor=R.+Sharmaauthor=A.+E.+Hagen&title=A+rapid+and+specific+derivatization+procedure+to+identify+acyl-glucuronides+by+mass+spectrometry&doi=10.1002%2Frcm.4621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and specific derivatization procedure to identify acyl-glucuronides by mass spectrometry</span></div><div class="casAuthors">Vaz, Alfin D. N.; Wang, Wei Wei; Bessire, Andrew J.; Sharma, Raman; Hagen, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2109-2121</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A simple procedure is described to identify acyl-glucuronides by coupled liq. chromatog./mass spectrometry after derivatization to a hydroxamic acid with hydroxylamine.  The reaction specificity obviates the need for isolation of the acyl-glucuronide from an ext.  Glucuronides derived from carbamic acids, and alkyl- and arom. amines, are inert to the derivatization reaction conditions, making the hydroxamic acid deriv. a fingerprint for acyl-glucuronides.  This derivatization procedure provides a key advantage for the quant. anal. of acyl-glucuronide metabolites in a drug discovery setting.  Copyright © 2010 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDR6oEUBtuHbVg90H21EOLACvtfcHk0lgbRx6KapDsCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVOgurk%253D&md5=1f282304cec298e7db621c9478d14d3e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Frcm.4621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.4621%26sid%3Dliteratum%253Aachs%26aulast%3DVaz%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DW.%2BW.%26aulast%3DBessire%26aufirst%3DA.%2BJ.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DHagen%26aufirst%3DA.%2BE.%26atitle%3DA%2520rapid%2520and%2520specific%2520derivatization%2520procedure%2520to%2520identify%2520acyl-glucuronides%2520by%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2010%26volume%3D24%26spage%3D2109%26epage%3D2121%26doi%3D10.1002%2Frcm.4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauli, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godecke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaki, B. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lankin, D. C.</span></span> <span> </span><span class="NLM_article-title">Quantitative 1H NMR: Development and potential of an analytical method: an update</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1021/np200993k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200993k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=834-851&author=G.+F.+Pauliauthor=T.+Godeckeauthor=B.+U.+Jakiauthor=D.+C.+Lankin&title=Quantitative+1H+NMR%3A+Development+and+potential+of+an+analytical+method%3A+an+update&doi=10.1021%2Fnp200993k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fnp200993k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200993k%26sid%3Dliteratum%253Aachs%26aulast%3DPauli%26aufirst%3DG.%2BF.%26aulast%3DGodecke%26aufirst%3DT.%26aulast%3DJaki%26aufirst%3DB.%2BU.%26aulast%3DLankin%26aufirst%3DD.%2BC.%26atitle%3DQuantitative%25201H%2520NMR%253A%2520Development%2520and%2520potential%2520of%2520an%2520analytical%2520method%253A%2520an%2520update%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D834%26epage%3D851%26doi%3D10.1021%2Fnp200993k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauli, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lankin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godecke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaki, B. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlpine, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napolitano, J. G.</span></span> <span> </span><span class="NLM_article-title">Importance of purity evaluation and the potential of quantitative <sup>1</sup>H NMR as a purity assay</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9220</span>– <span class="NLM_lpage">9231</span>, <span class="refDoi"> DOI: 10.1021/jm500734a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500734a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslahsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9220-9231&author=G.+F.+Pauliauthor=S.+N.+Chenauthor=C.+Simmlerauthor=D.+C.+Lankinauthor=T.+Godeckeauthor=B.+U.+Jakiauthor=J.+B.+Friesenauthor=J.+B.+McAlpineauthor=J.+G.+Napolitano&title=Importance+of+purity+evaluation+and+the+potential+of+quantitative+1H+NMR+as+a+purity+assay&doi=10.1021%2Fjm500734a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of Purity Evaluation and the Potential of Quantitative 1H NMR as a Purity Assay</span></div><div class="casAuthors">Pauli, Guido F.; Chen, Shao-Nong; Simmler, Charlotte; Lankin, David C.; Godecke, Tanja; Jaki, Birgit U.; Friesen, J. Brent; McAlpine, James B.; Napolitano, Jose G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9220-9231</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In any biomedical and chem. context, a truthful description of chem. constitution requires coverage of both structure and purity.  This qualification affects all drug mols., regardless of development stage (early discovery to approved drug) and source (natural product or synthetic).  Purity assessment is particularly crit. in discovery programs and whenever chem. is linked with biol. and/or therapeutic outcome.  Compared with chromatog. and elemental anal., quant. NMR (qNMR) uses nearly universal detection and provides a versatile and orthogonal means of purity evaluation.  Abs. qNMR with flexible calibration captures analytes that frequently escape detection (water, sorbents).  Widely accepted structural NMR workflows require minimal or no adjustments to become practical 1H qNMR (qHNMR) procedures with simultaneous qual. and (abs.) quant. capability.  This study reviews underlying concepts, provides a framework for std. qHNMR purity assays, and shows how adequate accuracy and precision are achieved for the intended use of the material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqquFEu5lLVVrVg90H21EOLACvtfcHk0lgeaNsvztzrcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslahsLzF&md5=78900d0b03e31739e50c04c63c55dba7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm500734a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500734a%26sid%3Dliteratum%253Aachs%26aulast%3DPauli%26aufirst%3DG.%2BF.%26aulast%3DChen%26aufirst%3DS.%2BN.%26aulast%3DSimmler%26aufirst%3DC.%26aulast%3DLankin%26aufirst%3DD.%2BC.%26aulast%3DGodecke%26aufirst%3DT.%26aulast%3DJaki%26aufirst%3DB.%2BU.%26aulast%3DFriesen%26aufirst%3DJ.%2BB.%26aulast%3DMcAlpine%26aufirst%3DJ.%2BB.%26aulast%3DNapolitano%26aufirst%3DJ.%2BG.%26atitle%3DImportance%2520of%2520purity%2520evaluation%2520and%2520the%2520potential%2520of%2520quantitative%25201H%2520NMR%2520as%2520a%2520purity%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9220%26epage%3D9231%26doi%3D10.1021%2Fjm500734a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Espina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vashishtha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.</span></span> <span> </span><span class="NLM_article-title">Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1021/tx800251p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800251p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaiu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=299-310&author=R.+Espinaauthor=L.+Yuauthor=J.+Wangauthor=Z.+Tongauthor=S.+Vashishthaauthor=R.+Talaatauthor=J.+Scatinaauthor=A.+Mutlib&title=Nuclear+magnetic+resonance+spectroscopy+as+a+quantitative+tool+to+determine+the+concentrations+of+biologically+produced+metabolites%3A+implications+in+metabolites+in+safety+testing&doi=10.1021%2Ftx800251p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear Magnetic Resonance Spectroscopy as a Quantitative Tool To Determine the Concentrations of Biologically Produced Metabolites: Implications in Metabolites in Safety Testing</span></div><div class="casAuthors">Espina, Robert; Yu, Linning; Wang, Jianyao; Tong, Zeen; Vashishtha, Sarvesh; Talaat, Rasmy; Scatina, JoAnn; Mutlib, Abdul</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-310</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NMR spectroscopy has traditionally been considered as an indispensable tool in elucidating structures of metabolites.  With the advent of Fourier transform (FT) spectrometers, along with improvements in software and hardware (such as high-field magnets, cryoprobes, versatile pulse sequences, and solvent suppression techniques), NMR is increasingly being considered as a crit. quant. tool, despite its lower sensitivity as compared to mass spectrometry.  A specific quant. application of NMR is in detg. the concns. of biol. isolated metabolites, which could potentially be used as ref. stds. for further quant. work by liq. chromatog./mass spectrometry.  With the recent demands from regulatory agencies on quant. information on metabolites, it is proposed that NMR will play a significant role in strategies aimed at addressing metabolite coverage in toxicol. species.  Traditionally, biol. isolated metabolites have not been considered as a way of generating "ref. stds." for further quant. work.  However, because of the recent FDA guidance on safety testing of metabolites, one has to consider means of authenticating and quantitating biol. or nonbiol. generated metabolites.  1H NMR is being proposed as the method of choice, as it is able to be used as both a qual. and a quant. tool, hence allowing structure detn., purity check, and quant. measurement of the isolated metabolite.  In this publication, the application of NMR as a powerful and robust anal. technique in detg. the concns. of in vitro or in vivo isolated metabolites is discussed.  Furthermore, to demonstrate the reliability and accuracy of metabolite concns. detd. by NMR, validation and cross-validation with gravimetric and mass spectrometric methods were conducted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhv9f79k3pGLVg90H21EOLACvtfcHk0lgeaNsvztzrcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaiu7vL&md5=f509721655fa5d28edada912a2d90841</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Ftx800251p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800251p%26sid%3Dliteratum%253Aachs%26aulast%3DEspina%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DZ.%26aulast%3DVashishtha%26aufirst%3DS.%26aulast%3DTalaat%26aufirst%3DR.%26aulast%3DScatina%26aufirst%3DJ.%26aulast%3DMutlib%26aufirst%3DA.%26atitle%3DNuclear%2520magnetic%2520resonance%2520spectroscopy%2520as%2520a%2520quantitative%2520tool%2520to%2520determine%2520the%2520concentrations%2520of%2520biologically%2520produced%2520metabolites%253A%2520implications%2520in%2520metabolites%2520in%2520safety%2520testing%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2009%26volume%3D22%26spage%3D299%26epage%3D310%26doi%3D10.1021%2Ftx800251p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rundlof, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiasson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekiroglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakkarainen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvidsson, T.</span></span> <span> </span><span class="NLM_article-title">Survey and qualification of internal standards for quantitation by 1H NMR spectroscopy</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2010.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.jpba.2010.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=20207092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jsFertw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=645-651&author=T.+Rundlofauthor=M.+Mathiassonauthor=S.+Bekirogluauthor=B.+Hakkarainenauthor=T.+Bowdenauthor=T.+Arvidsson&title=Survey+and+qualification+of+internal+standards+for+quantitation+by+1H+NMR+spectroscopy&doi=10.1016%2Fj.jpba.2010.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Survey and qualification of internal standards for quantification by 1H NMR spectroscopy</span></div><div class="casAuthors">Rundlof Torgny; Mathiasson Marie; Bekiroglu Somer; Hakkarainen Birgit; Bowden Tim; Arvidsson Torbjorn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutical and biomedical analysis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">645-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In quantitative NMR (qNMR) selection of an appropriate internal standard proves to be crucial.  In this study, 25 candidate compounds considered to be potent internal standards were investigated with respect to the ability of providing unique signal chemical shifts, purity, solubility, and ease of use.  The (1)H chemical shift (delta) values, assignments, multiplicities and number of protons (for each signal), appropriateness (as to be used as internal standards) in four different deuterated solvents (D(2)O, DMSO-d(6), CD(3)OD, CDCl(3)) were studied.  Taking into account the properties of these 25 internal standards, the most versatile eight compounds (2,4,6-triiodophenol, 1,3,5-trichloro-2-nitrobenzene, 3,4,5-trichloropyridine, dimethyl terephthalate, 1,4-dinitrobenzene, 2,3,5-triiodobenzoic acid, maleic acid and fumaric acid) were qualified using both differential scanning calorimetry (DSC) and NMR spectroscopy employing highly pure acetanilide as the reference standard.  The data from these two methods were compared as well as utilized in the quality assessment of the compounds as internal standards.  Finally, the selected internal standards were tested and evaluated in a real case of quantitative NMR analysis of a paracetamol pharmaceutical product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQaSIJzqfbu1SXXDYhVZBdlfW6udTcc2ebIxdjxLTA1ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jsFertw%253D%253D&md5=97ae3cdb4f4b6ce73c12ce17cd7c031d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2010.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2010.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DRundlof%26aufirst%3DT.%26aulast%3DMathiasson%26aufirst%3DM.%26aulast%3DBekiroglu%26aufirst%3DS.%26aulast%3DHakkarainen%26aufirst%3DB.%26aulast%3DBowden%26aufirst%3DT.%26aulast%3DArvidsson%26aufirst%3DT.%26atitle%3DSurvey%2520and%2520qualification%2520of%2520internal%2520standards%2520for%2520quantitation%2520by%25201H%2520NMR%2520spectroscopy%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2010%26volume%3D52%26spage%3D645%26epage%3D651%26doi%3D10.1016%2Fj.jpba.2010.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwanathan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babalola, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatina, J.</span></span> <span> </span><span class="NLM_article-title">Application of quantitative NMR in pharmacological evaluation of biologically generated metabolites: implications in drug discovery</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.032490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.110.032490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=106-116&author=A.+Mutlibauthor=R.+Espinaauthor=K.+Vishwanathanauthor=K.+Babalolaauthor=Z.+Chenauthor=C.+Dehnhardtauthor=A.+Venkatesanauthor=T.+Mansourauthor=I.+Chaudharyauthor=R.+Talaatauthor=J.+Scatina&title=Application+of+quantitative+NMR+in+pharmacological+evaluation+of+biologically+generated+metabolites%3A+implications+in+drug+discovery&doi=10.1124%2Fdmd.110.032490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.032490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.032490%26sid%3Dliteratum%253Aachs%26aulast%3DMutlib%26aufirst%3DA.%26aulast%3DEspina%26aufirst%3DR.%26aulast%3DVishwanathan%26aufirst%3DK.%26aulast%3DBabalola%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DVenkatesan%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DTalaat%26aufirst%3DR.%26aulast%3DScatina%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520quantitative%2520NMR%2520in%2520pharmacological%2520evaluation%2520of%2520biologically%2520generated%2520metabolites%253A%2520implications%2520in%2520drug%2520discovery%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D106%26epage%3D116%26doi%3D10.1124%2Fdmd.110.032490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.059204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.114.059204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=25053618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yqur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1627-1639&author=G.+S.+Walkerauthor=J.+N.+Baumanauthor=T.+F.+Ryderauthor=E.+B.+Smithauthor=D.+K.+Spracklinauthor=R.+S.+Obach&title=Biosynthesis+of+drug+metabolites+and+quantitation+using+NMR+spectroscopy+for+use+in+pharmacologic+and+drug+metabolism+studies&doi=10.1124%2Fdmd.114.059204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies</span></div><div class="casAuthors">Walker, Gregory S.; Bauman, Jonathan N.; Ryder, Tim F.; Smith, Evan B.; Spracklin, Douglas K.; Scott Obach, R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1627-1639, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The contribution of drug metabolites to the pharmacol. and toxicol. activity of a drug can be important; however, for a variety of reasons metabolites can frequently be difficult to synthesize.  To meet the need of having samples of drug metabolites for further study, we have developed biosynthetic methods coupled with quant. NMR spectroscopy (qNMR) to generate solns. of metabolites of known structure and concn.  These quant. samples can be used in a variety of ways when a synthetic sample is unavailable, including pharmacol. assays, stds. for in vitro work to help establish clearance pathways, and/or as anal. stds. for bioanal. work to ascertain exposure, among others.  We illustrate five examples of metabolite biosynthesis and qNMR.  The types of metabolites include one glucuronide and four oxidative products.  Concns. of the isolated metabolite stock solns. ranged from 0.048 to 8.3 mM, with vols. from approx. 0.04 to 0.150 mL in hexadeutarated dimethylsulfoxide.  These specific quantified isolates were used as stds. in the drug discovery setting as substrates in pharmacol. assays, for bioanal. assays to establish exposure, and in variety of routine absorption, distribution, metab., and excretion assays, such as protein binding and detg. blood-toplasma ratios.  The methods used to generate these materials are described in detail with the objective that these methods can be generally used for metabolite biosynthesis and isolation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIcWqizvGukLVg90H21EOLACvtfcHk0ljZZBYhp9o3pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yqur3N&md5=8d763ea8c23f07f680949c005e2ea7c7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.059204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.059204%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DBiosynthesis%2520of%2520drug%2520metabolites%2520and%2520quantitation%2520using%2520NMR%2520spectroscopy%2520for%2520use%2520in%2520pharmacologic%2520and%2520drug%2520metabolism%2520studies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D1627%26epage%3D1639%26doi%3D10.1124%2Fdmd.114.059204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, A.</span></span> <span> </span><span class="NLM_article-title">Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">433</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.036343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.110.036343" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=433-440&author=G.+S.+Walkerauthor=T.+F.+Ryderauthor=R.+Sharmaauthor=E.+B.+Smithauthor=A.+Freund&title=Validation+of+isolated+metabolites+from+drug+metabolism+studies+as+analytical+standards+by+quantitative+NMR&doi=10.1124%2Fdmd.110.036343"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.036343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.036343%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26aulast%3DFreund%26aufirst%3DA.%26atitle%3DValidation%2520of%2520isolated%2520metabolites%2520from%2520drug%2520metabolism%2520studies%2520as%2520analytical%2520standards%2520by%2520quantitative%2520NMR%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D433%26epage%3D440%26doi%3D10.1124%2Fdmd.110.036343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K.</span>; <span class="NLM_string-name">Edmonds, D. J.</span>; <span class="NLM_string-name">Kalgutkar, A.</span>; <span class="NLM_string-name">Ebner, D.</span>; <span class="NLM_string-name">Thuma, B.</span>; <span class="NLM_string-name">Filipski, K. J.</span>; <span class="NLM_string-name">Kumar, R.</span></span> <span> </span><span class="NLM_article-title">Indole and indazole compounds that activate AMPK</span>. <span class="NLM_patent">WO 2016092413</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+Cameron&author=D.+J.+Edmonds&author=A.+Kalgutkar&author=D.+Ebner&author=B.+Thuma&author=K.+J.+Filipski&author=R.+Kumar&title=Indole+and+indazole+compounds+that+activate+AMPK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%26atitle%3DIndole%2520and%2520indazole%2520compounds%2520that%2520activate%2520AMPK%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span> <span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1410</span>, <span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0lgyjY2H-4SGLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spahn-Langguth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutschler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">lin, E. T.</span></span> <span> </span><span class="NLM_article-title">Predictability of the covalent binding of acidic drugs in man</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">PL141</span>– <span class="NLM_lpage">PL146</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(93)90279-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2F0024-3205%2893%2990279-C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=PL141-PL146&author=L.+Z.+Benetauthor=H.+Spahn-Langguthauthor=S.+Iwakawaauthor=C.+Vollandauthor=T.+Mizumaauthor=S.+Mayerauthor=E.+Mutschlerauthor=E.+T.+lin&title=Predictability+of+the+covalent+binding+of+acidic+drugs+in+man&doi=10.1016%2F0024-3205%2893%2990279-C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2893%2990279-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252893%252990279-C%26sid%3Dliteratum%253Aachs%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DSpahn-Langguth%26aufirst%3DH.%26aulast%3DIwakawa%26aufirst%3DS.%26aulast%3DVolland%26aufirst%3DC.%26aulast%3DMizuma%26aufirst%3DT.%26aulast%3DMayer%26aufirst%3DS.%26aulast%3DMutschler%26aufirst%3DE.%26aulast%3Dlin%26aufirst%3DE.%2BT.%26atitle%3DPredictability%2520of%2520the%2520covalent%2520binding%2520of%2520acidic%2520drugs%2520in%2520man%26jtitle%3DLife%2520Sci.%26date%3D1993%26volume%3D53%26spage%3DPL141%26epage%3DPL146%26doi%3D10.1016%2F0024-3205%2893%2990279-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L.</span></span> <span> </span><span class="NLM_article-title">Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies by tandem mass spectrometry</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=246-256&author=Y.+Qiuauthor=A.+L.+Burlingameauthor=L.+Benet&title=Mechanisms+for+covalent+binding+of+benoxaprofen+glucuronide+to+human+serum+albumin.+Studies+by+tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DBurlingame%26aufirst%3DA.%2BL.%26aulast%3DBenet%26aufirst%3DL.%26atitle%3DMechanisms%2520for%2520covalent%2520binding%2520of%2520benoxaprofen%2520glucuronide%2520to%2520human%2520serum%2520albumin.%2520Studies%2520by%2520tandem%2520mass%2520spectrometry%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1998%26volume%3D26%26spage%3D246%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span> </span><span class="NLM_article-title">Safety testing of drug metabolites</span>.  <i>Guidances
(Drugs)</i>; <span class="NLM_publisher-name">US Food and Drug Administration</span>, <span class="NLM_year">2016</span>; <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm" class="extLink">http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm</a> (accessed 31 October, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety+testing+of+drug+metabolites.+Guidances%0A%28Drugs%29%3B+US+Food+and+Drug+Administration%2C+2016%3B+http%3A%2F%2Fwww.fda.gov%2FDrugs%2FGuidanceComplianceRegulatoryInformation%2FGuidances%2Fdefault.htm+%28accessed+31+October%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DSafety%2520testing%2520of%2520drug%2520metabolites%26jtitle%3DGuidances%250A%2528Drugs%2529%26pub%3DUS%2520Food%2520and%2520Drug%2520Administration%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atherton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reily, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.</span></span> <span> </span><span class="NLM_article-title">Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1021/tx600297u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx600297u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVymtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=876-886&author=G.+S.+Walkerauthor=J.+Athertonauthor=J.+Baumanauthor=C.+Kohlauthor=W.+Lamauthor=M.+Reilyauthor=Z.+Louauthor=A.+Mutlib&title=Determination+of+degradation+pathways+and+kinetics+of+acyl+glucuronides+by+NMR+spectroscopy&doi=10.1021%2Ftx600297u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of Degradation Pathways and Kinetics of Acyl Glucuronides by NMR Spectroscopy</span></div><div class="casAuthors">Walker, Gregory S.; Atherton, James; Bauman, Jonathan; Kohl, Christopher; Lam, Wing; Reily, Michael; Lou, Zhen; Mutlib, Abdul</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">876-886</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl glucuronides have been implicated in the toxicity of many xenobiotics and marketed drugs.  These toxicities are hypothesized to be a consequence of covalent binding of the reactive forms of the acyl glucuronide to proteins.  Reactive intermediates of the acyl glucuronide arise from the migration of the aglycon leading to other positional and stereoisomers under physiol. conditions.  In order to screen for the potential liabilities of these metabolites during the early phase of pharmaceutical development, an NMR method based on the disappearance of the anomeric resonance of the O-1-acyl glucuronide was used to monitor the degrdn. kinetics of 11 structurally diverse acyl glucuronides, including those produced from the known nonsteroidal anti-inflammatory drugs (NSAIDs).  The acyl glucuronides were either chem. synthesized or were isolated from biol. matrixes (bile, urine, and liver microsomal exts.).  The half-lives attained utilizing this method were found to be comparable to those reported in the literature.  NMR anal. also enabled the delineation of the two possible pathways of degrdn.: acyl migration and hydrolytic cleavage.  The previously characterized 1H resonances of acyl migrated products are quite distinguishable from those that arise from hydrolysis.  The NMR method described here could be used to rank order acyl glucuronide forming discovery compds. based on the potential reactivity of the conjugates and their routes of decompn. under physiol. conditions.  Furthermore, we have shown that in vitro systems such as liver microsomal prepns. can be used to generate sufficient quantities of acyl glucuronides from early discovery compds. for NMR characterization.  This is particularly important, as we often have limited supply of early discovery compds. to conduct in vivo studies to generate sufficient quantities of acyl glucuronides for further characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3aeMkwVvVErVg90H21EOLACvtfcHk0ljYaRIcmLVCUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVymtrw%253D&md5=b0ffe295d85c8a7a6816f3e22eac5bec</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Ftx600297u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx600297u%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DAtherton%26aufirst%3DJ.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLam%26aufirst%3DW.%26aulast%3DReily%26aufirst%3DM.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DMutlib%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520degradation%2520pathways%2520and%2520kinetics%2520of%2520acyl%2520glucuronides%2520by%2520NMR%2520spectroscopy%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D876%26epage%3D886%26doi%3D10.1021%2Ftx600297u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaat, R.</span></span> <span> </span><span class="NLM_article-title">A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1206</span>– <span class="NLM_lpage">1216</span>, <span class="refDoi"> DOI: 10.1021/tx049900+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx049900%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt12qurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=1206-1216&author=J.+Wangauthor=M.+Davisauthor=F.+Liauthor=F.+Azamauthor=J.+Scatinaauthor=R.+Talaat&title=A+novel+approach+for+predicting+acyl+glucuronide+reactivity+via+Schiff+base+formation%3A+development+of+rapidly+formed+peptide+adducts+for+LC%2FMS%2FMS+measurements&doi=10.1021%2Ftx049900%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Approach for Predicting Acyl Glucuronide Reactivity via Schiff Base Formation: Development of Rapidly Formed Peptide Adducts for LC/MS/MS Measurements</span></div><div class="casAuthors">Wang, Jianyao; Davis, Margaret; Li, Fangbiao; Azam, Farooq; Scatina, JoAnn; Talaat, Rasmy</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1206-1216</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel technique to study the reactivity of acyl glucuronide metabolites to protein has been developed and is described herein.  Considered here are acyl glucuronide metabolites, which have undergone the rearrangement of the glucuronic acid moiety at physiol. temp. and pH.  The investigation of the reactivity of these electrophilic metabolites was carried out by measuring the rate of reaction of rearranged AG metabolites in forming the corresponding acyl glucuronide-peptide adduct in the presence of Lys-Phe.  This differs from the parallel technique used in forming AG adducts of proteins that have been previously reported.  In the study described here, the Schiff base adduct, diclofenac acyl glucuronide-Lys-Phe product, was generated and structurally elucidated by liq. chromatog. tandem mass spectrometry (LC/MS/MS) anal.  The product structure was proved to be a Schiff base adduct by chem. derivatization by nucleophilic addn. of HCN and chem. redn. with NaCNBH3, followed by LC/MS/MS anal.  It is proposed here that the degree of reactivity of acyl glucuronides as measured by covalent binding to protein is proportional to the amt. of its peptide adduct generated with the peptide technique described.  The application of this technique to the assessment of the degree of reactivity of acyl glucuronide metabolites was validated by developing a reactivity rank of seven carboxylic acid-contg. drugs.  Consistency was achieved between the ranking of reactivity in the peptide technique for these seven compds. and the rankings found in the literature.  In addn., a correlation (R2 = 0.95) was revealed between the formation of a peptide adduct and the rearrangement rate of the primary acyl glucuronide of seven tested compds.  A structure effect on the degree of reactivity has demonstrated the rate order: acetic acid > propionic acid > benzoic acid derivs.  A rational explanation of this order was proposed, based on the inherent electronic and steric properties of each specific aglycon.  In addn., adaptation of this technique to automation in order to more rapidly assess the ranking of reactivity of acyl glucuronide covalent binding to proteins by new chem. entities is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIzH7J0RPEhrVg90H21EOLACvtfcHk0ljYaRIcmLVCUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt12qurg%253D&md5=1cee861849c7acb1ae3fe47d7c1b5d87</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Ftx049900%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx049900%252B%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DAzam%26aufirst%3DF.%26aulast%3DScatina%26aufirst%3DJ.%26aulast%3DTalaat%26aufirst%3DR.%26atitle%3DA%2520novel%2520approach%2520for%2520predicting%2520acyl%2520glucuronide%2520reactivity%2520via%2520Schiff%2520base%2520formation%253A%2520development%2520of%2520rapidly%2520formed%2520peptide%2520adducts%2520for%2520LC%252FMS%252FMS%2520measurements%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D1206%26epage%3D1216%26doi%3D10.1021%2Ftx049900%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, T.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for the degradation reaction of 1-beta-O-acyl glucuronides. Part 3: Electronic and steric descriptors predicting the reactivity of aralkyl carboxylic acid 1-beta-O-acyl glucuronides</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1998</span>– <span class="NLM_lpage">2008</span>, <span class="refDoi"> DOI: 10.1021/tx9002963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx9002963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2qu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=1998-2008&author=A.+Babaauthor=T.+Yoshioka&title=Structure-activity+relationships+for+the+degradation+reaction+of+1-beta-O-acyl+glucuronides.+Part+3%3A+Electronic+and+steric+descriptors+predicting+the+reactivity+of+aralkyl+carboxylic+acid+1-beta-O-acyl+glucuronides&doi=10.1021%2Ftx9002963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships for the Degradation Reaction of 1-β-O-Acyl Glucuronides. Part 3: Electronic and Steric Descriptors Predicting the Reactivity of Aralkyl Carboxylic Acid 1-β-O-Acyl Glucuronides</span></div><div class="casAuthors">Baba, Akiko; Yoshioka, Tadao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1998-2008</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since 1-β-O-acyl glucuronides (βGAs) are thought to be chem. reactive metabolites capable of binding to tissue proteins, possibly leading to adverse drug reactions of the parent carboxylic acid drugs, we have initiated research efforts to derive structure-activity relationships (SARs) of βGAs, with a focus on finding appropriate descriptors that predict their intrinsic electrophilic reactivity or degrdn. rate consts. (k values).  Our previous SAR studies on the k values of βGAs derived from o-, m-, and p-substituted benzoic acids demonstrated that the diversity and complexity of the k values were controlled by the electronic and/or steric effects of the parent carboxylic acids.  In the present study, we performed further SAR studies on the k values of 13 βGAs derived from aralkyl carboxylic acids, focusing on the substituents and stereochem. at the α-position of the parent carboxylic acids.  In single regression analyses, the pKa and 1H NMR chem. shifts (δCOOH) of the parent carboxylic acids correlated well with the log k values of seven βGAs derived from five arylacetic and two (R)-2-arylpropionic acids, whereas the 13C NMR chem. shifts [δC=O and δ(C=O)OH] correlated with the log k values of another seven βGAs derived from the five arylacetic and two (S)-2-arylpropionic acids.  Excellent correlations were also obtained between the log k values of four βGAs with a common 4-phenylbenzyl moiety and the partial at. charges (natural type) of the corresponding carboxylic hydrogen atoms (Hpac), the molar volume (MV), and the molar refractivity (MR).  In multiple regression analyses, appropriate combinations of electronic (δCOOH or pKa) and steric [Taft's steric const. (Es) or δ(C=O)OH] descriptors could predict the log k values of βGAs; electron-withdrawing 1-β-O-acyl groups increased the k values, while increasing steric hindrance around the linkages decreased them.  The std. partial regression coeffs. indicated that the steric effects of the 1-β-O-acyl groups of βGAs affected the k values as strongly as the electronic effects.  External validation of the derived SAR models is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMRVLPvP_JALVg90H21EOLACvtfcHk0lhoua4UuIaGLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2qu77F&md5=5b25cd783fa5597dff4183ed56474dd3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Ftx9002963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9002963%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DA.%26aulast%3DYoshioka%26aufirst%3DT.%26atitle%3DStructure-activity%2520relationships%2520for%2520the%2520degradation%2520reaction%2520of%25201-beta-O-acyl%2520glucuronides.%2520Part%25203%253A%2520Electronic%2520and%2520steric%2520descriptors%2520predicting%2520the%2520reactivity%2520of%2520aralkyl%2520carboxylic%2520acid%25201-beta-O-acyl%2520glucuronides%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2009%26volume%3D22%26spage%3D1998%26epage%3D2008%26doi%3D10.1021%2Ftx9002963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolkipli, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satriano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogac, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nortier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farquhar, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naviaux, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1038/ki.2013.462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1038%2Fki.2013.462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=24304883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCqsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=611-623&author=A.+E.+Declevesauthor=Z.+Zolkipliauthor=J.+Satrianoauthor=L.+Wangauthor=T.+Nakayamaauthor=M.+Rogacauthor=T.+P.+Leauthor=J.+L.+Nortierauthor=M.+G.+Farquharauthor=R.+K.+Naviauxauthor=K.+Sharma&title=Regulation+of+lipid+accumulation+by+AMP-activated+kinase+%5Bcorrected%5D+in+high+fat+diet-induced+kidney+injury&doi=10.1038%2Fki.2013.462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury</span></div><div class="casAuthors">Decleves, Anne-Emilie; Zolkipli, Zarazuela; Satriano, Joseph; Wang, Lin; Nakayama, Tomohiro; Rogac, Mihael; Le, Thuy P.; Nortier, Joelle L.; Farquhar, Marilyn G.; Naviaux, Robert K.; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">611-623</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is an important energy sensor that may be crit. in regulating renal lipid accumulation.  To evaluate the role of AMPK in mediating renal lipid accumulation, C57BL/6J mice were randomized to a std. diet, a high-fat diet, or a high-fat diet plus AICAR (an AMPK activator) for 14 wk.  Renal functional and structural studies along with electron microscopy were performed.  Mice given the high-fat diet had proximal tubule injury with the presence of enlarged clear vacuoles, and multilaminar inclusions concurrent with an increase of tissue lipid and overloading of the lysosomal system.  The margins of the clear vacuoles were pos. for the endolysosomal marker, LAMP1, suggesting lysosome accumulation.  Characterization of vesicles by special stains (Oil Red O, Nile Red, Luxol Fast Blue) and by electron microscopy showed they contained onion skin-like accumulations consistent with phospholipids.  Moreover, cholesteryl esters and phosphatidylcholine-contg. phospholipids were significantly increased in the kidneys of mice on a high-fat diet.  AMPK activation with chronic AICAR treatment prevented the clin. and structural effects of high-fat diet.  Thus, high-fat diet contributes to a dysfunction of the lysosomal system and altered lipid metab. characterized by cholesterol and phospholipid accumulation in the kidney.  AMPK activation normalizes the changes in renal lipid content despite chronic exposure to lipid challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVVBeeRcEQSbVg90H21EOLACvtfcHk0lhoua4UuIaGLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqsLvJ&md5=64ea7fda54ac5822f19081d2d96c8846</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fki.2013.462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2013.462%26sid%3Dliteratum%253Aachs%26aulast%3DDecleves%26aufirst%3DA.%2BE.%26aulast%3DZolkipli%26aufirst%3DZ.%26aulast%3DSatriano%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DRogac%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DT.%2BP.%26aulast%3DNortier%26aufirst%3DJ.%2BL.%26aulast%3DFarquhar%26aufirst%3DM.%2BG.%26aulast%3DNaviaux%26aufirst%3DR.%2BK.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DRegulation%2520of%2520lipid%2520accumulation%2520by%2520AMP-activated%2520kinase%2520%255Bcorrected%255D%2520in%2520high%2520fat%2520diet-induced%2520kidney%2520injury%26jtitle%3DKidney%2520Int.%26date%3D2014%26volume%3D85%26spage%3D611%26epage%3D623%26doi%3D10.1038%2Fki.2013.462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0ljYPCHXbVOJPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClean, S.</span></span> <span> </span><span class="NLM_article-title">An improved method for the determination of distribution coefficients</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">144</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.1990.tb05373.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1111%2Fj.2042-7158.1990.tb05373.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1972404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=144&author=D.+Stopherauthor=S.+McClean&title=An+improved+method+for+the+determination+of+distribution+coefficients&doi=10.1111%2Fj.2042-7158.1990.tb05373.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for the determination of distribution coefficients</span></div><div class="casAuthors">Stopher, David; McClean, Siobhan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The traditional shake flash method for measuring the distribution coeff. (D) of drugs (Leo et al., 1971) was modified to minimize the amt. of compd. required by employing HPLC to detn. the concn. of the compd. in the octanol and buffer phases.  The HPLC employed a reverse-phase Spherisorb octyl column with a mobile phase of MeOH-ammonium phosphate 0.01 M, pH 7.  The method was validated using drugs with a range of log D values of -2 to 4.  The method is suitable for rapid evaluation of the compds. since it decreases errors due to any impurities present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodB1AZ9RwrrLVg90H21EOLACvtfcHk0ljYPCHXbVOJPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D&md5=4d4ab2e9a04d54dbb868cb1b212e8e55</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1990.tb05373.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1990.tb05373.x%26sid%3Dliteratum%253Aachs%26aulast%3DStopher%26aufirst%3DD.%26aulast%3DMcClean%26aufirst%3DS.%26atitle%3DAn%2520improved%2520method%2520for%2520the%2520determination%2520of%2520distribution%2520coefficients%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1990%26volume%3D42%26spage%3D144%26doi%3D10.1111%2Fj.2042-7158.1990.tb05373.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genung, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jatkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhok, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cialdea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreeger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coskran, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opsahl, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolph, T.</span></span> <span> </span><span class="NLM_article-title">Selective activation of AMPK β1-containing isoforms improves kidney function in a rat model of diabetic nephropathy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.237925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fjpet.116.237925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=28289077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOqtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2017&pages=303-311&author=C.+T.+Salattoauthor=R.+A.+Millerauthor=K.+O.+Cameronauthor=E.+Cokorinosauthor=A.+Reyesauthor=J.+Wardauthor=M.+F.+Calabreseauthor=R.+G.+Kurumbailauthor=F.+Rajamohanauthor=A.+S.+Kalgutkarauthor=D.+A.+Tessauthor=A.+Shavnyaauthor=N.+E.+Genungauthor=D.+J.+Edmondsauthor=A.+Jatkarauthor=B.+S.+Maciejewskiauthor=M.+Amaroauthor=H.+Gandhokauthor=M.+Monettiauthor=K.+Cialdeaauthor=E.+Bollingerauthor=J.+M.+Kreegerauthor=T.+M.+Coskranauthor=A.+C.+Opsahlauthor=G.+G.+Boucherauthor=M.+J.+Birnbaumauthor=P.+DaSilva-Jardineauthor=T.+Rolph&title=Selective+activation+of+AMPK+%CE%B21-containing+isoforms+improves+kidney+function+in+a+rat+model+of+diabetic+nephropathy&doi=10.1124%2Fjpet.116.237925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of AMPK β1-containing isoforms improves kidney function in a rat model of diabetic nephropathy</span></div><div class="casAuthors">Salatto, Christopher T.; Miller, Russell A.; Cameron, Kimberly O.; Cokorinos, Emily; Reyes, Allan; Ward, Jessica; Calabrese, Matthew F.; Kurumbail, Ravi G.; Rajamohan, Francis; Kalgutkar, Amit S.; Tess, David A.; Shavnya, Andre; Genung, Nathan E.; Edmonds, David J.; Jatkar, Aditi; Maciejewski, Benjamin S.; Amaro, Marina; Gandhok, Harmeet; Monetti, Mara; Cialdea, Katherine; Bollinger, Eliza; Kreeger, John M.; Coskran, Timothy M.; Opsahl, Alan C.; Boucher, Germaine G.; Birnbaum, Morris J.; Da Silva-Jardine, Paul; Rolph, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-311, S1-S33</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Diabetic nephropathy remains an area of high unmet medical need, with current therapies that slow down, but do not prevent, the progression of disease.  A reduced phosphorylation state of adenosine monophosphate-activated protein kinase (AMPK) has been correlated with diminished kidney function in both humans and animal models of renal disease.  Here, we describe the identification of novel, potent, small mol. activators of AMPK that selectively activate AMPK heterotrimers contg. the β1 subunit.  After confirming that human and rodent kidney predominately express AMPK β1, we explore the effects of pharmacol. activation of AMPK in the ZSF1 rat model of diabetic nephropathy.  Chronic administration of these direct activators elevates the phosphorylation of AMPK in the kidney, without impacting blood glucose levels, and reduces the progression of proteinuria to a greater degree than the current std. of care, angiotensin-converting enzyme inhibitor ramipril.  Further analyses of urine biomarkers and kidney tissue gene expression reveal AMPK activation leads to the modulation of multiple pathways implicated in kidney injury, including cellular hypertrophy, fibrosis, and oxidative stress.  These results support the need for further investigation into the potential beneficial effects of AMPK activation in kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps8STmG-nZsrVg90H21EOLACvtfcHk0ljyWm-ZfnQdcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOqtb3E&md5=808a4036f5c55486c3d8f61beeb2faa4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237925%26sid%3Dliteratum%253Aachs%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DReyes%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DGenung%26aufirst%3DN.%2BE.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DJatkar%26aufirst%3DA.%26aulast%3DMaciejewski%26aufirst%3DB.%2BS.%26aulast%3DAmaro%26aufirst%3DM.%26aulast%3DGandhok%26aufirst%3DH.%26aulast%3DMonetti%26aufirst%3DM.%26aulast%3DCialdea%26aufirst%3DK.%26aulast%3DBollinger%26aufirst%3DE.%26aulast%3DKreeger%26aufirst%3DJ.%2BM.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DOpsahl%26aufirst%3DA.%2BC.%26aulast%3DBoucher%26aufirst%3DG.%2BG.%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DRolph%26aufirst%3DT.%26atitle%3DSelective%2520activation%2520of%2520AMPK%2520%25CE%25B21-containing%2520isoforms%2520improves%2520kidney%2520function%2520in%2520a%2520rat%2520model%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D361%26spage%3D303%26epage%3D311%26doi%3D10.1124%2Fjpet.116.237925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahasrabudhe, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoth, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subashi, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londregan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span> <span> </span><span class="NLM_article-title">Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1016/j.str.2014.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.str.2014.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=25066137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ags7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1161-1172&author=M.+F.+Calabreseauthor=F.+Rajamohanauthor=M.+S.+Harrisauthor=N.+L.+Caspersauthor=R.+Magyarauthor=J.+M.+Withkaauthor=H.+Wangauthor=K.+A.+Borzilleriauthor=P.+V.+Sahasrabudheauthor=L.+R.+Hothauthor=K.+F.+Geogheganauthor=S.+Hanauthor=J.+Brownauthor=T.+A.+Subashiauthor=A.+R.+Reyesauthor=R.+K.+Frisbieauthor=J.+Wardauthor=R.+A.+Millerauthor=J.+A.+Landroauthor=A.+T.+Londreganauthor=P.+A.+Carpinoauthor=S.+Cabralauthor=A.+C.+Smithauthor=E.+L.+Connauthor=K.+O.+Cameronauthor=X.+Qiuauthor=R.+G.+Kurumbail&title=Structural+basis+for+AMPK+activation%3A+natural+and+synthetic+ligands+regulate+kinase+activity+from+opposite+poles+by+different+molecular+mechanisms&doi=10.1016%2Fj.str.2014.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms</span></div><div class="casAuthors">Calabrese, Matthew F.; Rajamohan, Francis; Harris, Melissa S.; Caspers, Nicole L.; Magyar, Rachelle; Withka, Jane M.; Wang, Hong; Borzilleri, Kris A.; Sahasrabudhe, Parag V.; Hoth, Lise R.; Geoghegan, Kieran F.; Han, Seungil; Brown, Janice; Subashi, Timothy A.; Reyes, Allan R.; Frisbie, Richard K.; Ward, Jessica; Miller, Russell A.; Landro, James A.; Londregan, Allyn T.; Carpino, Philip A.; Cabral, Shawn; Smith, Aaron C.; Conn, Edward L.; Cameron, Kimberly O.; Qiu, Xiayang; Kurumbail, Ravi G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1161-1172</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a principal metabolic regulator affecting growth and response to cellular stress.  Comprised of catalytic and regulatory subunits, each present in multiple forms, AMPK is best described as a family of related enzymes.  In recent years, AMPK has emerged as a desirable target for modulation of numerous diseases, yet clin. therapies remain elusive.  Challenges result, in part, from an incomplete understanding of the structure and function of full-length heterotrimeric complexes.  In this work, we provide the full-length structure of the widely expressed α1β1γ1 isoform of mammalian AMPK, along with detailed kinetic and biophys. characterization.  We characterize binding of the broadly studied synthetic activator A769662 and its analogs.  Our studies follow on the heels of the recent disclosure of the α2β1γ1 structure and provide insight into the distinct mol. mechanisms of AMPK regulation by AMP and A769662.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFqyeOwFToerVg90H21EOLACvtfcHk0liST0pyL0x7oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ags7bM&md5=8a4edd6c5ff990d9e4c7e0cb16b7b873</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2014.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2014.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DM.%2BS.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DMagyar%26aufirst%3DR.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DSahasrabudhe%26aufirst%3DP.%2BV.%26aulast%3DHoth%26aufirst%3DL.%2BR.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DSubashi%26aufirst%3DT.%2BA.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DLandro%26aufirst%3DJ.%2BA.%26aulast%3DLondregan%26aufirst%3DA.%2BT.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26atitle%3DStructural%2520basis%2520for%2520AMPK%2520activation%253A%2520natural%2520and%2520synthetic%2520ligands%2520regulate%2520kinase%2520activity%2520from%2520opposite%2520poles%2520by%2520different%2520molecular%2520mechanisms%26jtitle%3DStructure%26date%3D2014%26volume%3D22%26spage%3D1161%26epage%3D1172%26doi%3D10.1016%2Fj.str.2014.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haire, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of AMPK regulation by small molecule activators</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3017</span>, <span class="refDoi"> DOI: 10.1038/ncomms4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1038%2Fncomms4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=24352254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=3017&author=B.+Xiaoauthor=M.+J.+Sandersauthor=D.+Carmenaauthor=N.+J.+Brightauthor=L.+F.+Haireauthor=E.+Underwoodauthor=B.+R.+Patelauthor=R.+B.+Heathauthor=P.+A.+Walkerauthor=S.+Hallenauthor=F.+Giordanettoauthor=S.+R.+Martinauthor=D.+Carlingauthor=S.+J.+Gamblin&title=Structural+basis+of+AMPK+regulation+by+small+molecule+activators&doi=10.1038%2Fncomms4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of AMPK regulation by small molecule activators</span></div><div class="casAuthors">Xiao Bing; Sanders Matthew J; Heath Richard B; Carmena David; Bright Nicola J; Patel Bhakti R; Carling David; Haire Lesley F; Underwood Elizabeth; Walker Philip A; Martin Stephen R; Gamblin Steven J; Hallen Stefan; Giordanetto Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP.  Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase.  AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer.  A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK.  Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components.  The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK.  Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp1w2ofyr07jXfW6udTcc2eZirxM9HpLCY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D&md5=b261b7498514e258ea6ec99a34d04794</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fncomms4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4017%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DM.%2BJ.%26aulast%3DCarmena%26aufirst%3DD.%26aulast%3DBright%26aufirst%3DN.%2BJ.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DB.%2BR.%26aulast%3DHeath%26aufirst%3DR.%2BB.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DHallen%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520AMPK%2520regulation%2520by%2520small%2520molecule%2520activators%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D3017%26doi%3D10.1038%2Fncomms4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckett, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liljevald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohlooly-Y, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span> <span> </span><span class="NLM_article-title">Liver-specific activation of AMPK prevents steatosis on a high-fructose diet</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3043</span>– <span class="NLM_lpage">3051</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2017.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.celrep.2017.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=28355557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt12ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=3043-3051&author=A.+Woodsauthor=J.+R.+Williamsauthor=P.+J.+Muckettauthor=F.+V.+Mayerauthor=M.+Liljevaldauthor=M.+Bohlooly-Yauthor=D.+Carling&title=Liver-specific+activation+of+AMPK+prevents+steatosis+on+a+high-fructose+diet&doi=10.1016%2Fj.celrep.2017.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet</span></div><div class="casAuthors">Woods, Angela; Williams, Jennet R.; Muckett, Phillip J.; Mayer, Faith V.; Liljevald, Maria; Bohlooly-Y, Mohammad; Carling, David</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3043-3051</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a key role in integrating metabolic pathways in response to energy demand.  We identified a mutation in the γ1 subunit (γ1D316A) that leads to activation of AMPK.  We generated mice with this mutation to study the effect of chronic liver-specific activation of AMPK in vivo.  Primary hepatocytes isolated from these mice have reduced gluconeogenesis and fatty acid synthesis, but there is no effect on fatty acid oxidn. compared to cells from wild-type mice.  Liver-specific activation of AMPK decreases lipogenesis in vivo and completely protects against hepatic steatosis when mice are fed a high-fructose diet.  Our findings demonstrate that liver-specific activation of AMPK is sufficient to protect against hepatic triglyceride accumulation, a hallmark of non-alc. fatty liver disease (NAFLD).  These results emphasize the clin. relevance of activating AMPK in the liver to combat NAFLD and potentially other assocd. complications (e.g., cirrhosis and hepatocellular carcinoma).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgaNUehVkO_bVg90H21EOLACvtfcHk0lhJpaVgdDuXfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt12ru7k%253D&md5=5ebec7dea0a82251bcc4f120e1e8ff03</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2017.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2017.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DJ.%2BR.%26aulast%3DMuckett%26aufirst%3DP.%2BJ.%26aulast%3DMayer%26aufirst%3DF.%2BV.%26aulast%3DLiljevald%26aufirst%3DM.%26aulast%3DBohlooly-Y%26aufirst%3DM.%26aulast%3DCarling%26aufirst%3DD.%26atitle%3DLiver-specific%2520activation%2520of%2520AMPK%2520prevents%2520steatosis%2520on%2520a%2520high-fructose%2520diet%26jtitle%3DCell%2520Rep.%26date%3D2017%26volume%3D18%26spage%3D3043%26epage%3D3051%26doi%3D10.1016%2Fj.celrep.2017.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esquejo, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moccia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peloquin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barricklow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreeger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opsahl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span> <span> </span><span class="NLM_article-title">Activation of liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2018.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.ebiom.2018.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=29673898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADC%252BC1MjksFCquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=122-132&author=R.+M.+Esquejoauthor=C.+T.+Salattoauthor=J.+Delmoreauthor=B.+Albuquerqueauthor=A.+Reyesauthor=Y.+Shiauthor=R.+Mocciaauthor=E.+Cokorinosauthor=M.+Peloquinauthor=M.+Monettiauthor=J.+Barricklowauthor=E.+Bollingerauthor=B.+K.+Smithauthor=E.+A.+Dayauthor=C.+Nguyenauthor=K.+F.+Geogheganauthor=J.+M.+Kreegerauthor=A.+Opsahlauthor=J.+Wardauthor=A.+S.+Kalgutkarauthor=D.+Tessauthor=L.+Butlerauthor=N.+Shiraiauthor=T.+F.+Osborneauthor=G.+R.+Steinbergauthor=M.+J.+Birnbaumauthor=K.+O.+Cameronauthor=R.+A.+Miller&title=Activation+of+liver+AMPK+with+PF-06409577+corrects+NAFLD+and+lowers+cholesterol+in+rodent+and+primate+preclinical+models&doi=10.1016%2Fj.ebiom.2018.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models</span></div><div class="casAuthors">Esquejo Ryan M; Salatto Christopher T; Delmore Jake; Albuquerque Bina; Reyes Allan; Shi Yuji; Cokorinos Emily; Peloquin Matthew; Monetti Mara; Bollinger Eliza; Ward Jessica; Birnbaum Morris J; Moccia Rob; Barricklow Jason; Smith Brennan K; Day Emily A; Steinberg Gregory R; Nguyen Chuong; Geoghegan Kieran F; Kreeger John M; Opsahl Alan; Butler Lynne; Shirai Norimitsu; Kalgutkar Amit S; Tess David; Osborne Timothy F; Cameron Kimberly O; Miller Russell A</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">122-132</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dysregulation of hepatic lipid and cholesterol metabolism is a significant contributor to cardiometabolic health, resulting in excessive liver lipid accumulation and ultimately non-alcoholic steatohepatitis (NASH).  Therapeutic activators of the AMP-Activated Protein Kinase (AMPK) have been proposed as a treatment for metabolic diseases; we show that the AMPK β1-biased activator PF-06409577 is capable of lowering hepatic and systemic lipid and cholesterol levels in both rodent and monkey preclinical models.  PF-06409577 is able to inhibit de novo lipid and cholesterol synthesis pathways, and causes a reduction in hepatic lipids and mRNA expression of markers of hepatic fibrosis.  These effects require AMPK activity in the hepatocytes.  Treatment of hyperlipidemic rats or cynomolgus monkeys with PF-06409577 for 6weeks resulted in a reduction in circulating cholesterol.  Together these data suggest that activation of AMPK β1 complexes with PF-06409577 is capable of impacting multiple facets of liver disease and represents a promising strategy for the treatment of NAFLD and NASH in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKwo8-BMi-wmxpATR2EQURfW6udTcc2eZd_enlo01s4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MjksFCquw%253D%253D&md5=b566de696f76e623975433c49ea94ddf</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2018.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2018.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DEsquejo%26aufirst%3DR.%2BM.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DDelmore%26aufirst%3DJ.%26aulast%3DAlbuquerque%26aufirst%3DB.%26aulast%3DReyes%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DMoccia%26aufirst%3DR.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DPeloquin%26aufirst%3DM.%26aulast%3DMonetti%26aufirst%3DM.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DBollinger%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DB.%2BK.%26aulast%3DDay%26aufirst%3DE.%2BA.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DKreeger%26aufirst%3DJ.%2BM.%26aulast%3DOpsahl%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DTess%26aufirst%3DD.%26aulast%3DButler%26aufirst%3DL.%26aulast%3DShirai%26aufirst%3DN.%26aulast%3DOsborne%26aufirst%3DT.%2BF.%26aulast%3DSteinberg%26aufirst%3DG.%2BR.%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26atitle%3DActivation%2520of%2520liver%2520AMPK%2520with%2520PF-06409577%2520corrects%2520NAFLD%2520and%2520lowers%2520cholesterol%2520in%2520rodent%2520and%2520primate%2520preclinical%2520models%26jtitle%3DEBioMedicine%26date%3D2018%26volume%3D31%26spage%3D122%26epage%3D132%26doi%3D10.1016%2Fj.ebiom.2018.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malik, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lal, J.</span></span> <span> </span><span class="NLM_article-title">Role of enterohepatic recirculation in drug disposition: cooperation and complications</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.3109/03602532.2016.1157600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.3109%2F03602532.2016.1157600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=26987379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVeksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=281-327&author=M.+Y.+Malikauthor=S.+Jaiswalauthor=A.+Sharmaauthor=M.+Shuklaauthor=J.+Lal&title=Role+of+enterohepatic+recirculation+in+drug+disposition%3A+cooperation+and+complications&doi=10.3109%2F03602532.2016.1157600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Role of enterohepatic recirculation in drug disposition: cooperation and complications</span></div><div class="casAuthors">Malik, Mohd Yaseen; Jaiswal, Swati; Sharma, Abhisheak; Shukla, Mahendra; Lal, Jawahar</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-327</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Enterohepatic recirculation (EHC) concerns many physiol. processes and notably affects pharmacokinetic parameters such as plasma half-life and AUC as well as ests. of bioavailability of drugs.  Also, EHC plays a detrimental role as the compds./drugs are allowed to recycle.  An in-depth comprehension of this phenomenon and its consequences on the pharmacol. effects of affected drugs is important and decisive in the design and development of new candidate drugs.  EHC of a compd./drug occurs by biliary excretion and intestinal reabsorption, sometimes with hepatic conjugation and intestinal deconjugation.  EHC leads to prolonged elimination half-life of the drugs, altered pharmacokinetics and pharmacodynamics.  Study of the EHC of any drug is complicated due to unavailability of the apposite model, sophisticated procedures and ethical concerns.  Different in vitro and in vivo methods for studies in exptl. animals and humans have been devised, each having its own merits and demerits.  Involvement of the different transporters in biliary excretion, intra- and inter-species, pathol. and biochem. variabilities obscure the study of the phenomenon.  Modeling of drugs undergoing EHC has always been intricate and exigent models have been exploited to interpret the pharmacokinetic profiles of drugs witnessing multiple peaks due to EHC.  Here, we critically appraise the mechanisms of bile formation, factors affecting biliary drug elimination, methods to est. biliary excretion of drugs, EHC, multiple peak phenomenon and its modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAGytBPJXE3bVg90H21EOLACvtfcHk0liuqQhSyw8S1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVeksbc%253D&md5=35a26554595b10c65b4533da62c02e92</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.3109%2F03602532.2016.1157600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602532.2016.1157600%26sid%3Dliteratum%253Aachs%26aulast%3DMalik%26aufirst%3DM.%2BY.%26aulast%3DJaiswal%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DShukla%26aufirst%3DM.%26aulast%3DLal%26aufirst%3DJ.%26atitle%3DRole%2520of%2520enterohepatic%2520recirculation%2520in%2520drug%2520disposition%253A%2520cooperation%2520and%2520complications%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2016%26volume%3D48%26spage%3D281%26epage%3D327%26doi%3D10.3109%2F03602532.2016.1157600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fagerholm, U.</span></span> <span> </span><span class="NLM_article-title">Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1211/jpp.60.5.0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1211%2Fjpp.60.5.0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=18416932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlemsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=535-542&author=U.+Fagerholm&title=Prediction+of+human+pharmacokinetics-biliary+and+intestinal+clearance+and+enterohepatic+circulation&doi=10.1211%2Fjpp.60.5.0001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation</span></div><div class="casAuthors">Fagerholm, Urban</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">535-542</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review.  The main objective was to evaluate and propose methods for predicting biliary clearance (CLbile) and enterohepatic circulation (EHC) of intact drugs in man.  Another aim was to evaluate to role of intestinal drug secretion and propose a method for prediction of intestinal secretion CL (CLi).  Animal data poorly predict the CL and CLbile of biliary excreted drugs, and the suggested mol. wt. threshold for bile excretion as the dominant elimination route does not seem to hold.  Active transport, low metabolic intrinsic CL (CLint) and, as an approxn., permeability (Pe) less than that of metoprolol is required for substantial CLbile to occur.  The typical EHC plasma concn. vs time profile (multiple peaks) is demonstrated for many low metabolic CLint-compds. with efflux and moderate to high intestinal Pe and fraction absorbed.  Physiol.-based in-vitro to in-vivo (PB-IVIV) methodol. with in-vitro intrinsic CLbile-data obtained with sandwich-cultured human hepatocytes has generated 2- and 5-fold underpredictions for two compds. with intermediate to high CLbile.  This is despite not considering the unbound fraction.  Possible explanations include low transporter activity and diffusion limitations in the in-vitro expts.  Intestinal resorption and EHC were also neglected in these predictions and in-vivo CLbile estns.  The sandwich model and these ref. data are still very useful.  Consideration of an empirical scaling factor and a newly developed approach that accounts for intestinal resorption and EHC could potentially lead to improved PB-IVIV predictions of CLbile.  Apparently, no attempts have been made to predict CLi.  Elimination via the intestinal route does not appear to be of great importance for the few compds. with available data, but could be equally as important as bile excretion.  Net secretion in-vitro Pe and newly estd. in-vivo intrinsic CLi data for digoxin and rosuvastatin could be useful for approxn. of CLi of other compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppqKJMNxNjALVg90H21EOLACvtfcHk0liuqQhSyw8S1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlemsbc%253D&md5=d51f46d7d87d64e6c4f4479821895526</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1211%2Fjpp.60.5.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.60.5.0001%26sid%3Dliteratum%253Aachs%26aulast%3DFagerholm%26aufirst%3DU.%26atitle%3DPrediction%2520of%2520human%2520pharmacokinetics-biliary%2520and%2520intestinal%2520clearance%2520and%2520enterohepatic%2520circulation%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2008%26volume%3D60%26spage%3D535%26epage%3D542%26doi%3D10.1211%2Fjpp.60.5.0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagas, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparidans, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagenaar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1124/mol.109.062364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fmol.109.062364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=20086033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVyku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=687-694&author=J.+S.+Lagasauthor=R.+W.+Sparidansauthor=E.+Wagenaarauthor=J.+H.+Beijnenauthor=A.+H.+Schinkel&title=Hepatic+clearance+of+reactive+glucuronide+metabolites+of+diclofenac+in+the+mouse+is+dependent+on+multiple+ATP-binding+cassette+efflux+transporters&doi=10.1124%2Fmol.109.062364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters</span></div><div class="casAuthors">Lagas, Jurjen S.; Sparidans, Rolf W.; Wagenaar, Els; Beijnen, Jos H.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-694</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Diclofenac is an important analgesic and anti-inflammatory drug that is widely used for the treatment of postoperative pain, rheumatoid arthritis, and chronic pain assocd. with cancer.  Diclofenac is extensively metabolized in the liver, and the main metabolites are hydroxylated and/or glucuronidated conjugates.  We show here that loss of multidrug resistance protein 2 (MRP2/ABCC2) and breast cancer resistance protein (BCRP/ABCG2) in mice results in highly increased plasma levels of diclofenac acyl glucuronide, after both oral and i.v. administration.  The absence of Mrp2 and Bcrp1, localized at the canalicular membrane of hepatocytes, leads to impaired biliary excretion of acyl glucuronides and consequently to elevated liver and plasma levels.  Mrp2 also mediates the biliary excretion of two hydroxylated diclofenac metabolites, 4'-hydroxydiclofenac and 5-hydroxydiclofenac.  We further show that the sinusoidal efflux of diclofenac acyl glucuronide, from liver to blood, is largely dependent on multidrug resistance protein 3 (MRP3/ABCC3).  Diclofenac acyl glucuronides are chem. instable and reactive, and in patients, these metabolites are assocd. with rare but serious idiosyncratic liver toxicity.  This might explain why Mrp2/Mrp3/Bcrp1(-/-) mice, which have markedly elevated levels of diclofenac acyl glucuronides in their liver, display acute, albeit very mild, hepatotoxicity.  We believe that the handling of diclofenac acyl glucuronides by ATP binding cassette transporters may be representative for the handling of acyl glucuronide metabolites of many other clin. relevant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7hz__m1sE7LVg90H21EOLACvtfcHk0liYP1VKSV4GHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVyku7o%253D&md5=3f943eaaded06e34a7c3ccf0a3c09a5f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.062364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.062364%26sid%3Dliteratum%253Aachs%26aulast%3DLagas%26aufirst%3DJ.%2BS.%26aulast%3DSparidans%26aufirst%3DR.%2BW.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DHepatic%2520clearance%2520of%2520reactive%2520glucuronide%2520metabolites%2520of%2520diclofenac%2520in%2520the%2520mouse%2520is%2520dependent%2520on%2520multiple%2520ATP-binding%2520cassette%2520efflux%2520transporters%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D687%26epage%3D694%26doi%3D10.1124%2Fmol.109.062364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, J.</span></span> <span> </span><span class="NLM_article-title">Hepatic secretion of conjugated drugs and endogenous substances</span>. <i>Semin. Liver Dis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1055/s-2000-9391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1055%2Fs-2000-9391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11076395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVOmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=265-272&author=D.+Kepplerauthor=J.+K%C3%B6nig&title=Hepatic+secretion+of+conjugated+drugs+and+endogenous+substances&doi=10.1055%2Fs-2000-9391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic secretion of conjugated drugs and endogenous substances</span></div><div class="casAuthors">Keppler, Dietrich; Konig, Jorg</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Liver Disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-272</span>CODEN:
                <span class="NLM_cas:coden">SLDIEE</span>;
        ISSN:<span class="NLM_cas:issn">0272-8087</span>.
    
            (<span class="NLM_cas:orgname">Thieme Medical Publishers, Inc.</span>)
        </div><div class="casAbstract">A review is given with 81 refs. on the role of multidrug resistance protein (MRP) family members in the hepatocellular secretion of anionic substances formed in the conjugation phase.  Xenobiotic and endogenous lipophilic substances may be conjugated with glutathione, glucuronate, sulfate, or other neg. charged groups and thus become substrates for export pumps of the MRP family.  The apical isoform, MRP2 (gene symbol ABCC2), was localized to the apical membrane of several polarized epithelia and particularly to the canalicular membrane of hepatocytes.  Absence of functionally active MRP2 glycoprotein from this membrane domain prevents the secretion of many anionic conjugates into bile.  Prototypic endogenous substrates of high affinity for recombinant human MRP2 include bisglucuronosyl bilirubin, monoglucuronosyl bilirubin, and the glutathione S-conjugate leukotriene C4.  Several mutations in the human MRP2 gene were identified that lead to the absence of MRP2 from the canalicular membrane and to the conjugated hyperbilirubinemia of Dubin-Johnson syndrome.  MRP2-mediated conjugate export represents a decisive final step in the detoxification of drugs, toxins, and endogenous substances.  The basolateral isoform, MRP3 (gene symbol ABCC3), is upregulated in MRP2 deficiency and in extrahepatic cholestasis.  MRP3 mediates the ATP-dependent transport of anionic conjugates, particularly of glucuronides and sulfoconjugates, across the basolateral hepatocyte membrane into sinusoidal blood.  The inverse regulation of MRP3 and MRP2 expression under many conditions is consistent with their distinct localization and with a compensatory role of MRP3 in the hepatic secretion of anionic conjugates during impaired transport into bile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfEeDwhncV47Vg90H21EOLACvtfcHk0liYP1VKSV4GHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVOmurw%253D&md5=e6512080940457af12f15b03ecfcdfb1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-9391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-9391%26sid%3Dliteratum%253Aachs%26aulast%3DKeppler%26aufirst%3DD.%26aulast%3DK%25C3%25B6nig%26aufirst%3DJ.%26atitle%3DHepatic%2520secretion%2520of%2520conjugated%2520drugs%2520and%2520endogenous%2520substances%26jtitle%3DSemin.%2520Liver%2520Dis.%26date%3D2000%26volume%3D20%26spage%3D265%26epage%3D272%26doi%3D10.1055%2Fs-2000-9391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stachulski, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindon, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. D.</span></span> <span> </span><span class="NLM_article-title">Acyl glucuronides: biological activity, chemical reactivity, and chemical synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6931</span>– <span class="NLM_lpage">6945</span>, <span class="refDoi"> DOI: 10.1021/jm060599z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060599z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Gls7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6931-6945&author=A.+V.+Stachulskiauthor=J.+R.+Hardingauthor=J.+C.+Lindonauthor=J.+L.+Maggsauthor=B.+K.+Parkauthor=I.+D.+Wilson&title=Acyl+glucuronides%3A+biological+activity%2C+chemical+reactivity%2C+and+chemical+synthesis&doi=10.1021%2Fjm060599z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Acyl Glucuronides: Biological Activity, Chemical Reactivity, and Chemical Synthesis</span></div><div class="casAuthors">Stachulski, Andrew V.; Harding, John R.; Lindon, John C.; Maggs, James L.; Park, B. Kevin; Wilson, Ian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6931-6945</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the synthesis, chem. reactivity with biomols. and anal. technol. for their detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGPGlj0fHykrVg90H21EOLACvtfcHk0liYP1VKSV4GHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Gls7jP&md5=b5bc088699cbd60c78ac52d79c634f59</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm060599z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060599z%26sid%3Dliteratum%253Aachs%26aulast%3DStachulski%26aufirst%3DA.%2BV.%26aulast%3DHarding%26aufirst%3DJ.%2BR.%26aulast%3DLindon%26aufirst%3DJ.%2BC.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26atitle%3DAcyl%2520glucuronides%253A%2520biological%2520activity%252C%2520chemical%2520reactivity%252C%2520and%2520chemical%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6931%26epage%3D6945%26doi%3D10.1021%2Fjm060599z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stachulski, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span> <span> </span><span class="NLM_article-title">Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">806</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1039/c3np70003h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1039%2Fc3np70003h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=23648894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1ahsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=806-848&author=A.+V.+Stachulskiauthor=X.+Meng&title=Glucuronides+from+metabolites+to+medicines%3A+a+survey+of+the+in+vivo+generation%2C+chemical+synthesis+and+properties+of+glucuronides&doi=10.1039%2Fc3np70003h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides</span></div><div class="casAuthors">Stachulski, Andrew V.; Meng, Xiaoli</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">806-848</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The fourteen years that have passed since the previous review on this topic have seen a significant increase of interest in many aspects of glucuronide chem. and biol.  Glucuronides are the most important class of phase 2 xenobiotic metabolites and typically act in a detoxifying role.  While this is generally true for O-alkyl and O-aryl glucuronides, a no. of glucuronides are known to be pharmacol. active per se.  Addnl. the use of glucuronide prodrugs, notably to ameliorate the cytotoxicity of anticancer agents, has markedly increased.  Whereas the previous review covered only the synthesis of O-glucuronides, we now include N-, S- and C-glucuronides also and discuss both synthetic and biol. aspects.  Synthetic methods for all classes of glucuronides are reviewed and updated, together with advances in the enzymic synthesis of glucuronides and methods for their detection.  Finally we discuss the biol. reactivity of glucuronides where known, including the important morphine-6-glucuronide.  A lively debate has continued for several years on whether O-acyl glucuronide metabolites of carboxylic acids are toxic, affecting both the safety assessment of well-used drugs and new drug development programs.  We summarise the current understanding, together with other known examples of interaction between glucuronides and macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwzUgkR4b3vLVg90H21EOLACvtfcHk0litrODM9hRQuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1ahsrg%253D&md5=ff61864421447aaf55fec7ffec1e9ee2</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1039%2Fc3np70003h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3np70003h%26sid%3Dliteratum%253Aachs%26aulast%3DStachulski%26aufirst%3DA.%2BV.%26aulast%3DMeng%26aufirst%3DX.%26atitle%3DGlucuronides%2520from%2520metabolites%2520to%2520medicines%253A%2520a%2520survey%2520of%2520the%2520in%2520vivo%2520generation%252C%2520chemical%2520synthesis%2520and%2520properties%2520of%2520glucuronides%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2013%26volume%3D30%26spage%3D806%26epage%3D848%26doi%3D10.1039%2Fc3np70003h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, T.</span></span> <span> </span><span class="NLM_article-title">Physiological parameters in laboratory animals and humans</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1093</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1023/A:1018943613122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1023%2FA%3A1018943613122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=8378254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=1093-1095&author=B.+Daviesauthor=T.+Morris&title=Physiological+parameters+in+laboratory+animals+and+humans&doi=10.1023%2FA%3A1018943613122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological parameters in laboratory animals and humans</span></div><div class="casAuthors">Davies B; Morris T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-5</span>
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDDwka3A6hEYYPsCkJIw00fW6udTcc2eaQFQIc-D-mH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D&md5=094cdd17306b58cc17c8cf4fd5db9927</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018943613122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018943613122%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%26atitle%3DPhysiological%2520parameters%2520in%2520laboratory%2520animals%2520and%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D1093%26epage%3D1095%26doi%3D10.1023%2FA%3A1018943613122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Safety assessment of acyl glucuronides – A simplified paradigm</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">912</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.080515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1124%2Fdmd.118.080515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=29559442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWltrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=908-912&author=D.+A.+Smithauthor=T.+Hammondauthor=T.+A.+Baillie&title=Safety+assessment+of+acyl+glucuronides+%E2%80%93+A+simplified+paradigm&doi=10.1124%2Fdmd.118.080515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Safety assessment of acyl glucuronides-a simplified paradigm</span></div><div class="casAuthors">Smith, Dennis A.; Hammond, Timothy; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">908-912</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">While simple O-(ether-linked) and N-glucuronide drug conjugates generally are unreactive and considered benign from a safety perspective, the acyl glucuronides that derive from metab. of carboxylic acid-contg. xenobiotics can exhibit a degree of chem. reactivity that is dependent upon their mol. structure.  As a result, concerns have arisen over the safety of acyl glucuronides as a class, several members of which have been implicated in the toxicity of their resp. parent drugs.  However, direct evidence in support of these claims remains sparse, and due to frequently encountered species differences in the systemic exposure to acyl glucuronides (both of the parent drug and oxidized derivs. thereof), coupled with their instability in aq. media and potential to undergo chem. rearrangement (acyl migration), qualification of these conjugates by traditional safety assessment methods can be very challenging.  In this Commentary, we discuss alternative (non-acyl glucuronide)mechanisms by which carboxylic acids may cause serious adverse reactions, and propose a novel, practical approach to compare systemic exposure to acyl glucuronide metabolites in humans to that in animal species used in preclin. safety assessment based on relative ests. of the total body burden of these circulating conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEevJPQ6waKbVg90H21EOLACvtfcHk0litrODM9hRQuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWltrnK&md5=bb4d99cdc5bf87751b6d796366ed7e46</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.080515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.080515%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DHammond%26aufirst%3DT.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DSafety%2520assessment%2520of%2520acyl%2520glucuronides%2520%25E2%2580%2593%2520A%2520simplified%2520paradigm%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26spage%3D908%26epage%3D912%26doi%3D10.1124%2Fdmd.118.080515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prueksaritanont, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Complicating factors in safety testing of drug metabolites: kinetic differences between generated and preformed metabolites</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2006.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2Fj.taap.2006.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=17055014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SmsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2006&pages=143-152&author=T.+Prueksaritanontauthor=J.+H.+Linauthor=T.+A.+Baillie&title=Complicating+factors+in+safety+testing+of+drug+metabolites%3A+kinetic+differences+between+generated+and+preformed+metabolites&doi=10.1016%2Fj.taap.2006.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Complicating factors in safety testing of drug metabolites: Kinetic differences between generated and preformed metabolites</span></div><div class="casAuthors">Prueksaritanont, Thomayant; Lin, Jiunn H.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-152</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  This paper aims to provide a scientifically based perspective on issues surrounding the proposed toxicol. testing of synthetic drug metabolites as a means of ensuring adequate nonclin. safety evaluation of drug candidates that generate metabolites considered either to be unique to humans or are present at much higher levels in humans than in preclin. species.  We put forward a no. of theor. considerations and present several specific examples where the kinetic behavior of a preformed metabolite given to animals or humans differs from that of the corresponding metabolite generated endogenously from its parent.  The potential ramifications of this phenomenon are that the results of toxicity testing of the preformed metabolite may be misleading and fail to characterize the true toxicol. contribution of the metabolite when formed from the parent.  It is anticipated that such complications would be evident in situations where (a) differences exist in the accumulation of the preformed vs. generated metabolites in specific tissues, and (b) the metabolite undergoes sequential metab. to a downstream product that is toxic, leading to differences in tissue-specific toxicity.  Owing to the complex nature of this subject, there is a need to treat drug metabolite issues in safety assessment on a case-by-case basis, in which a knowledge of metabolite kinetics is employed to validate exptl. paradigms that entail administration of preformed metabolites to animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS61bFOTELG7Vg90H21EOLACvtfcHk0liuv6Mcryj8rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SmsLbP&md5=e5482de97034be7ca31f884a7dd4aded</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2006.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2006.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DComplicating%2520factors%2520in%2520safety%2520testing%2520of%2520drug%2520metabolites%253A%2520kinetic%2520differences%2520between%2520generated%2520and%2520preformed%2520metabolites%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2006%26volume%3D217%26spage%3D143%26epage%3D152%26doi%3D10.1016%2Fj.taap.2006.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodnar, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inturrisi, C. E.</span></span> <span> </span><span class="NLM_article-title">Morphine-6-glucuroinde, a potent mu agonist</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2845</span>– <span class="NLM_lpage">2849</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(87)90431-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1016%2F0024-3205%2887%2990431-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1987&pages=2845-2849&author=G.+W.+Pasternakauthor=R.+J.+Bodnarauthor=J.+A.+Clarkauthor=C.+E.+Inturrisi&title=Morphine-6-glucuroinde%2C+a+potent+mu+agonist&doi=10.1016%2F0024-3205%2887%2990431-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2887%2990431-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252887%252990431-0%26sid%3Dliteratum%253Aachs%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26aulast%3DBodnar%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DJ.%2BA.%26aulast%3DInturrisi%26aufirst%3DC.%2BE.%26atitle%3DMorphine-6-glucuroinde%252C%2520a%2520potent%2520mu%2520agonist%26jtitle%3DLife%2520Sci.%26date%3D1987%26volume%3D41%26spage%3D2845%26epage%3D2849%26doi%3D10.1016%2F0024-3205%2887%2990431-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standifer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inturrisi, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>251</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=2810109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADyaK3cXmvFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1989&pages=477-483&author=D.+Paulauthor=K.+M.+Standiferauthor=C.+E.+Inturrisiauthor=G.+W.+Pasternak&title=Pharmacological+characterization+of+morphine-6+beta-glucuronide%2C+a+very+potent+morphine+metabolite"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite</span></div><div class="casAuthors">Paul, Dennis; Standifer, Kelly M.; Inturrisi, Charles E.; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">477-83</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Morphine 6β-glucuronide is a major metabolite of morphine with potent analgesic actions.  The analgesic actions of morphine and its 6β-glucuronide metabolite were compared in mice after peripheral and central administration.  Given s.c., morphine 6β-glucuronide elicited analgesia with an effect approx. twice that of morphine due to its long duration of action and also inhibited gastrointestinal motility.  Both actions were easily reversed by s.c. naloxone.  When injected intracerebroventricularly (i.c.v.) or intrathecally, morphine 6β-glucuronide was ∼90- and 650-fold more potent analgesic than morphine, resp.  Whereas morphine was equipotent at both levels of the central nervous system as an analgesic, the 6β-glucuronide was ∼5-fold more effective at the level of the spinal cord than supraspinally.  The μ1-selective antagonist naloxonazine blocked the analgesic effect of s.c. and i.c.v. morphine 6β-glucuronide much as it blocked morphine, implying a role for μ1-receptors in these actions.  Like morphine, morphine 6β-glucuronide analgesia after intrathecal injection was not sensitive to naloxonazine, suggesting a μ2 mechanism within the spinal cord.  Thus, morphine 6β-glucuronide elicited its analgesic actions through the same receptor mechanisms as morphine.  Mice highly tolerant to morphine after implantation of morphine pellets showed cross-tolerance to s.c. morphine 6β-glucuronide.  The high potency of morphine 6β-glucuronide strongly suggests that this metabolite plays an important role in morphine actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiGi1lWpdrPbVg90H21EOLACvtfcHk0liuv6Mcryj8rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmvFOktA%253D%253D&md5=a2397ae055be55ea31410dce506b966f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DStandifer%26aufirst%3DK.%2BM.%26aulast%3DInturrisi%26aufirst%3DC.%2BE.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DPharmacological%2520characterization%2520of%2520morphine-6%2520beta-glucuronide%252C%2520a%2520very%2520potent%2520morphine%2520metabolite%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D251%26spage%3D477%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lotsch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span> <span> </span><span class="NLM_article-title">Morphine-6-glucuronideL an analgesis of the future?</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.2165/00003088-200140070-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.2165%2F00003088-200140070-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=11510626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms1arsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=485-499&author=J.+Lotschauthor=G.+Geisslinger&title=Morphine-6-glucuronideL+an+analgesis+of+the+future%3F&doi=10.2165%2F00003088-200140070-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-6-glucuronide. An analgesic of the future?</span></div><div class="casAuthors">Lotsch, Jorn; Geisslinger, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">485-499</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Morphine-6-β-glucuronide (M6G) is an opioid agonist that plays a role in the clin. effects of morphine.  Although M6G probably crosses the blood-brain barrier with difficulty, during long-term morphine administration it may reach sufficiently high CNS concns. to exert clin. relevant opioid effects.  As a consequence of its almost exclusive renal elimination, M6G may accumulate in the body of patients with impaired renal function and cause severe opioid adverse effects with insidious onset and long persistence.  Its profile of receptor affinities, however, gives reason to speculate that M6G may exhibit analgesic effects while causing fewer adverse effects than morphine.  This is supported by reports of the good tolerability of intrathecal and i.v. injections of M6G in humans with intact renal function.  M6G may thus be contemplated as an analgesic for short-term postoperative analgesia, esp. for intrathecal analgesic therapy.  In addn., its possibly higher potency than morphine makes M6G a candidate opioid for local or peripheral analgesic therapy.  However, current knowledge is too incomplete to finally judge the clin. usefulness of M6G.  The next topics for clin. research on M6G should include: (1) a comparison of the potencies of M6G and morphine to cause wanted and unwanted clin. effects; (2) development of a predictive population pharmacokinetic-pharmacodynamic model of M6G with calcn. of the transfer half-life between plasma and effect site; and (3) identification of cofactors influencing the action of M6G that can serve as predictors for the clin. outcome of morphine/M6G therapy in an individual including the pharmacogenetics of M6G.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZmW_qkNVkbVg90H21EOLACvtfcHk0liLnt2J3QC4jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms1arsrc%253D&md5=8a32f45bbd7fdd65f4db19817160548a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2165%2F00003088-200140070-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200140070-00001%26sid%3Dliteratum%253Aachs%26aulast%3DLotsch%26aufirst%3DJ.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DMorphine-6-glucuronideL%2520an%2520analgesis%2520of%2520the%2520future%253F%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2001%26volume%3D40%26spage%3D485%26epage%3D499%26doi%3D10.2165%2F00003088-200140070-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klimas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikus, G.</span></span> <span> </span><span class="NLM_article-title">Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">944</span>, <span class="refDoi"> DOI: 10.1093/bja/aeu186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1093%2Fbja%2Faeu186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=24985077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Chtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2014&pages=935-944&author=R.+Klimasauthor=G.+Mikus&title=Morphine-6-glucuronide+is+responsible+for+the+analgesic+effect+after+morphine+administration%3A+a+quantitative+review+of+morphine%2C+morphine-6-glucuronide%2C+and+morphine-3-glucuronide&doi=10.1093%2Fbja%2Faeu186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6 glucuronide, and morphine-3-glucuronide</span></div><div class="casAuthors">Klimas, R.; Mikus, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">935-944</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">0007-0912</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Morphine-6-glucuronide (M6G) is a strong μ-receptor agonist with higher affinity than morphine itself.  It has been suggested that M6G contributes to the analgesic effect after administration of morphine, but the extent of its contribution remains unclear.  Methods: In order to elucidate the relative contribution of both drugs to the overall analgesic effect mediated by the μ-receptor, published data on μ-receptor binding, plasma protein binding, concns. [preferably area under the concn.-time curve (AUC)] of morphine and M6G in blood or cerebrospinal fluid (CSF), or concn. ratios were used to calc. free CSF concn. cor. for receptor binding for each compd.  To compare different routes of administration, free CSF concns. of M and M6G cor. for potency were added and compared with oral administration.  Results: Based on AUC data, there is a major contribution of M6G to the overall analgesic effect; the mean contributions being estd. as 96.6%, 85.6%, 85.4%, and 91.3% after oral, s.c., i.v., and rectal administration of morphine, resp.  In patients with renal insufficiency, 97.6% of the analgesic effect is caused by M6G when morphine is given orally.  Owing to accumulation of M6G over time in these patients, morphine may be regarded as a prodrug.  Conclusions: When administering morphine to patients, the analgesic effect is mainly caused by M6G instead of morphine itself, irresp. of the route of administration.  Therefore, the patient's kidney function plays a key role in detg. the optimal daily dose of morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7VNCqIHZXq7Vg90H21EOLACvtfcHk0liLnt2J3QC4jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Chtb8%253D&md5=293e3a2a1782649fa747d941a141cacc</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1093%2Fbja%2Faeu186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbja%252Faeu186%26sid%3Dliteratum%253Aachs%26aulast%3DKlimas%26aufirst%3DR.%26aulast%3DMikus%26aufirst%3DG.%26atitle%3DMorphine-6-glucuronide%2520is%2520responsible%2520for%2520the%2520analgesic%2520effect%2520after%2520morphine%2520administration%253A%2520a%2520quantitative%2520review%2520of%2520morphine%252C%2520morphine-6-glucuronide%252C%2520and%2520morphine-3-glucuronide%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2014%26volume%3D113%26spage%3D935%26epage%3D944%26doi%3D10.1093%2Fbja%2Faeu186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luffer-Atlas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrakchi, A.</span></span> <span> </span><span class="NLM_article-title">A decade of drug metabolite safety testing: industry and regulatory shared learning</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1364362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1080%2F17425255.2017.1364362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=28797172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A280%3ADC%252BC1cfmsVyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=897-900&author=D.+Luffer-Atlasauthor=A.+Atrakchi&title=A+decade+of+drug+metabolite+safety+testing%3A+industry+and+regulatory+shared+learning&doi=10.1080%2F17425255.2017.1364362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of drug metabolite safety testing: industry and regulatory shared learning</span></div><div class="casAuthors">Luffer-Atlas Debra; Atrakchi Aisar</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug metabolism & toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">897-900</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvghRhWF_WzhdUSIfHIn4FfW6udTcc2ebNfYsY1iB_x7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfmsVyhsg%253D%253D&md5=fa9aacec75b7772338c9863d413bb093</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1364362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1364362%26sid%3Dliteratum%253Aachs%26aulast%3DLuffer-Atlas%26aufirst%3DD.%26aulast%3DAtrakchi%26aufirst%3DA.%26atitle%3DA%2520decade%2520of%2520drug%2520metabolite%2520safety%2520testing%253A%2520industry%2520and%2520regulatory%2520shared%2520learning%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26spage%3D897%26epage%3D900%26doi%3D10.1080%2F17425255.2017.1364362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roversi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2221</span>, <span class="refDoi"> DOI: 10.1107/S0907444904016427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1107%2FS0907444904016427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=15572774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2210-2221&author=E.+Blancauthor=P.+Roversiauthor=C.+Vonrheinauthor=C.+Flensburgauthor=S.+M.+Leaauthor=G.+Bricogne&title=Refinement+of+severely+incomplete+structures+with+maximum+likelihood+in+BUSTER-TNT&doi=10.1107%2FS0907444904016427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT</span></div><div class="casAuthors">Blanc, E.; Roversi, P.; Vonrhein, C.; Flensburg, C.; Lea, S. M.; Bricogne, G.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2210-2221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">BUSTER-TNT is a max.-likelihood macromol. refinement package.  BUSTER assembles the structural model, scales obsd. and calcd. structure-factor amplitudes and computes the model likelihood, while TNT handles the stereochem. and NCS restraints/constraints and shifts the at. coordinates, B factors and occupancies.  In real space, in addn. to the traditional at. and bulk-solvent models, BUSTER models the parts of the structure for which an at. model is not yet available ('missing structure') as low-resoln. probability distributions for the random positions of the missing atoms.  In reciprocal space, the BUSTER structure-factor distribution in the complex plane is a two-dimensional Gaussian centered around the structure factor calcd. from the at., bulk-solvent and missing-structure models.  The errors assocd. with these three structural components are added to compute the overall spread of the Gaussian.  When the at. model is very incomplete, modeling of the missing structure and the consistency of the BUSTER statistical model help structure building and completion because (i) the accuracy of the overall scale factors is increased, (ii) the bias affecting at. model refinement is reduced by accounting for some of the scattering from the missing structure, (iii) the addn. of a spatial definition to the source of incompleteness improves on traditional Luzzati and σA-based error models and (iv) the program can perform selective d. modification in the regions of unbuilt structure alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0psykpyEUoLVg90H21EOLACvtfcHk0lgs0T-Du1vapg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars7rO&md5=6ea77dcafccd3e87facac18928469bfa</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444904016427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904016427%26sid%3Dliteratum%253Aachs%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DRoversi%26aufirst%3DP.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DLea%26aufirst%3DS.%2BM.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DRefinement%2520of%2520severely%2520incomplete%2520structures%2520with%2520maximum%2520likelihood%2520in%2520BUSTER-TNT%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2210%26epage%3D2221%26doi%3D10.1107%2FS0907444904016427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgs0T-Du1vapg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5','PDB','5KQ5'); return false;">PDB: 5KQ5</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i33"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00807">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40710"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00807">10.1021/acs.jmedchem.8b00807</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional experimental information for: Procedure for plasma protein binding, mass spectra of <b>1</b>–<b>3</b> and M1–M3, comparative HPLC-UV chromatograms and mass spectra for the biochemical and synthetic acyl glucuronides M1–M3, COSY NMR spectra of M1–M3, comparative HSQC NMR spectra of biochemical and synthetic acyl glucuronides M1–M3, degradation kinetics of M1–M3 in deuteriated phosphate buffer (pH 7.4), inhibition of de novo lipogenesis, X-ray data collection and refinement statistics, crystallization and refinement methods (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_001.pdf">jm8b00807_si_001.pdf (1.44 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00807/suppl_file/jm8b00807_si_002.csv">jm8b00807_si_002.csv (0.74 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structure coordinates for compounds M1, M2, and M3 will be deposited to the RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00807&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-16%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00807%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00807" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b9ab5d0fd1b3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
